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ABSTRACT 
The cellular degradation of the I ow dens i t y I ipoprotein 
CLDL) receptor, and its ligand, LDL, were investigated in 
order to clarify certain mechanistic aspects of these 
important processes. 
Long-term lymphoblastoid c e I I I i n es and cu I tu red human s k i n 
fibroblasts were used to examine the fate of 1 a a 1,- L D L 
subsequent to its uptake via receptor-mediated endocytosis. 
In both cases, binding activity was saturab I e, depended on 
the presence of calcium ions in the medium, and was 
calculated to have an equilibrium dissociation constant at 
4 " C o f 2 µg 126 1-LDL/ml. No high-affinity binding was 
detected when the I igand was modified by acetylation. After 
incubating the monolayers at 37°c, LDL/LDL receptor 
complexes were internalized, and the receptors were recycled 









LDL particles was largely degraded to the 
chloroquine, a lysosomotropic agent, 
formation of the 126 1 -LDL degradation 
Cel Is obtained from a number of heterozygous and 
f am i I i a I hypercholesterolemic as 
expected, bound markedly reduced amounts of 
patients, 
I i g and. The 
been half-life of 125 1-LDL was measured after i t had 
i n t rod u c e d i n to cu I t u red f i bro b I as t s by one of the f o I I ow i n g 
processes: Ci) uptake via receptor-mediated endocytosis in 
human skin fibroblasts with normal LDL receptors, or Ci i) 
incorporation via scrape-loading into fibroblasts defective 
3 
in LDL receptor content. The half-lives obtained were about 
1 hour and 50 hours, respectively, indic~ting that efficient 
degradation of LDL occurred only when it · was de Ii vered to 
lysosomes via receptor-mediated endocytosis. 
A pulse-chase procedure using [35SJ-methionine, and 
the involving specific i mm u n o i s o I a t i o n , was used f o r 
accurate quant itation of radioactive LDL receptors. Using 
this protocol, the half-life of labeled LDL receptors on 
normal fibroblast monolayers was shown to be 11.7 + 2.2 
hours Cn=10), irrespective of the status of the cells with 
respect to prior up- or downregulation of the receptors. 
The presence of LDL or 25-hydroxycholesterol in the culture 
medium also did not affect the half-lives of the receptors. 
Asimilar half-life was. obtained using an internalization-
defective fibroblast 
receptor clustering 
Ce I I I i ne 
in coated 
CGM 2408A), indicating that 
pits and receptor recyc Ii ng 
are not prerequisites for receptor degradation. LDL 
receptor turnover was not a I tered by the prior removal of 
terminal sialic acid residues from the receptors as wel as 
other plasma membrane glycoproteins. Degradation was 




of leupeptin in the chase-
occurred when the cells were 
incubated at 18°C, albeit at a slower rate than was the case 
at 37°C . The latter two results strongly indicate that the 











by stopping the synthesis of a short-lived 




ammonium chloride a I appeared to produce 






In the case 
in int race I lular 
increase in the receptor 
of mo n ens i n , the i n c re as e d 
rate of degradation was partially inhibited by leupeptin. 
F r om t h i s , i t can be s u rm i zed th a t the rat e - I i m i t i n g i n i t i a I 
step(s) in 
lysosomal 
LDL receptor degradation are mediated by non-
proteases, wh i I e lysosomal enzymes ~osslbly 
participate in the degradation of the receptors when the 
latter are trapped in endosomes. 
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ABBREVIATIONS ANO SYMBOLS. 
= acetylated LDL 
= apo Ii poprote in B Cor apo Ii poprote in E) 
= asialoglycoprotein 
= maximum binding capacity 
= bovine serum albumin 
= degrees Celsius 
= complementary DNA 
= 3-CC3-cholamidopropyl)dimethylammoniol-
1-propane-sulphonate 
= Chinese hamster ovary 
= counts per minute 
= ·compartment of uncoupling of receptor 
and I igand . 
= Dulbecco's modification of Eagle's 
Minimum Essential Medium. 
= medium containing LPOS instead of fetal 
ca I f serum. 
= disintegrations per minute 
= ethylenediamine tetracetic acid 
= epidermal growth factor 
= ethyleneglycol-bis-Caminoethyl ether)-
N,N,N' ,N'-tetracetic acid 
= MEM without L-methionine & L-glutamine 
& with 2 g/1 sodium bicarbonate 
= endoplasmic reticulum 
= f e ta I ca I f s e r um 
= Familial hypercholesterolemia 
= acceleration due to gravity Cal 
given are for Qav) 





HIFCS = heat-inactivated fetal calf serum 




















S • D • 
sos 
SOS-PAGE 
t 1 ;' 2 
TCA 
t r i s 
VLDL 
WH H L r a b b i t s 
= hour 
= human skin fibroblasts 
= intermediate density lipoprotein 
= i mm u n o g I o b u I i n G / A / M 
= kilobase 
= kilodalton 
= equilibrium dissociation constant 
= low density lipoprotein 
= I ipoprotein-deficient serum 
= Ea g I e ' s Mi n i ma I Essen t i a I Med i um 
buffered with Earle's salts. 
= medium containing LPDS instead of FCS 
= messenger RNA 
= molecular weight 
= polyacrylamide gel electrophoresis 
= phosphate buffered sat ine 
=PBS+ 0 . 2% albumin 
= phenylmethylsulphonyl fluoride 
= revolutions per minute 
= standard deviation cnc~-x) 2 /(n-1)] 1 " 2 
= sodium dodecyl sulphate 
= sodium dodecyl sulphate polyacrylamide 
gel electrophoresis 
= half-life Cyt =Yin,+ Cyo - Y1n,Je-ktJ 
= trichloroacetic acid 
= trisChydroxymethyl) amino methane 
= very low density I ipoprotein 
= Watanabe heritable hyperlipidemic 
r a b b i t s . 
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Many fundamental advances in biology have been inspired by 
analyses of human genetic diseases (19, 74, 110, 183, 238). 
One such classic example has i nvo I ved the study of the 
disea·se known as Fam i I i a I Hypercholesterolemia CFH), which 
was first described in 1938 by Carl Mu I I er C 166) as a 
disorder that produced . high blood-cholesterol levels and 
myocardial infarctions in young people. About three decades 
later, Khachadurian (124) and 







C 7 3 l 
the 
heterozygous or the homozygous form. The research team 
headed by M.S . Brown and J.L . Goldstein began an extensive 
lJl vitro 
1970's; 
biochemical analysis of this disease in the early 
their studies have lead to the discovery of a cell 
surface receptor for a plasma cholesterol transport protein 
known ' as low density ipoprotein 
generally 
CL DL l, and to the 
elucidation of a pathway, known as receptor-
mediated endocytosis, via which this receptor mediates the 
feedback control of cholesterol synthesis. 
Recently, findings by Dietschy have emphasised the central 
role played by hepatic LDL receptors in most mammals 
(reviewed in reference 59). Circulating levels 0 f LDL-
determined mainly by: Ci ) t.h e rate of L DL cholesterol are 
production, and Ci i) the rate of LDL uptake. Both of these 
events are mediated largely by the I iver. Furthermore, most 
receptor-mediated of the hepatic LDL uptake occurs via 
processes. Alterations in dietry cholesterol input are 
usually adequately compensated for by a I tered hepatic (and 
intestinal) cholesterol synthesis rates, thereby ensuring 
the maintenance of constant circulating plasma cholesterol 
1 2 
I eve Is. However, when the adaptive alterations in 
cholesterol synthesis are unable to compensate adequately 
for the changed cholesterol input, the level of LDL receptor 
activity in the liver may be varied as an additional means 
to restore the normal cholesterol balance. 
1 . 1 Receptor-mediated endocytosis. 
membranes a: re impermeable to ·many Biological 
molecules. Various eel lular processes exist which are able 
to c i r c umv en t this problem - they are termed "endocytosis", 
and may 
ingestion 




"pi no cy to sis 11 (the 
of sma I I the ext race I lular 
environment) or "phagocytosis" C the uptake of large, 
particulate material) 
such processes i s 
proportion to their 
( 6) . 
that 
The significant disadvantage of 
molecules are internalized in 
concentration in the ext race I lular 
en v i r o nme n t . Viewed in t h i s perspective, the value of 
receptor-mediated endocytosis Ct he process whereby eel 
surface proteins - "receptors" - are able to recognize, bind 
with high affinity and internalize specific groups 
than 
of 
25 extra c e I I u I a r mac r omo I e cu I es) , is obvious. More 
different receptors are known to participate in recel?tor-
mediated endocytosis (Table 1.1). 




receptors always move to coated pits 
of the surface membrane containing the 
which then invaginate rapidly into the 
ce I I during endocytos is to form endocytot i c vesicles. 
1 3 
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ce I Is 
A I y sos oma I deg r a -
dation;cholesterol 
retained by eel Is 
hepatocytes B iron retained 















. fetal yolk D 
sac, neonatal 
intestinal 
ce I Is 
lysosomal degra-
dation. Ligand 
also delivered to 
nuclei & golgi 









to basal surface 
of cells where 
lgG is discharged 
• = the pathway fol lowed subsequent to receptor-mediated 
endocytosis, as detailed in section 1.1. 
• • = s mo o t h m u s c .I e c e I I s 
# = asialoglycoproteins 
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although many receptors enter coated 
eg. the even in the absence of igand 
receptors for : LDL 
asialoglycoproteins (24, 
( 1 • 
254), 
1 5) , 
there 
ins u I i n C 1 3 5 ) and 
are some, eg . the 
epidermal growth 
remain diffusely 
factor CEGF) receptor (66, 205), which 
distributed on the eel surface, and only 
become trapped in coated pits once bound to ligand . 
There is substantial evidence to indicate that many endo-
cytot ic receptors can enter cells in the same coated pits, 
and may be delivered to the same acidified endosomes (182, 
252) . Thereat ter, the pathways diverge, and the receptor-
I igand complexes may fol low one of four different routes (as 
discussed below, and i I lust rated in Fig . 1 . 1) . 
Route A: Receptor is recycled, ligand is degraded. 
This pathway was des er i bed originally for the LDL receptor 
in 1974 (83, 84), and has subsequently been shown to be the 
classic route whereby many diverse I igands are endocytosed 
( T a b I e 1 . 1 ) . Upon exposure to the low pH of the endosome, 
an organelle alternately known as "CURL" (the compartment of 
uncoup Ii ng of receptor and igand), the receptor-I igand 
complexes dissociate (30, 98). The Ii gand is transported to 
lysosomes, where i t i s subsequently degraded, whereas the 
receptors are thought to leave the en dos ome in recyc Ii ng 
vesicles originating as tubular endosomal extensions in 
which receptors gather. These extensions probably pinch off 
f r om t he main endosome body, recycle to the eel I surface, 


















-Transcobalamin I I 
Receptor and I igand 
recycled. 
-Transferr in 
- CI ass I MHC mo I e cu I es 
onTcells 








F i g . 1 . 1 : Four pathways of receptor-mediated endocytosls. 
Code: Y= receptor •=ligand 
Adapted from Reference 88. 
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(12) have proposed the existence of an additi
onal pathway 
operational in the LDL receptor system: 
in studies 






fibroblasts CHSF), these 
half the LDL entering 
investigators 





state was subsequent I y discharged 
by a route they termed "retro-
e n d o c y t o s i s " ; the remainder of the endocytosed I igand was 
degraded I y sos oma I I y. 
In route A, receptors may be re-used once every 10 to 20 
minutes Cthe time taken to traverse one endocytotic cycle), 
which means that a single receptor can mediate the uptake of 
many Ii gands during its Ii fespan . If one assumes an average 
receptor half-I ife of 3 0 hours, and a recycling time of 15 
minutes, then such a receptor should (in theory) be able to 




is adequately stable to withstand repeated 
the acidic endosomal environment without 
Conformational changes sufficient to enable 
the release of ligands, but not such that receptors are 
reversibly denatured, must occur within the endosomes. 
Route B: Receptor and ligand are recycled. 
This pathway was originally described for the transferrin 
receptor C 1 69) , and is c h a r a c t e r i z e d· b y the fact that the 
1 7 
receptor-I igand complex does not dissociate in the endosome. 
Apotransferrin Ca major serum glycoprotein which transports 
iron fr om s i t es of absorpt i on (intestine) and storage 
(liver) to tissue cells C48)], binds iron very tightly to 
form ferrotransferrin, which is the igand for the ce I I 
surface transferrin receptor. At the pH 5 of the endosomes, 




ferrotransferrin, but the 
to the receptor, and is 
recycled to the cell surface. Subsequent exposure to the 
neutral pH of the e x t r a c.e 11 u I a r i n t e r s t i t i a I fluid causes 
the dissociation of receptor and its iron-free I igand (48) . 
Recently, work by other investigators has suggested that 
this type of recyc Ii ng pathway may provide the mechanism 
1 8 
whereby cells of the immune system process and p .resent · 
antigen to effector eel Is (for review, see 184}. 
Route C: Receptor and I igand are degraded. 
This pathway, characterized originally for the EGF receptor, 
involves the degradation of both components of the receptor-







It is likely that dissociation of the complex is 
event, since EGF is known to dissociate from 
at low pH (60) . The majority of the 
but 
EGF 
not recycle to the ce I I surface, are 
the lysosomes and degraded there. This 
provides for an effective I igand-induced 
downregulation of receptors. 
Route 0: Receptor and I igand are transported. 
This routing 
receptor that 
has been described in greatest detai for the 
carries polymeric · immunoglobulin A ClgA) and 
immunoglobul in M ClgM) across epi the I ial surfaces, e g . 
across liver cells for excretion into the bile (222). 
of four known pathways for the routing of The operation 





indicative of the 





receptors. Furthermore, within each pathway, there occurs 
the continuous and precise movement of the membrane-embedded 
r e c e pt or pro t e i n s f r om one organ e I I e to the n ex t , as we I I as 
the segregation from neighbouring membrane proteins that do 
not f o I I ow 
sorting and 
the same route, at each stage. Accuracy in such 
targeting events is essential to this end, 
fun ct i ona I 
sequential 
each receptor probably comprises multiple 
domains, and regions which faci itate the 
interact ion with other macromolecules, to enable successive 
transport to various intracellular S i t 8 S . In those cases 
where receptors are normally recycled, there must exist some 
additional mechanismCsJ capable of partitioning the 
receptors into a recycling route normally, and a degradation 
pathway event u a I I y . 
The physiologically important LDL receptors, which bind 
cholesterol-carrying LDL particles, are recycling receptors, 
whose structure has been well elucidated Csee section 
1 . 2. 4 J • 
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1.2 The LDL receptor, 
1. 2. 1 LDL receptor purification and cDNA cloning a 
historical perspective. 
Un t i I recently, LDL receptor had been studied 
extensively in 
the 
intact ce I Is and isolated membranes by 
biochemical, genetic and ultrastructural techniques (2, 82 
In 1979, Schneider and 85), but i t had not been purified. 
~ Al. (208) solubi I ized the LDL receptor from bovine adrenal 
cortex membranes using the nonionic detergent octylglucoside 
(the bovine adrenal cortex is an organ that contains a 
relative abundance of LDL receptors - about 1x10 6 molecules 
per eel -I - see Section 2, Table 2.3 for comparative receptor 
numbers in two other cell types). Using a solid-phase 
assay, they were able to show that the solubi I ized receptors 
exhibited normal 1 as 1 -LD-L binding characteristics (208). 
The fol"lowing year, these investigators partially purified 
the LDL receptor protein using, sequentially, DEAE-cellulose 
chromatography, agarose gel fi I tration and phosphatidyl-
cho Ii ne-acetone precipitation (211), to achieve a 350-fold 
purification relative to the activity of the starting 
material . This preparation was injected into rabbits, and a 
polyclonal antibody to the LDL receptor was isolated (21). 
Studies with these antibodies showed that there was 
i mm u n o I o g i c c r o s s - r e a c t i v i t y of L DL receptors from bovine 
adrenal cortex, human fibroblasts, canine I iver and adrenal 




an i ma I spec i es 
structure had 
and tissues 
been widely conserved among 
( 2 1) . In 1982, Schneider .11.1. tl 
described the procedure for the complete purification of the 
LDL receptor 
this entailed 
from bovine adrenal cortex membranes (209) -
the procedures described above, fol lowed by 
a ff i n i t y chromatography on LDL coupled to Sepharose 48, and 
elution of the receptor with suramin Can inhibitor of 
LOL/LOL receptor interactions). The purified receptor 
retained all of the binding properties of the LDL receptor 
of intact eel Is and crude membranes. Monoclonal antibodies 
against the LOL receptor (designated "lgG-C7") were prepared 
as described (23), and were used to fo 11 ow the LDL receptor 
processing (see section 1.2.2). 
In 1983, 
to the 
Russell tl tl (199) used the polyclonal antibodies 
LOL receptor to enrich for the rare LOL recep _tor 
messenger RNA CmRNA) by p o I y s om e i mm u n e purification. · A 
complementary ONA 
purified mRNA; 
CcONA) I ibrary was constructed fr om the 
this was screened with two families of 
oligonucleotides derived from the amino acid sequence of a 
cyanogen bromide fragment of the bovine protein. 
U I t i ma t e I y , t hes e me t hods en ab I e d the i so I at i on of a par t i a I 
cDNA for the bovine LOL receptor (199). This was then used 
• as a probe to isolate a fragment of the human LOL receptor 
gene, and, in turn, an exon probe from this genomic fragment 
was employed 
complete 5.3 
to isolate a cONA clone which represented the 
kilobase Ckb) human LDL receptor mRNA (260). 
Yamamoto tl ~ (260) t rans f e ct e d s i mi an COS c e I I s w i th t he 
human LDL receptor cDNA I inked to the SV 40 early promotor, 
and were able to demonstrate the expression of functional 
21 
ce I I surface receptors. These investigators used the 
oligonucleotide sequence of this cDNA to derive the complete 
amino acid sequence of the human LDL receptor (260). 
These tools - Vi Z. antibodies directed against the LDL 
receptor, and the receptor cDNA - were used to examine the 
synthesis, 
protein . 
processing and structure of this important 
1.2.2 LPL receptor synthesis and processing . 
The LDL receptor is synthesised in the rough endoplasmic 
r e t i cu I um CE R) as a precursor (243) containing high-mannose 
N-1 inked carbohydrate chains and the core sugar of the 0-
linked chains 
occur either 
C 4 6 ) . Addition of the 0-1 inked sugars must 
in the ER, or in a transitional zone between 
the ER and the golgi apparatus, because these sugars are 
added before the mannose residues of the N-1 inked chains are 
golgi event). t r i mme d Ca 
subjected to sodium dodecyl 




The immature receptor, 
sulphate-polyacrylamide 
migrates as a sing I e 





120 kilodalton Ckd) (243). Toi leshaug tl tl (243), using a 
monoclonal antibody directed against the LDL receptor to 




that within 30 minutes after synthesis, the 
of the receptors increases from 120 to 160 kd . 
coincides with the elongation of each of the 18 
0-linked chains Cby the addition of one galactose and one or 
22 
two sialic acid residues), and the conversion of the t WO 
as pa rag i ne-1 inked CN-1 inked) high-mannose o Ii gosacchar i de 
chains to the complex endoglycosidase H-resistant form (46). 
The apparent 40 kd increase in mwt is mainly due to a change 
in conformation of the protein as a result of the elongation 
of the clustered 0-1 inked sugars (46, 49) . 
Approximately 45 minutes after synthesis, LDL receptors 
appear on the cell surface, where they gather in coated 
pi ts; binding of either of the two I igand types for which 
specific may occur (section 1.2.3) . Irrespective they are 
of whether or not ligand binding has occurred, the coated 
pits invaginate to form coated endocytic vesicles within 3-5 
minutes of t he i r format i on , and the process of receptor-
med i at e d end o c y to s i s takes p I ace as des c r i bed i n sect i on 1 . 1 
(route A). 
1.2.3 Nature of the I igandCs) for the LPL receptor. 




the external, amino-terminal portion 
can potentially bind either ( i ) 4 
apol ipoprotein B Capo 8) molecules located on separate LDL 
particles, with an equilibrium dissociation constant CKol of 
about 3x10-e M (77), or Ci i) 4 molecules of apol ipoprotein E 
Capo E), a I I probably located on a sing I e I ipoprotein 
particle, with a Ko of approximately 10-1° M C149) . Many 
investigators refer to the LDL receptor as the "apo B-100,E" 
receptor, for reasons which are obvious from Ci) and Ci i). 
(In all the experimental work reported in this thesis, LDL 
23 
24 
was used as the source of I igand for the LDL receptor, hence 
the term "ligand" used with respect to the LDL receptor, 
refers in every case to the apo 8 containing LDL particles). 
Apo E is an arginine-rich 33 kd protein, which may be 
associated with a variety of particles including, mainly, 
chylomicrons, very low density lipoproteins CVLDL) and 
certain species of high density ipoproteins CHOL) . Hu i tl 
tl (109) have defined , the i mi t ed amino acid sequence 
responsible for apo E binding, partly on the basis of human 
mutations affecting 
of apo E contains 
binding to the LDL receptor. 
clustered positive charges, 
This part 
which i s 
indicative of the important role of electrostatic 
interactions in the strength and specificity of this ligand-
receptor interaction Ct he putative LDL receptor binding 
domain contains clustered negative charges; section 1.2.4). 
Apo B is a protein which is known to exist as one of at 
I east two isoforms; these are commonly known as apo B-100 
and apo B-48. Apo 8-100 is the only isoform present in LDL, 
and is the natural igand for the LDL receptor (apart from 
apo E); 
the past 
apo 8-48 does not bind to the LDL receptor. For 
20 years, less than 5% of the apo B-100 sequence 
was known, despite the efforts of many investigators working 
i n th i s f i e I d . Recently, however, two independent research 
teams have pub I ished the sequence of apo B-100 - one of the 
prate ins yet known. Knott tl tl (129) largest monomeric 
used over I app i ng cDNAs, isolated from liver and Hep G2 cDNA 
libraries, to determine the complete 4536 amino acid 
sequence of the human apo B-100 precursor Cmwt 5 1 4 k d). 
Numerous lipid-binding stru<:tures were found 





probably essential to the functioning of this protein in 
I ipoprotein assembly and plasma I ipoprotein i n t e g r i t y . 
There are two basic amino acid sequences (residues 3147-3157 
and 3359-3367); the second of these bears some similarity 
to the receptor binding domain of apo E (residues 142-150) -
the consensus being Arg-X-X-Arg-Lys-Arg-X-X-Arg/Lys. Yang 
.!Ll.. ..2..l (263) deduced the complete primary amino acid sequence 
of human apo B-100 by sequence analysis of apo B-100 tryptic 
peptides and overlapping partial cDNA clones. They mapped 
the non-random d i s t r i b u t i o n of trypsin-accessible and 
inaccessible peptides, and on the basis of their results, 
were able to d i vide apo B-100 into 5 hypothetical domains in 
terms of the clustering of trypsin-accessible peptides. 
These investigators also defined a putative LDL receptor 
b i n d i n g d oma i n of th i s I i g and by ch em i ca I I y syn the s i s i n g the 
region corresponding to residues 3345-3381 of their 
sequence; the synthetic peptides could mediate binding and 




This sequence corresponds, 
of the two basic amino acid 
sequences reported by Knott JU. AL (129). 
1. 2. 4 The five structural domains of the LDL receptor. 
An examination of the structure of the LDL receptor 
CFig. 1.2), 
the possible 
is of value since it yields some insight into 
signals which direct the highly selective 




















Fig. 1.2: Structure of the normal human LDL receptor . 
Each dot denotes the position of one cyste i ne residue . 
Numbers represent the seven amino-terminal I igand binding 
domains . 
Adapted from Reference 144 . 
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There is a hydrophobic sequence of 21 amino acids at the 
extreme NHa-terminus of the LDL receptor; this is cleaved 
off immediately after translation, and functions as a 
classic signal domain to· direct the receptor-synthesising 
ribosomes to the ER membrane . The mature receptor (minus 
the signal domain) consists of 839 amino acids (260) . 




comprises the NHa-terminal 292 amino acids, and 
a sequence 
with some 
of 40 amino acids that is repeated 
variation. Studies performed on 
intact cells with anti-peptide antibodies revealed that this 
domain i s located on the external surface of the plasma 
membrane (212). Each of the seven repeat sequences contains 
six cysteine residues, which are in register for al I of the 
repeats. I t i s likely that a II of these cysteines are 
disulphide-bonded, since the receptor cannot be labeled with 
[ 3 HJ-iodoacetamide without prior reduction C 88). This 
region of the receptor must therefore exist in 
accounts 
a tightly 
cross-I inked, convoluted s t a t e , which for 
extreme stabi ity of the receptot-binding domain 
the 
the 
st i II receptor can be boiled i n strong denaturants yet 




C 8 8) • A noticable feature of each cysteine-
sequence, is a cluster of negatively charged 
The near the COOH-terminus of each (228). 
charges on these sequences are complementary to a cluster of 
positively charged residues (representing the binding site 
to the LDL receptor), in apo E (section 1 . 2.3 and references 
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1 1 1 & 149). Goldstein~~ (88), have speculated that the 
negatively charged clusters of amino acids within the 
cys te i ne-r i ch repeat sequences of the LDL receptor 
constitute multiple binding sites, . each capable of binding a 
single apo E molecule by attaching to its positively charged 
alpha-he I ix . 
Domain 2: Homology with the EGF precursor. 
The second domain of the LDL receptor consists of about 400 
amino acids, and is approximately 35% homologous to a 
portion of the extracellular domain of the EGF precursor 
(198, 230, 260). 
repeat sequences 
There are three cysteine-rich amino acid 
in this domain (represented as A, B, and C 
some i n s i g ht as to the f u n ct i on of 
the second LDL receptor domain, Davis ~ ~ (50) have 
recently used ollgonucleotide directed mutagenesis to delete 
the sequences encoding the 400 amino acids that comprise the 
EGF precursor homology region. The deletion-bearing plasmid 
was transfected into a I ine of mutagenized Chinese hamster 
ovary C CHO) cells that did not produce LDL receptors, and 
the.cells which subsequently expressed high levels of the 
transfected receptor cDNA were used for analyses. Results 
obtained by these investigators demonstrated at least three 
functions for the EGF precursor homology region in the LDL 
receptor: C i ) i t is necessary for the binding of LDL, bu! 
not of beta-VLOL, to intact cells; Cii) it is needed for 
acid-dependent dissociation of beta-VLDL and C i i i ) i t s 
presence is needed for the receptor to participate in 
repeated recycling without degradation. The deleted LDL 
receptor performed many of its functions normally - such as 
28 
the processing and maturation of 0- I i n k e d sugars - des pi t e 
of the entire precursor region the removal 
about half the protein). Furthermore, the 
(representing 
protein was 
obviously not denatured, since it remained able to reach the 
eel I surface and bind to 128 1-labeled beta-VLDL, with normal 
kinetics . 
Domain 3: 0-1 inked sugars. 
The third domain of the LDL receptor ies immediately 
external to the membrane-spanning domain; 
58 amino acid sequence, 1 8 of which are 
it consists of a 
either serine or 
threonine residues (228, 260). The entire domain is encoded 
by a single exon, and proteo!ysis studies have revealed that 
this region 
by 0-1 i nkage 
contains clustered carbohydrate chains attached 
(46, 198); each 0-linked sugar chain consists 
of a core N-acetylgalactosamine, a single galactose and one 
or two sialic acid residues. Davis Jl.1 ~ C49) deleted this 
domain fr om the cDNA for the human LDL receptor, and 
transfected the deleted cDNA into receptor-deficient hamster 
fibroblasts. Using th i S system, they were able to 
demonstrate conclusively that Ci) the serine- and threonine-
rich region of the LDL receptor is the site for addition of 
clustered 0-linked carbohydrates Ci i) the receptor contains 
a sma I I number of isolated chains of 0-1 inked carbohydrates 
in addition to the clustered chains; these are located in 
the NHa-terminal portion of the protein Ci ii) the clustered 
0-1 inked carbohydrates are not essential for normal 
receptor function in cultured hamster fibroblasts (49). 
LDL 
To 
date, the precise function of th i S domain remains 
speculative - perhaps the clustered 0-linked sugars merely 
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serve as struts to keep the receptors extended from the 
membrane surface so that they can bind to their I igands more 
efficiently (88). 
Domain 4: Membrane spanning region. 
This domain consists of a stretch of 22 hydrophobic amino 
acids; proteolysis experiments have confirmed that th i s 
region spans the plasma membrane (198, 260). Comparison of 






7 of the 
human and 
of the bovine and h urna n LDL 
this domain is relatively poorly 
22 amino acids in this region 
cow, but al of the substitutions 
are also hydrophobic in character. 
Domain 5: Cytoplasmic tai I. 





of a COCH-terminal segment of 50 
into the cytoplasm (198, 260). 
conserved among species: only 4 
of the 50 amino acids differ between human and cow, and each 
of these substitutions is conservative with respect to the 
The cytoplasmic domain of the LDL amino acid charge (88). 













clathrin on the cytoplasmic side of the membrane (30, 82). 
Evidence for this is obtained from the molecular analysis of 
mutations at the LDL receptor locus which produce receptors 
capable of binding LDL normally, but which do not cluster in 
coated pits, and are not internalized. These mutations, 
30 
which also al I produce defects in the cytoplasmic tai I, are 
discussed in section 1 . 3.2 . 
1.2.5 A comparison with other receptors. 
The structure and transmembrane orientation of the LDL 
receptor is compared with that of f i Ve other we I I 
characterized coated pit receptors in Table 1 . 2 . Compa r ison 
obviously of the amino acid sequences has yielded no 
conserved featureCs) . 
1.2.6 The LDL receptor at a genetic level. 
mRNA structure. 
The human LDL receptor mRNA appears as a single species of 
5 . 3 kb on Northern blots (reviewed in approximately 
reference 88), 
3·' u n t r ans I a t e d 
2.5 kb of which comprises an unusua 11 y I ong 
region . A remarkable feature of th i s 
untranslated region is the presence of 2 1 /2 RNA copies, 








generally occur once in every 
genome (section 1.3 . 3 and reference 
The human LDL receptor gene, located on chromosome 19, spans 
more than 45 kb, and comprises 1 8 axons which show a 
s t r i k i n g correlation to the functional domains 0 f the 
3 1 
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Table 1.2: A comparison of the structure of the LDL 
receptor with 5 other receptors that enter coated pita. 
Each protein spans the plasma membrane once. 
Receptors for .... 
Parameter LDL In su I in Trans- ASGP EGF lgA 
ferrin lgM 
No. of amino acids 839 1343 760 283 1186 755 
i n mature receptor 
No. of polypeptide 2 2 
chains 
NHa terminal end i s .. E• E I .... E E 
No. of amino acids in 50 402 6 1 38 542 105 
cytoplasmic portion 
No. of potential s i t es 5 34 6 3 1 2 2 
for attachment of N-
I inked ol igosaccharide 
chains. 
Presence of clustered yes no no no no no 
0-linked sugars 
Cysteine-rich regions y e-s yes no no yes no 
Tyrosine kinase activity no yes no no yes no 
"= extracellular ""=intracellular 
Adapted from reference 88. 
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protein (Fig. 1. 3). Other noticable features of this gene 
include: 
produce a 
Ci) a multiple duplication 
binding domain containing 
of a 
seven 
single exon to 
repeats of a 
single 40-amino acid sequence (section 1.2.4, and references 
34 & 88 for comprehensive reviews), and Ci i) a large 3, 
untranslated region of 2. 5 kb (encoded for by exon 1 8 ) , 
which includes several copies of a repetetive sequence of 
the Alu family. 
1 . 3 Naturally occurring genetic defects in the LDL 
receptor. 
Many n at u r a I I y occurring mutations in the LDL receptor gene 
are known to exist; such mutations disrupt receptor 
functioning in various ways. Individuals who inherit one 
mutant LDL receptor gene (heterozygous for FH), produce 
a b o u t 5 0% o f t h e number of normal receptors, so that in. 
vivo, plasma LDL levels are doubled. U I t i mate I y , the 
elevated plasma LDL levels lead to heart attacks by about 40 
years of 
two mutant 
age in the affl icte~ persons. In individuals with 
LDL receptor genes CFH homozygotes), few or no 






levels 8 to 10 times higher than is 
develop atherosclerosis at a very 
and usually die from heart attacks in childhood . 
Many of the apparent FH homozygotes are, in fact, compound 
heterozygotes, who 
from each parent. 
have inherited 
The research 
different mutant alleles 
team headed by M.S. Brown 




EGF precursor homology 
0- linked sugars 

















Fig. 1.3: The normal human LDL receptor - a correlation 
between exon organization and protein domains. 
Arrow heads indicate intron positions. Boxes indic
ate 
exons . The 7 cysteine-rich amino acid repeats in the 
LDL 
receptor binding domain are numbered I to VI I. The 3
 
c y s t e i n e - r i ch repeat s i n the d oma i n t hat i s homo I o go us w i t h
 
the EGF precursor, are lettered A, Band C . 
Adapted from Reference 228. 
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has studied cultured skin fibroblasts obtained from over 100 
FH homozygotes; their results have revealed that the 
mutations can be divided into four broad classes, on the 
basis of their effects on receptor structure and function 
(Table 1 • 3 , and see reference 88 for a comprehensive 
review). 
The analysis of these mutations especially at the 
mo I e cu I a r gene t i c I eve I - has p r o v i de d v a I u ab I e i n s i g h t i n to 
the structure-function relationships of the LDL receptor, 





the receptor-mediated endocytosis 
investigations carried out on the LDL 
receptor mutants are reviewed below, and summarized in Table 
1 . 4 . This review is up-to-date at the t i me of writing 
(June, 1987). I t should be noted, however, that t~is area 
is the subject of intense research at present. With each 
new mutant that is investigated and reported, further 
fascinating insight into this field is gained. 
1. 3. 1 Population groups with increased incidence of FH. 
The prevalence of heterozygous FH appears to be 
approximately 1 in 500 among the general population of most 
countries, while that of the homozygous form of this disease 
in 1 million. However, two population groups are is about 
known to exist in which the frequency of the homozygous 
con d i t i on i s mo r e t ha n 10-fold higher, viz. the Lebanese 
population (124) and the white Afrikaans-speaking South 
Table 1.3: Mutations at the 































1 7 0 
1 1 0 
120 











1 5 5 ) 
LOL receptor locus that 
LDL binding Frequency 
in FH 
patients 

























• = apparent molecular weight Cin kd) on SOS-PAGE . 
I= Precursor 
• • = Watanabe her i tab I e hyper Ii pi demi c rabbi ts (see section 
1 . 3 . 1 ) . 
Adapted from reference 88. 
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Table 1 • 4 : Summary of some naturally occurring and 
constructed mutations in the LDL receptor gene. 
Mutation Desig- Genetic 
yields nation Cause 
insight 
i n to ... 
movement 
of re-
e pt ors 


























in exon 4 




amino acid 660: 










144 base pairs 







of domain 1 
11 s I ow process i n g 11 
of 120 kd to 160 
k d. 





l & 2 
6th repeat of 




of exons 1-8 
400 amino a Cid 
deletion Cdo-
main 2 i s 
removed) 
48 amino acids 
slow processing 
Cas above) 




100 kd to 140 
kd.Binds VLDL 
but not LDL. 
170. kd to 210 
k d. Low LDL 
binding 
72 kd to 125 
kd.VLDL Cb u t 
not LDUbinds 
100 kd to 120 
encoded by exon Normal bind-












FH deletion of 
7 81 7. 8 kb. lntron 
1 5 joined to 
exon 1 8 
FH deletion of 
274 5 kb 
FH single base 
380 sub st i tut ion 
at aa" 807: 
TAT to TGT 
FH 4 base d up I i -
763 cation i n reg-
ion of aa 796 
FH single base 
683 substitution 
at aa 792: 




& 5 missing.55 
Receptor 
Characteristics 
4 155 kd mat-
u r e . >90% 








4 & 5 
5 has 
6 normal, & 8 
additional ,aa 
only 2 aa in 
domain 5 
1 1 0 kd to 150 
kd. Mostly 
secreted. 
120 to 160 kd 
No clustering 
i n pi ts 
1 1 5 to 155 kd 
No clustering 
i n pi ts 
1 1 5 kd to 1 5 5 
kd 
construe- 24 different mutations in domain 5 
ted 
FH 5 kb deletion null 
381 lntron 15 joined phenotype 
to exon 13 
T . D . 
• = amino acid 
exons 13 & 14 
deleted 
Truncated domain 
2 & no domains 
3, 4 & 5 
biosynthe-
tic study 
not yet done 
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African population (43,248). I n both cases, this is 
attributable to a high prevalence of heterozygosity, coupled 
with a high incidence of consanguinity, which increases the 
proportion of homozygotes. The first clear delineation of 
the existence of homozygous FH was done by Khachadur i an 
(124) on studies of the Lebanese population. 
Lehrman~ 1t.L (144) have recently described a mutant LDL 
receptor gene 
a shortened 
(the "Lebanese al lele 11 , FH 264) that produces 
receptor protein lacking three domains: the 
region of clustered 0-linked carbohydrates, th~ membrane-
spanning region, and the cytoplasmic tai I. Using genomic 
cloning techniques, these investigators were able to 
es tab Ii sh that the defect was caused by a single nucleotide 
substitution that creates a premature termination codon at 
amino acid 660, thus eliminating 180 residues from the 
mature protein. The resultant truncated protein retains 
only two domains - a complete I igand-binding region, and a 
partial EGF precursor homology region. After synthesis, 
most of the receptors remained within the eel I for several 
hours in the unprocessed form, which possibly indicates that 
the shortened receptors leave the ER at an abnormally slow 
rate, most I i ke I y due to the abnormal folding of the 
truncated protein. 
Biosynthetic studies have shown that the LDL receptor gene 
mutation existing in the South African population produces a 
120 kd receptor precursor 
s I ow I y to 
molecular 
the mature 160 kd 
basis of t h i s 
that i s processed abnormally 
form (210). To date, the 
novel mutation has not been 
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reported. I t i s of interest to note that there exists a 
s i mi I a r II s I ow process i n g II L D L receptor mu tat i on i n a s t r a i n 
of rabbits designated Watanabe hereditary hyper I i p i demi c 
C WH H L ) r a b b i t s 
sequenced cONAs 
C 2 1 0 ) . Yamamoto~~ (259) have cloned and 
from these and normal rabbits, and have 
shown that this defect a r i s es f r om an i n - f r ame de I et i on of 
12 nucleotides 
cys te i ne-r i ch 
that eliminates four amino acids from the 
igand binding domain of the LDL receptor. 
They also examined one slow-processing patient CFH 563, not 
one of the Afrikaner patients), and found a s i mi I a r sma I I 
deletion in exon 4 of the LDL receptor gene. Such mutations 
do not remove any of the cysteine residues, but probably are 
s u f f i c i e n t t o a I t e r t h e f o I d i n g p a t t e r n o f t h e c y· s t e i n e - r i c h 
region, thereby preventing the formation of proper 
disulphide bonds. It is feasible that such mutant proteins 
may be trapped by detection mechanism~ ("gatekeeper 
proteins") that are specifically designed to prevent the 
movement of abnormally folded proteins to the eel surface. 
Such mechanisms might be of crucial biological importance 
since the surface appearance and/or secretion of even a few 
denatured molecules may produce harmful immune re~ponses. 
1. 3. 2 I n tern a I i z at i on-defect i v e mu ta t i on & • 
The importance of coated 
endocytosis was originally 
mutations at the cellular 
pi ts 
revealed 




study of these 
Lehrman tl tl 
(145) characterized a mutation in the structural gene for a 
patient - designated FH 274 - who possessed a (maternally 
40 
inherited) internalization-defective mutation for the LDL 
receptor Cand a paternal nul a I I e I e) . A comparison of the 
nucleotide sequences of the normal and FH 274 genes showed 
the presence of a 5 kb deletion, which eliminated the exons 
encoding the membrane-spanning and the carboxyl terminal 
cytoplasmJc receptor domains. lntrastrand recombination 
between two r e p e t i t i v e seq u en c es o f t he A I u f am i I y C sec t i on 
1.3.3), appeared to be the cause of the deletion. The 
truncated receptors lacked 
cytoplasmic regions, and were 
culture medium. 
remaining adherant 
The sma I I 
to the eel 




secreted into the 
of t h e. r e c e p t o r s 




to cluster in coated pi ts. 
of 
These studies 
receptor the f i rs t elucidation an LDL 
a mo I e cu I a r I eve I , and t he r es u I t s , among o t her 
things, were indicative of a putative role of 
clathrin/clathrin-associated 
receptor internalization. 
cytoplasmic proteins i n 
The splicing pattern of the 
dele·ted mRNA, and the precise COOH terminus of the protein 
have not yet been identified. [Three other LDL receptor 
mutations have recently been described, al I of which involve 
intra-strand recombinations between the Alu sequences; 
these are detailed in 1.3.3 Ca)]. 
The same research group subsequently isolated the segment of 
the LDL receptor gene encoding the COCH-terminal cytoplasmic 
domain from the eel Is of two other individuals with the same 
internal lzation-defective phenotype C 1 4 0 ) . Their findings 
showed that one mutant gene (from patient FH 683), contained 
a single base subs ti tut ion which changed a tryptophan codon 
4 1 
CTGG) to a terml nation codon C TGA) ; th i 8 produced a 
receptor with only 2 amino acids in the cytoplasmic domain. 
The other mutant gene, from patient FH 763, was found to 
contain a four-base duplication, which produced a frameshift 
that altered the reading frame; six of the nor ma I am i no 
acids and eight additional amino acids were found in the 
cytoplasmic tai of the LDL receptor encoded by this gene. 
Both of the mutations 
internalization-defective 









regions. These findings supported the hypothesis that the 
cytoplasmic domain 
receptors. 
is required for the clustering of LDL 
In 1986, these investigators reported on the nature of the 
LDL receptor mutation existing in patient J.D.CFH 380) (the 
internalization-defective phenotype was first documented in 
fibroblasts from th i s individual) C 5 1 ) . DNA sequence 
analysis revealed the substitution of a tyrosine codon for a 
cysteine codon at residue 807 in the cytoplasmic domain of 
the receptor. These researchers used ol igonucleotide-
directed . mutagenesis to produce the J . D . mu ta t i on i n a f u I I 
length cDNA for the normal LDL receptor that could be 
transfected and expressed in eel cultures, 
able to demonstrate conclusively that such 
and thus were 
a substitution 
was sufficient to produce the internalization-defective 
phenotype. 
effect of 
In addition, they showed Ci) that the disruptive 
the substitution was not due to the loss of the 
hydroxyl group of the tyrosine because .the substitution of a 
phenylalanine at t h i s position did not affect 
42 
internalization and Cii) that the defect was not due 





naturally occurring cysteine at 8 1 8, s i n c e 
replacement of the latter cysteine with alanine affected 
neither the internalization of the normal receptor nor the 
block in internalization produced by the cysteine 807 
substitution. They concluded that this cys 807 mu tat ion 
probably produces 
the cytoplasmic 
an altered three-dimensional structure of 
tai I, thereby preventing these receptors 
from binding to the proteins which would normally link them 
to coated pits. 
Very recently, the structural features in the cytoplasmic 
domain of LDL receptors which are required for the targeting 
of the receptors to coated p i ts ' were determined C 5 2 ) . 
Twenty-four mutations i n th i s domain were produced by 
o Ii gonuc I eot i de-directed mutagenes is. Biochemical analyses 
of these showed that the f i r s t 22 amino acids of the 
cytoplasmic domain (residues 790-811) are sufficient f o r 





critical. Aromatic residues 
tryptophan. ) at this position 
C t y r o s i n e , 
a I I ow rap i d 
with charged or uncharged aliphatic 
unable to substitute. Such specificities 
indicate that the region of the cytoplasmic domain which is 
adjacent to the plasma membrane may participate in protein-
protein interactions that faci I itate LDL receptor clustering 
in coated pi ts. Another striking finding was that none of 
the mutations (either produced in this study, or as observed 
previously in FH patients) interfered with the recycling of 
43 
the LDL receptors; it would seem that al I forms of the LDL 
receptor that enter coated pits, are also recycled. 
1. 3. 3 Mutations involving recombinations between Alu 
feguences. 
The human genome contains repetetive DNA sequences, known as 
"Alu sequences" . On average, these occur once i n every 
5 000 bp in the human genome; th~y are present frequently 
i n i n t er v en i n g sequences , and are removed by s p I i c i n g du r i n g 
mRNA processing (218) . Alu sequences are approximately 300 
b p in length, and consist of two head-to-tai I repeats, 
r e fer red to as the I e f t and r i g ht monomer i c u n i t s C 5 7) ; t he 
right monomeric uni t i s longer than the left unit due to a 
30 bp insertion. Sequence analysis has revealed that the 
Alu repeats have many of the characteristics of transposable 
elements and pseudogenes (218). In addition, they are often 
flanked by direct repeats, and have A-rich sequences at 
their 3' ends . 
Ca) Intra-strand recombinations. 
Lehrman .!Ll.. 1!.J.. (142) have reported the molecular basis of a 
deletion that produces a nul phenotype at the LDL receptor 
locus, using the mutant null allele from a patient known as 
FH 381 Cthe mother of J.0.) . This mutation is produced as 
the result of a 5 kb deletion: the Alu sequence in intron 
15 has been joined to an upstream sequence in exon 1 3 
The Ci nstead of recombining with a downstream sequence). 
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stretch of complementarity between the Alu unexpected 
sequence and 
for ma t i on of 
the coding sequence in exon 13 faci I itates the 
a double stem-loop structure. Similar double 
stem-loop structures can be drawn for other known deletions, 
e9i. the deletion in the beta-globin gene cluster. This 
raises the possibility that such structures may predispose 
to large deletions in the human genome. 
A mutant allele at the LDL receptor locus, bearing a 
deletion of one of the seven repeats, CFH 626), has been 
described by Hobbs~ lLl. (104). Molecular cloning was used 
to show that homologous recombination between repetetive Alu 
sequences in intron 4 and intron 5 of the gene produced a 
deletion which removed exon 5 (which norma 11 y encodes for 
the sixth repeat of the igand binding domain). The 
resultant mRNA 
preserving the 
in which exon 4 is spliced to exon 6, thus 
reading frame - produced a shortened protein 
that reached the eel I surface and reacted with anti-receptor 
antibodies, but did pot bind LDL (this igand contains only 
a I ipoprotein type apo B-100: section 1.2.3). Beta-VLDL, 
that contains both apo E and apo B-100, was st i 11 able to 
Such data indicate that the bind to the deleted protein. 
sixth repeat is required for LDL binding but not for that of 
beta-VLDL. In addition, these data support the hypothesis 
that the seven repeated sequences in the receptor constitute 
the LDL receptor binding domain. 
Genomic cloning and DNA · sequencing techniques have recent I y 
been used to identify the nature of the LDL receptor gene 
mutation in a Japanese FH homozygote patient CFH 781) (143). 
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Recomb i nation between the Alu elements in intron 15 and exon 
1 8 o f the LDL 
joins intron 
receptor gene have produced a delet i on which 
15 to the middle of exon 18 (this exon encodes 
t h e 3 • 
the 3' 
untranslated region) CFig . 1.4A), 
sp Ii ce acceptor sites di st a I t 0 
truncated receptor is thus formed, which 
membrane-spanning region and cytoplasm i c 
thus removing al I 
intron 1 5 . A 
lacks the normal 
domain, and which 
has 55 abnormal amino acids at its COOH terminus . More than 
90% of these receptors are secreted from the eel Is; those 
remain i ng on the surface show defective internal i zation, as 
has been previously reported C 165, 2 32) . The mechanism(s) 
by wh i ch some of these receptors remain attached to the eel I 
surface is, as yet, unknown . 
To date, 
originate 
four different mutant LDL receptor genes, which 
from intra-strand recombinat i on between Alu 
sequences, have been identif i ed (as reviewed above, and as 
s u mm a r i z e d i n Fig. 1.4A). A total of seven Alu sequences 
are involved in these deletions Ci I lustrated in F i g . 1 . 48). 
The breakpoints are apparently not randomly located - six of 
the seven occur in the left arm, in the region between the A 
and B sequences that are homologous to the internal 
promoters found in genes transcribed by RNA polymerase I I I 
(181) . I t i s wo r t h not i n g that Alu sequences are a Is o 
apparently involved in four deletions of the glob i n gene 
complex CF i g . 1 . 4 B) ; three of the four breakpoints have 
been shown t 0 occur in the I e f t arm, and two of these are 
found between the A and B sequences C 100 , 1 1 4 , 177, 2 5 0) . 
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F i g . 1 . 4 : CA) Intra-strand deletions involving Alu 
sequences in the LDL receptor gene. 
Portions of the LDL receptor gene are sh own schema t i ca I I y, 
with exons, introns and Alu repeats represented by closed, 
~ and striped segments, respectively. The horizontal 
arrows indicate the four deletions described in sections 
1 . 3. 2 and 1. 3. 3 Ca) . 
CB) : Clustering of Cintra-strand) deletion endpoints within 
the consensus Alu repeat for mutations in the human LDL 
receptor and the globin genes. 
A consensus Alu repeat (57) is drawn with left and right 
3• 
arms indicated. The locations of nine deletion joints are 
noted, and the direction of each deletion is indicated by 
closed Cglobin deletions) o r Q...QJ!.!1. C L D L receptor 
deletions) arrowheads. Regions of the Alu repeat that 
correspond to the A and B sequences of RNA polymerase I I I 
promoters (181) are shown by the solid bars. 
Adapted from reference 143. 
most of the deletion breakpoints to occur between the A and 
B sequences 
receptor gene 
of the left arm Cin the cases of the LDL 
and the globin gene complex), may indicate 
that these sequences are unwound/bent during transcription 




in so doing, the potential for recombination 
These data suggest that genetic delelions may 
caused by Alu sequence recombinations 
Ca I though i t i s kn own th a t th i s i s not a I ways the case , Ce g . 
175)]. Further molecular genetic analysis of the large 
number of mutations at the LDL receptor locus should clarify 
t h i s . 
Cb) Inter-strand recombinations. 
Evidence to support a model in which homologous 
recombination between Alu repetetive sequences in intrans 
leads to exon duplication during the evolution of proteins, 
is provided by the molecular analysis of a subject CFH 295) 
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with an unusual LDL receptor · gene defect. Lehrman tl tl 
C 1 4 1 ) have es tab I i shed t ha t t he ab nor ma I I y I on g L D L r e c e pt or 
precursor (170 kd instead of 120 k d) produced by this 
defective gene, resu I ted from a 1 4 kb duplication 
2 through t O 8: unequal encompassing axons 
occurred between homologous Alu sequences in 
crossing-over 
intron 1 and 
exon 8, to produce a mutant receptor bearing 18 continuous 
cysteine-rich repeat sequences instead of the normal nine. 
(Seven of the dup Ii cated repeats are derived from the 
I igand-binding domain, and two repeats are part of the EGF 
factor precursor homology region). The apparent mwt of the 
1 7 0 kd precursor increased to 210 kd a f t er normal 
carbohydrate processing. On the eel surface, the receptor 
bound reduced amounts of LDL and underwent inefficient 
internalization and recycling. 
Horsthemke ~ ~ (107) have recently described a mutant LDL 
receptor gene which bears 
obtained from patient T.0.) 
a 4 kb deletion (using ce I Is 
It is thought that the deletion 
a r i s es fr om unequal crossing-over between two Alu sequences 
that are 
other in 
in the same or i en tat i on : one in intron 12, the 
intron 14. The fusion of exons 12 and 15 alters 
the reading 
stop codon. 
frame of the mRNA, thereby creating a premature 




specify a truncated receptor 
100 amino acids of the EGF 
region, as we I as the 0-linked sugar, 
transmembrane and cytoplasmic domains. I mm u n o - a n d I i g a n d -
blot analyses have failed to detect any truncated protein . 
1.4 Experjmentallv Induced mutations in the LPL receptor. 
The power of biochemical-genetics in 





mediated endocytosis - is obvious, but there do exist severe 
restrictions to the genetic analysis using c e I I s derived 
from human patients. For example, the variety of naturally 
occurring human mutations is I imi ted, and these mutations 
must be compatible with the growth and survival of the 
entir·e organism. To 
have been developed to 
c i r c umv en t these prob I ems , tech n i q u es 
i so I ate cu I tu red mamma I i an soma t i c 
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eel I mutants with defects in receptor-mediated endocytosis . 
Krieger and co-investigators have devised two methods for 
isolating mutants with defects in the endocytosis of LDL, 
and a nutritional selection procedure to detect the 









isolated a large 
several revertants of these mutants. 
CHO c e I I mutants , and 
The mutants define at 
least four genetic complementation groups [known as ldl A, 
Id I B, ldl C and Id I D see (134)], which probably 
represent four distinct genes required for normal LDL 
receptor function. 
Studies performed with polyclonal antibodies on the 
of collection of 
multiple forms 




ldl C and ldl 
receptors that 
Id I A mutants, showed the existence 
of the receptor in these mutants, confirming 
locus is the structural gene for the LDL 
(thus the ldl A mutants are analagous to 
from FH 
that the 
patients). FurtheT antibody studies 
LDL receptor deficiencies in ldl B, 
D mutants (which al produce mature LDL 
are abnormally sma I I and heterogeneous in 
size) are associated with general defects in processing N-
linked, 0-linked and lipid-linked carbohydrate chains (126). 
Kingsley tl tl (125) recently used ldl D cells to show that 
0-1 inked chains may be crucial for receptor stabi Ii ty. 
I t is anticipated that the study of such mutants wi I I 
valuable insight into the structure and provide further 
functioning of the LDL receptor - knowledge which has thus 
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far been de r i v e d ma i n I y f r om stud i es of n at u r a I I y occur r i n g 
human mutations. 
1.5 Regulation of eel lular cholesterol homeostasis. 
A I I an i ma I c e I Is require cholesterol as a structural 
componerit of plasma membranes. Cellular cholesterol content 
through the integration of two pathways that is regulated 
govern the supply of exogenous and endogenous ~holesterol, 
both of which are control led by end-product repression (for 
review, see 8 6) . Under conditions of cholesterol 
deprivation, cells synthesise large amounts of mRNA for the 
LDL receptor; the increased expression of this receptor 
faci Ii tates the uptake of exogenous cholesterol by receptor-
mediated endocytosis C 3 2 , 1 9 9 ) . In addition, cells also 
increase their endogenous cholesterol production by 
increasing the amount of mRNA for two sequential enzymes in 
cholesterol biosynthesis, namely 3-hydroxy-3-
(79) and HMG methylglutaryl coenzyme 
CoA reductase (86). 
A CHMG CoA) synthase 
A I I three of these mRNAs are strongly repressed when 
cholesterol accumulates intracel lularly, thereby I i mi t in g 
the uptake and synthesis of this compound C40, 78, 1 9 2 , 
199) . Relatively little is known about the mechanisms of 
feedback suppression of mRNA production in higher eukaryotes 
compared to what is known for prokaryotes. In 1985, Osborne 
~ ~ (176) established that the sequences responsible for 
t he Promo t i on and i n h i b i t i on of t rans c r i p t i on of t he HMG Co A 
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reductase gene are located within 300 bp of the 5' side of 
the transcription initiation sites. Sudhof tl tl (229), 
working on the LOL receptor gene, have recently published 
evidence in support of a model in which a single 42 bp 
element contains a sequence that binds a positive 
transcription factor . It is conceivable that transcription 
is repressed by sterols due to inactivation of this positive 
transcription factor. Alternatively, i t is possible that 
sterols may b i n d to a pro t e i n wh i ch , i n turn , b i n d s to t h i s 
4 2 b p e I eme n t , the re by pre v en t i n g the po s i t i v e t r: ans c r i pt i on 
factor from binding . Kandutsch C118, 
that repression of HMG CoA reductase 
119) has postulated 
could be mediated by 
the binding of i n t race I I u I a r ox y s t er o I me tab o I i t es C such as 
25-hydroxycholesterol or 7-ketocholesterol) to a cytosol ic 
p r o t e i n ; this sterol-protein complex could then inhibit the 
transcription or translation of the HMG CoA reductase gene . 
In support of this mode I, a cytosolic binding protein, 
specific for oxysterols, has been identified (119, 239). 
1.6 Receptor and I iqand degradation. 
The degradative process, or any step which comm i ts a 
receptor to th i s pathway, wo u I d be one of the Io g i ca I s i t es 
at which to regulate receptor level (the absolute level of 
receptor is determined both by its rate of synthesis and its 
rate of degradation). Receptors and I i g ands may , or may 
not, share the same fate after entry into the eel I, and in 
some cases - part i cu I ar I y those where recyc Ii ng occurs - the 
receptors escape the final destiny of the I igands whose 
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uptake they mediate (namely, lysosomal degradation). For 
example, recent studies with the Fa receptor and mannose 
6-phosphate receptor suggest that these proteins are 
deg rad e d i n t r a I y sos oma I I y , toge the r w i th t he i r I i g ands C 162 , 
253), as is the case for the EGF receptor (20, 67). On the 
other hand, various investigators C 1 3 l. 135) , using the 
heavy isotope density-shift method, have shown that i nsulin 
and the insulin receptor traverse different p a .t hwa y s for 
degradation . 
I t has been suggested that igand dissociation from 
internalized receptors, within an acidic vesicle, plays a 
c r i t i ca I r o I e i n a I I ow i n g the receptor to undergo rec y c I i n g , 
perhaps by providing a signal that targets receptors to be 
recycled (30). Recently, Huecksteadt ~ JU (108) have 
published results which are contrary to this 
these investigators covalently attached 
proposal: 
iodinated, 
photoreact i ve i nsu Ii n to insulin receptors on the ce I I 
surface of isolated rat adipocytes, and were able to show 
that such covalently occupied receptors recycled at rates 
comparable to rates observed for native insulin/insulin-
(108) . It would therefore appear that receptor complexes 
the physiological dissociation of insulin from internalized 
receptors may represent an independent event, not casually 
related to the steps governing insulin receptor recycling; 
such processes may a I so be t rue of o t her receptor rec y c I i n g 
systems . 
As an alternate approach to address the problem of receptor 
degradation, Schwartz ~ J!...l (215) examined the fate of the 
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asialoglycoprotein CASGP) receptors on Hep G2 ce I Is 
f o I I ow i n g expos u r e to po I y c I on a I an t i bod i e s d i r e c t e d a g a i n s t 
the receptor. 
eel lular loss 
They showed that the antibody induced a rapid 
of the ASGP receptors; addition of the weak 
base, pr i ma q u i n e , 
protease inhibitors , 
I ysosomal degradation 
blocked th i s I o s s , 
or EC 




of the igand but not the receptors. 
Thus, the pathway and/or mechanism(s) responsible for the 
antibody- i nduced ASGP receptor I ass are apparent I y di st i net 
from the lysosomal I igand breakdown. 
The somewhat 
breakdown has 
complex field of general receptor and I igand 
been comprehensively reviewed by Van der 
Westhuyzen and Coetzee (247) . Other aspects of receptor 
degradation are 
thesis. 
reviewed in Sections Four and Five of this 
1.7 Conclusion . 
The study of the LDL receptor function and metabolism has 
been an exciting and very valuable one in several ways . I t 
has served as a prototype for the elucidation of the process 
of receptor-mediated endocytosis . Analyses of these 
the receptors have provided much insight regarding 
mechanisms by which genes regulate cholesterol metabolism. 
This receptor is of significant clinical importance since 
mutations occurring in the gene for the receptor disrupt the 
regulation of blood 
hypercholesterolemia and 





involved in the uptake and degradation of the I igand, LDL, 
have been characterized, and the accompanying regulation of 
c e I I u I a r ch o I ester o I home o st as i s i s we I I def i n ed. Extensive 
studies have yielded much information about the synthesis 
and structure of the receptor itself (reviewed in 34 & 88). 
by which these important receptors are The mechanismCs) 
segregated into degradation pathways Ca routing apparently 
d i s t i n ct f r om 
de Ii neated to 
i gand de Ii very to lysosomes) have not been 
date. The study reported in this thesis is 
focused mainly on the cellular degradation of the low 
density lipoprotein receptor, and is contrasted with that of 
its ligand, LDL. 
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2. 1 Introduction. 
Extensive studies, (performed mainly by M. S. Brown, J . L • 
Goldstein and coworkers - see Section One for I iterature 
review) on cultured HSF, 
I e_d to 
take up 
the elucidation 
and me tabo Ii ze 
as wel I as other eel I type·s, have 
of the pathway by which these cells 
LDL C 33, 34) . The concept of 
"receptor-mediated endocytosis" was formulated in 1974 (84) 
to explain 
cholesterol 
the observation that 
metabo Ii sm depended 
regulation of cellular 
on the sequential ce I I 
surface binding, internalization and degradation of plasma 
LDL. This postulate has been verified by further 
biochemical, eg. (2), and morphological, eg. (4), studies. 
There are four general properties that collectively define 
receptor - _.med i ate d end o c y to s i s C 8 2) : 
Ci) The cell surface binding component is a molecule which 
binds a specific exogenous I igand, 





components which function as binding sites for opportunistic 
foreign molecules, 
receptors) . 
eg. viruses; these are not classed as 
Ci i) Ligand binding and internalization are, effectively, 
coupled events; i t has been shown that the ha I f - t i me of 
internalization for a range of receptor-I igand complexes is 
less than 10 minutess (8, 83, 242). 
Ci ii) Receptor-bound proteins enter 
p i t s ; receptors may localize 




regions, or I igand binding may induce receptor migration to 
these areas (2, 157) . 
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C i v) Internal I zed proteins are usually delivered to 
I ysosomes, the s I te of their subsequent degradation to amino 
acids (2, 242) . 
The wel I-characterized LDL receptor system in cultured HSF 
exhibits each of the above characteristics of receptor-
mediated endocytosis. 
In 1976, Kayden tl tl (121) used long-term lymphoid cells, 
obtained from human lymphocytes, to study the regulation of 
cholesterol biosynthesis, and to show that genetic 
abnormalities in this regulation are expressed in these 
c e I Is. They reported 
manner s i mi I a r to HSF: 
that the ce 11 s responded to LDL in a 
human LDL, but not HOL, suppressed 
HMG CoA reductase activity and stimulated 
esterification. These effects were obtained 
cholesterol 
using LDL at 
fibroblast concentrations similar to those used in the 
I in es. Furthermore, lymphoid cells derived from individuals 
w i t h homozygous FH showed neither suppression of HMG CoA 
reductase activity, nor stimulation of cholesteryl ester 
formation when incubated with LDL (121). 
Ho tl tl (103) 
lymphoid cells 
subsequent I y used s i mi I a r est ab I i shed human 
from a nor ma I sub j e ct to con f i rm th a t these 
cells did indeed possess LOL receptors. Binding of LDL to 
these receptors was f o I I owed by internalization of 
receptor - I i g and comp I exes , with subsequent degradation 
the 
of 
the lipoprotein. Lymphoid cells from a patient with the 
homozygous form of FH 
1as1-LDL via any 
processes. 
did not bind. internalize or degrade 
high-affinity (receptor-mediated) 
58 
A I t er n ate met hods to introduce experimentally labeled LDL 
into c e I Is C i e. apart from receptor- and non-receptor 
mediated processes on intact ce I Is), can be drawn from 
techniques currently used to incorporate macromolecule·s into 
the cytoplasm of cultured cells (61, 161 ) - an essential 
tool in developing biological fields such as the analysis of 
cytoplasmic protein degradation. I de a I I y , me tho d s used for 
loading macromolecules should be simple and applicable to a 
they should be able to load a wide variety of cell types, 
r an g e of mac r omo I e cu I es i n to a s i g n i f i can t prop or t i on of t he 
target cell population, to a measurable extent. Macro-
molecule loading should, initially, be cytoplasmic, and eel I 
function, morphology and viabi I ity should not be extensively 
compromised by the procedure. 
Several methods are available for loading, each of which is 
known to possess certain disadvantages. Microneedles may be 
used to inject substances into individual cells (58); the 
procedure, however, is a tedious one, in which i t i s 
difficult to control the amount of macromolecule injected, 
and usually only a I imi ted number of cells are actually 




containing trapped substances, can be fused with 
thereby delivering the substances into the host 
Artifacts may be encountered in studies of the 
membrane fun ct ion i ng of c e I I s I o ad e d i n t h i s way , s i n c e the 
membrane of the I oaded eel 
ce I I or Ii po some membrane. 
(170) bears the disadvantage 
is contaminated with red blood 
Loading by hypo-osmotic shock 
that pinosomes containing the 
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macromolecules to be I oaded are also subject to osmotic 
thus may release their macromolecules into the lysis, and 
cytoplasm. I n addition, not a I I of these pinosomes 
containing molecules 
shock. 
McNei I ~ l!.J_ (161) 
macromolecules into 
to be I oaded, are I ysed by the osmotic 
recently described a method for loading 
the cytoplasm of adherant cells, which 
involves scraping the cells, thereby mechanically perturbing 
the plasma membrane. They propose that transient holes 
(probably about 50 nm in diameter) are opened in the plasma 
membrane at the sites of tightest eel I adherance to the 
plastic substratum; exogenous macromolecules would con-
the cytoplasm by diffusion through these ceivably enter 
holes (161). These investigators have shown that , by 
varying the concentration of the macromolecules present 
during scraping, and by sorting scrape-loaded c e I Is in a 
flow cytometer, cell populations which are loaded to a known 
extent, may be selected for. 
I n th i s section, long-term lymphoid Clymphoblastoid) ce I I 
lines, derived from normal subjects, were used to ex am i n e 
the fate of 128 1-LDL subsequent to its uptake via receptor-
mediated endocytosis. These results were compared with data 
av a i I ab I e f r om the we II-studied HSF system. Lymphoblastoid 
ce I Is are particularly suitable for detailed .l.!l vitro 
studies of lipid metabolism since they proliferate rapidly, 
are apparently permanent and they offer potential advantages 
in studies where large 
needed. 
volumes of c e I I u I a r ma t er i a I are 
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Finally, the degradation of ligand taken up in intact cells 
via receptor-mediated endocytosis on LDL receptor normal HSF 
was contrasted with the degradation of I igand introduced via 
scrape-loading into 
fibroblasts. 
the cytoplasm of LDL receptor negative 
2.2 Experimental procedures. 
2. 2. 1 Ce I Is. 
Routine tests were performed to check that a I I tissue 
culture media were pyrogen-free. The eel cultures were al I 
free of mycoplasma, as determined by the BRL Mycotect 
Mycoplasma Detection system (Bethesda Research Laboratories, 
Maryland, USA). 
Lymphoblastoid eel Is. 
Lymphoblastoid cells were prepared from human lymphocytes 
(248). In brief, medium containing Epstein-Barr virus CEBV) 
was prepared from semi-confluent cultures of -the virus-
producing marmoset cell line, B 95/8 (163). Fresh Ham's F10 
medium containing 15% bovine fetal calf serum CFCS) was 
added to the cells for 4 days, after which it was removed, 
filtered through a 0.45 µm membrane, and mixed with an equal 
volume of fresh Ham's F10/FCS medium. This mixture 
constituted the transformation medium, and was effective for 
at least 3 months when stored at 4°C. 
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Lymphocytes were prepared from 10 to 20 ml of blood, using 
either heparin or EDTA as the anticlotting agent. The blood 
was kept on ice for up to 24 hours before use . Aliquots of 
blood (10 ml) were layered above Histopaque solutions (5 ml) 
and centrifuged (1 500xg, 20 mins) . The white eel band was 
removed and washed once with Ham's F10 medium (10 ml), 
resuspended in 
a 25 cm 2 tissue 
transformation medium (3 ml), transferred to 
culture flask, and incubated in a humified 
incubat.or (95% relative humidity, 5% COaL Sma I I v o I ume s of 
medium were added, generally on alternate days, until rapid 
multiplication of transformed lymphoblasts a 11 owed passage 
into 75 cm 2 f I asks. This process generally took between 
and 3 weeks. 
The transformed cells were routinely maintained i n 
suspension culture at densities between 0.2x10 8 and 1 . 0x10 8 
eel ls/ml, by discarding about 75% of the medium (and hence a 
corresponding proportion of the cells), and adding a similar 
volume of fresh medium to the remaining eel Is in the culture 
flask. The medium used for long-term propagation of the 
cells consisted of Eagle's minimal essential medium buffered 
with Earle's s a I ts CMEMJ, supp I eme n t e d w i t h 10% heat-
inactivated FCS 
µg/ml penicillin 
CHIFCS), 10% tryptose phosphate broth, 60 
sulphate . G and 100 µg/ml streptomycin 
Actively growing heal thy cultures existed as mixed 
suspensions of large clumps of cells, as wel as dispersed 
cells (Fig. 2. 1 A) . The clumps were easily broken up by 
aspirating gently 
2. 1 B) . 





Fig. 2.1: Phase contrast micrographs of a cultured LDL 
receptor normal lymphoblastoid strain. 
A: A he a I thy , act i v e I y gr ow i n g s us pens i on cu I t u r e , 
comprising clumps of cells, as well as dispersed cells. 
8: After gentle aspiration through a pipette several times, 
the eel I clumps become dispersed. 
Magnification: X 200. 
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To store the cells for subsequent use, cultures in the 
I o gar i t hm i c gr ow th phase were resuspended i n medium 
containing 10% glyc~rol at a concentration of approximately 
0.5x10 8 to 1x10 8 cells/ml. 1 ml aliquots were frozen under 
I iquid nitrogen vapour C-60°C, 30 mins) before final storage 
under I iquid 
rapidly in 
nitrogen. For re-use, the eel Is were thawed 
a 37°C water bath. The cells were then pelleted 
by centrifugation (2 000 rpm, 3 mi ns), washed once in 10 ml 
of medium to ensure 
resuspended finally 
complete removal 
in 4 ml medium. 
of the glycerol, and 
Hereafter, eel I growth 
and maintenance were carried 
transformed cultures. 
out as detailed for the newly 
A comparison of cell growth in cultures which had 
to 
been 
routinely disturbed, i e. ce I I clumps dispersed single 
ce I I suspensions by aspiration (5 to 10 passages through an 
automatic pipette-man) twice d a i I y, with cu I tu res where 
growth was undisturbed until the time of measurement, showed 
no significant differences in growth rate (data not given). 
Subsequently, lymphoblastoid cell cultures were routinely 
grown and maintained in 75 cma tissue culture flasks without 
disrupting the eel I clumps unnecessarily . 
The doub Ii ng ti me of these ce II s in medium containing 10% 
HIFCS was about 25-30 hours. Cel I density was found to 
plateau between 1.5x10 8 and 2.0x10 8 eel ls/ml C F i g . 2. 2) . 
If, during growth, the eel Is were spun down and resuspended 
in an identical volume of f res h med i um, c e I I growth was 
markedly increased compared to cultures where the medium had 


















Fig. 2.2: Growth characteristics of cultured normal human 
lymphoblastoid eel Is. 
Data are the mean values of duplicate flasks seeded at 
O.lxl0 8 cells/ml, and maintained i n culture medium as 
described in section 2.2.1. The arrow marks the point at 
which the eel Is from one set of flasks were pel lated and 
resuspended in an identical volume of fresh medium c D), 
while the cells in the remaining set of flasks were given no 
medium change ca). 
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measured by counting aliquots of dispersed cultures in a 
coulter counter, Model Zf. I den t i ca I gr ow t h ch a r act er i s t i cs 
were obtained using total eel protein as a means to assess 
cell proliferation (data not shown). The cultures were 
inspected daily under the phase-contrast microscope to check 
for the visible signs of good growth - namely, healthy, 
translucent appearing cell clumps. In healthy cultures, the 
cells on the edges of the CI ump S, a S we I I a S the . single 
cells, showed distinct "pseupodia-like" projections. These 
projections were observed to move gradually when cultures 
were watched continuously, for a period of several minutes, 
under the light microscope. 
Human skin fibroblasts. 
The fibroblast strains used were GM 3348A, (characterized as 
LDL receptor normal), and LVS, (characterized as LDL 
receptor negative); GM 3348A was obtained from the Human 
Genetic Mutant Ce 11 Repository (Camden, N . J., USA), and LVS 
was established 
(reference 248, 
in our labratory from an FH homozygote 
kindred 3b in that study). Mono layer 
cultures were grown in 75 cm 2 flasks and maintained in a 
humidified incubator (95% relative humid i t yr 5% COa) at 
37•c. Each f I ask contained approximately 12 ml of growth 
of Dulbecco's Modification of Eagle's medium consisting 
Minimum Essential ~edium, COMEMJ, 
G and 
supplemented with 10% 
HIFCS, 60 µg/ml penicillin 100 µg/ml 
sulphate. 
nineteenth 
Confluent monolayers, between the 
passages, were dissociated with 
trypsin/0.02% EOTA 
subsequently seeded 
solution for 7 mins 







dishes at a 
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concentration of o.1x1oa eel I a per dish Ci n 4 m I growth 
medium/dish) . Unless otherwise stated, cultures in the late 
I o gar i t hm i c gr ow th phase (day 5), were used . Cells were 
inspected da i I y under phase-contrast microscope 
c e I I s . fr om semi-confluent monolayers always 
optics; 
appeared 
spindle-shaped (Fig. 2.3). 
Cells were stored for later use as f o I I ow s: the 
trypsin/EDTA-dissociated cultures were resuspended at about 
lx10 8 cells/ml in medium containing 10% dimethylsulphoxide. 
1 ml aliquots were frozen in nitrogen vapour, prior to being 
stored under 
were thawed 
liquid nitrogen. For re-use, the frozen eel Is 
rapidly in a 37°C water bath, and the c e I I 
flasks suspensions were transferred to 75 cm 2 stock 
containing 12 ml growth medium. This medium was replaced 
with the same volume of fresh medium th~ next day, in order 
to remove the dimethylsulphoxide. 
2.2.2 Preparation of lipoproteins and I ipoprotein-deficient 
serum. 
Human LDL (density 1.019-1.063 g/ml) and human lipoprotein-
deficient serum CLPDS) Cdens i ty > 1.25 g/ml) were isolated 
from the plasma of nor mo I i pi demi c donors by 
ultracentrifugation, using a Beckman L8-70 ultracentrifuge. 
Fractions were isolated by discontinuous gradient 
centrifugation using the method of Chung ~ .!!..!. (41). A 
discontinuous NaCI/KBr density gradient was formed as 




Fig. 2.3: Phase contrast micrographs of a cultured LDL 
receptor no.rmal human skin fibroblast cell line CGM 3348A). 
The c e I I s were photographed 
as described in section 2.2 . 1. 
A: Sub-confluent layer 
spindle-shaped cells. 
Cday 
at various times after seeding 
3 after seeding), showing 
B: Confluent growth in monolayer. 
Mag n i f i ca t i on : X 200 
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and the protease inhibitors aprotinin (0.4%, v/v) and 
p h e n y I me t h y I s u I p ho n y I f I u o r i d e C PMS F ) C O . 2 mM) l w a s a d j u s t e d 
to 1.3 g/ml with solid KBr, and normal saline C0.9%NaCI -
0.01% EDTA, pH 7.0, density= 1.006 g/ml) was layered over 
the adjusted p I a sma. ' Gradients were centrifuged (50 000 
rpm, 2 . 5 hours, 10°CJ in a VT i 5 0 rotor; in each poly-
al lomer tube, the various ipoproteins resolved in we I I -
defined bands, corresponding to the i r specific density 
ranges, with VLDL and intermediate density lipoproteins 
(IOU at the top, fol lowed by LDL, then HDL, and finally 
LPDS i n the lower portion. The LDL fractions were 
recovered, pooled and washed at a d.ensity of 1.063 g/ml by 
an overnight centrifugation at 50 000 rpm in a Ti 60 rotor. 
The yellow LDL-containing layer at the top of each of the 
tubes was collected and these were pooled. 
The bot tom f r a c t i on ob ta i n e d a f t e r t he i n i t i a I 2 . 5 hour 
centrifugation was adjusted to 1.25 g/ml with solid KBr, and 
was spun in a VTi 50 rotor (50 000 rpm, 6-8 hours) . The 
residual HDL, which was con ta i n e d i n a ye I I ow I ayer at the 
top of each tube, was removed, and the LPDS fraction was 
retained . 
Both the LDL and LPDS fractions were dialysed extensively 
against 0.9% NaCl-0 . 01% EDTA, pH 7.4, at 4°c. A f t er 
dialysis, 2 uni ts/ml of thrombin was added to the LPOS; 
this fraction was then kept at 4°C for 24 hours, after which 
it was centrifuged in a JA 20 rotor (20 000 rpm, 10 mins, 
10°C), and the supernatant kept. 
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An alternate, shorter method of LPDS preparation, which did 
not involve the concurrent isolation of LDL, was sometimes 
used. Briefly, the procedure was as fol lows. The density 
of the plasma (containing 0 . 25 M EDTA) was increased to 
1.215 g/ml, and the adjusted plasma was subsequently spun in 
a Ti 60 rotor (59 000 
banded 
rpm, 36 hours, 4°C). VLDL, LDL and 
HDL fractions in the top portion of each 
ultracentrifuge tube, 
deficient fraction, 
and were discarded . 
which remained as a 
The lipoprotein-





portion of each 
normal sa I in e, a n-d 





The LDL and LPDS fractions were ster il ized by filtration 
through a mi I I ipore filter C0.45 µM pore diameter) . Heat 
inactivation of the LPDS was performed to remove complemint 
by incubating this fraction for 30 mins in a 56°C water 
bath. The protein content of both the LPDS and LDL 
fractions was 
using bovine 
determined by the method of Lowry~~ (147) 
serum a I bumi n CBSA) as standard. Protein 
the preparations were generally i n the concentrations of 
following ranges: LDL, 8-20 mg protein/ml and LPDS, 50-80 
mg protein/ml. The LPDS was frozen at -12°c unti 
LDL was stored at 4°C and used within a month . 
The purity of each LDL preparation was assessed 




( i ) 
3000 
Electrophoretic System, and the Beckman Paragon Lipoprotein 
Reagent Kit and Ci i) SOS-PAGE according to the method of 
Laemml i ~ ~ (137) on I inear 5-12% polyacrylamide gradients 
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containing glycerol, and a 3% stacking gel. Electrophoresis 
according to Ci) showed that the LDL preparations were 
essentially free of other human I ipoproteins. The second 
system, Ci i), demonstrated the presence of an apol ipoprotein 
B-100 band (apparent mwt about 340 000 daltons), 
contaminated only very slightly with minor bands C< 1%), and 
was thus essentially free of other plasma proteins. 
2. 2. 3 1 ••1-tabeling procedure for LDL. 
Iodination of LDL was performed using the iodine 
monoch I or i de procedure of MacFarlane, as modified by 
Bi I he i mer tl tl C 2 7) • I n most cases , 5 me i sod i um i o d i de 
used to iodinate 5 mg LDL, after which the 
radiolabeled LDL was dialysed for 24 hours at 4°C against 
sever a I changes of 0.9% NaCl containing 0.01% EDTA, pH 7.4, 
to remove free iodine. The label in LDL was 99% 
precipitable with 5% Cw/v) trichloroacetic acid CTCA), and 
lipid radioactivity, as assessed after extraction by the 
method of Fol ch.!!...!. 1!..L (71), was approximately 3% . Specific 
activities of the 128 1-LDL preparations ranged from about 
300-760 cpm/ng LDL protein. 
within 2 weeks of iodination. 
The labeled LDL was always used 
I mm e d i a t e I y p r i o r t o u s e , t h e 
,a 15 1-LDL was spun briefly in a microfuge (11 OOOxg, 1 min) 
to remove any particulate matter . 
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2 . 2. 4 Acetylation of LDL 
Acetylated LDL CAcLDL) was produced according to the method 
of Fraenkel-Conrat C 7 2 ) . An ice-cold saturated 
1 : 1 ( V / V ) 
sodium 
acetate solution was added to LDL in a rat i o. 
This was gently mixed, and then kept on ice for 5 minutes 
before adding acetic acid ( 1 µ I acetic acid /mg 
LDL). The acetic acid was added over a period of an hour, 
with mixing a f t er every addition . The solution was 
subsequent I y extensive I y dialysed as described in section 
2 . 2 . 3 , f o I I owed by a brief centrifugation (11 OOOxg, min) 
to remove any precipitated p r o t e i n . As measured by the 
Lowry method (147), the acetylation procedure resulted in a 
10-20% loss of I ipoprotein protein. 
Acetylated LDL was iodinated as described in section 2.2 . 3; 
the specific activity of these labeled I ipoproteins 
about 250-300 cpm/ng protein . 
2.2.5 Upregulation of LPL receptor activitv. 
Unless otherwise stated, LDL 
upregulated in ce I I cultures 
receptor 






ex per imen t . The me t hod used was es sen t i a I I y t ha t des c r i bed 
by Brown 
cells in 
and Goldstein (32), and entailed the incubation of 
medium containing LPDS instead of FCS . The ce I Is 
were always > 95% viable, as assessed by trypan blue dye 
exclusion, at the initiation of experiments . 
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lymphoblaatoid eel Is 
The cells were pelleted by centrifugation C2 OOOxg, 3 mins, 
room temp), resuspended in phosphate buffered saline CPBS) 
(pH 7 . 4), and then spun again. Final resuspension of the 
pellets was in MEM containing 5 mg LPDS protein/ml 
C ME M / L P D S ) , 6 0 µ g Im I p e n i c i I I i n G a n d 1 0 0 µ g Im I s t r e p t om y c i··n 
sulphate, at 1x10 8 eel ls/ml. The LPDS containing medium was 
changed a f t er 24 hours. Unless otherwise specified, 
upregulation was performed for 48 hours. 
Human akin fibroblasts 
Monolayers were washed once with PBS (usually on day 5 of 
c e I I gr ow t h) , and incubated with DMEM containing 5 mg 
protein/ml LPDS CDMEM/LPDS), 60 µg/ml penicillin G and 
100 µg/ml streptomycin sulphate for 48 
otherwise indicated. After 24 hours, the 
medium was 
medium. 




2. 2. 6 
37•c. 
1as1-LOL metabolism, after incubation with cells at 
Lymphoblaatoid cells. 
After incubation in upregulation medium, the c e I Is were 
resuspended in fresh MEM/LPDS at 2x10 8 cells/ml, and 
d i s p e n s e d i n 3 5 mm c u I t u r e d i s h e s C 1 m I I d i s h ) . 1215 1-LDL, in 
the absence or presence of excess unlabeled LDL, was added 
at the required concentration to each d i 5 h i incubations 
were then carried out at 37°C for 4 hours . The ce I I 
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suspensions were transferred to 15 ml plastic centrifuge 
tubes, chilled thoroughly on ice for 5 mins, and the cells 
were pelleted by centrifugation (2 OOOxg, 3 mins, 4°C). The 
medium was used to determine the noniodide TCA soluble 
degradation products, as described below. Each eel p e I I et 
0.2% 
was carefully resuspended in 2 . 5 ml PBS containing 
albumin CPBS-ALB), by aspirating twice with a disposable 
plastic pasteur pipette. The cells were centrifuged again, 
and the washing procedure was repeated twice using PBS. Al I 
. washing procedures were performed at 4°C. 
Determination of surface-bound 1 ••1-LDL - the final pellet 
was resuspended in 1 ml of ice-cold sodium heparin solution 
C4 mg/ml in PBS), and incubated on ice for hour, after 
which centrifugation (2 OOOxg, 6 mins, 4°C) was carried out 
to separate the cells fr om the heparin solution. This 
heparin-releasable radioactivity was taken 
eel I surface bound 188 1-LDL. 
as a measure of 
Determination of int race I lular 1 ••1-LDL 1 m I 5 0% a q u e o u s 
methanol was added to each pellet; the eel I suspension was 
vortexed and transferred to a glass test tube . The plastic 
centrifuge tube Cin which the pellet had been) was then 
washed twice with 
combined. 2.2 ml 
ml 100% methanol, and these washes were 
of chloroform was added to the methanol 
the test tubes containing these mixtures were vortexed wel I, 
and centrifuged (2 000 rpm, 3 0 mi n s , 4 ° C) to produce a 
protein pellet. After the centrifugation, the chloro-
form/methanol mixture was poured 0 f f carefully, and the 
d r y • 
pellets were maintained in a so•c water bath u n t i I 
They were then dissolved in 1 ml 1 N NaOH and left overnight 
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The solubilized protein in each test tube was 
transferred to a plastic counting V i a I and counted for 
intracellular ,as1-LOL content. The protein content in each 
NaOH-solubilized pellet was measured by adding 1 ml HaO to 
each sample Cie. final volume= 2 ml of 0.5 N NaOH); 0.5 ml 






of Lowry tl tl C 1 4 7 J w i th BSA as 
degraded 1 • 8 1-LDL 12s1-degradation 
products of apolipoprotein B were determined as described by 
Bierman tl tl (26). 
final concentration 
The incubation medium was brought to a 
of 12 . 5% TCA by the addition of 0.3 ml 
of 50% TCA, and the samples were then kept on ice for 30 
minutes or longer to ensure complete precipitation. Centri-
fugation C2 OOOxg, 30 mins) was performed to obtain the TCA-
so .1 u b I e f r a c t i on . The free iodide i n th i s fraction was 
subsequently converted to I a 
2 0 µ I 
by the addition of hydrogen 
peroxide, as f o I I ows: of 40% potassium iodide was 
added to each 1 ml of TCA supernatant solution, followed by 
the addition of 50 µI of 30% hydrogen peroxide. To extract 
the iodine, two volumes of chloroform were added, the 
mixtures vortexed vigorously, and the aqueous and chloroform 
phases were separated by centrifugation (2 000 rpm, 5 mins) . 
The radioactivity in the aqueous phase was counted. To 
control for any nonce I lular Ii poprote in metabolism, and to 
obtain a blank value, ,a 15 1-LOL was incubated in cell-free 
dishes, and the radioactivity obtained after performing the 
assays as described above, was subtracted from that obtained 
in the presence of cells. 
Human akin fibroblasts. 
After upregulation of the LDL receptors on the c e I Is as 
des er i bed above, monolayers were incubated i n fresh 
DMEM/LPDS, containing the required amount of 11u 1 1-LDL, in 
the absence or presence of excess unlabeled L DL. 
Incubations were performed for 4 hours at 37°c in a 
humidified incubator. The cells were then cooled to 4°C, 
and the medium was collected for the determinati_on of ,a 5 1-
I ipoprotein products Cas described above). 
Determination of surface b~und 1 ••t-LDL - After removing the 
incubation medium, the cells were washed 4 times with PBS-
ALB, and then 3 times with 3 ml of PBS to remove al I unbound 
radioactivity. The entire wash procedure was performed at 
4°C, using appropriately chilled solutions. Surface-bound 
1as1-LOL was released by i n cub a t i on o f t he mono I aye r s w i t h 
ice-cold sodium heparin solution (4 mg/ml in PBS) for 
at 4°C. 
Determination of intracellular 188 1-LDL Subsequent 
hour 
to 
heparin treatment, ·the intact eel monolayers were dissolv~d 
overnight In 2 ml 0.5 N NaOH at 37°c. An aliquot was 
counted for 12e1-radioact ivi ty to determine the 
intracellular ,ae1-LDL content Cie . the radioactivity 
associated with the eel Is after removal of receptor-bound 
LDL) . Cel protein was assayed (147) on aliquots of these 
NaOH-solubi ized cells. 
In a II cases (for HSF and lymphoblastoid cells) the data 
presented for surface-bound, int race I lular or degraded 125 1-
LDL are high-affinity values (unless otherwise specified). 
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These wer e calculated by subtracting the values obtained in 
the p r esence of excess unlabeled I i ga nd (non-specific 
component) from that obtained in its absence (total) . 
2.2.7 Cell-associated 1 ••1-LDL. 
The term "eel I-associated 125 1-LDL" refers t 0 the 
radiolabeled I igand associated with the eel Is, including 
that which i s receptor-bound. In th i s section, c e I I -
associated values were always obtained after incubating the 
1 a 6 I - I i g and w i th the c e I I s at 4 ° C; i n some other exp er i men ts 
(section 4.3 . 4 and Fig. 4.5), cell-associated radioactivity 
was measured after short 37°C incubations . 
Lymph ob I as to i d c e I I s 
After i ncubation in MEM/LPDS, the cells were transferred 
f r om t he upregulat ion f I a s k C s ) to centrifuge tubes and 
pelleted (2 000 rpm, 3 min s, 4°Cl. Each cell pellet was 
resuspended in 
resuspension at 
PBS and centrifuged again, before f i n a I 
about 2x10 8 ce II s/ml in Eagle's minimum 
e s s e n t i a I me d i um w i t h o u t b i c a r b o n a t e s u p p I em e n t e d w i t h 1 0 mM 
Hepes CpH 7 . 4 ) , 60 .ug/ml 







1 ml/d i sh 
mm cu I tu re 
of the cell suspension was dispensed into each 35 
dish and 125 1-LDL, in the absence or presence of 
excess unlabeled LDL, was subsequent I y added at the 
indicated concentration to each . lncubat ions were performed 
for 2 hours at 4°c; after which the eel I suspensions were 
washed at 4°C as described in section 2.2 . 6 . Each pellet 
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was then dissolved in 2 ml 0.5 N NaOH; the radioactivity 
measured represented eel I-associated I igand. Aliquots of 
these samples were used for protein determinations (147) . 
In the cases where a 30 minute 37°C incubation period was 
used to assess eel I-associated 1215 1-LDL, the procedure 
fol lowed was 
the initial 
analagous to that described above , except that 
PBS wash of the ce I Is was at 37°C, before f i na I 
resuspension in DMEM/LPDS at the same temperature . During 
this short incubation period, 1215 1-LDL was bound t 0 the 
receptors, internalized, but no significant I i ga n d 
degradation was detected CFig . 2.7). 
Human skin fibroblasts 
After upregulation of the LDL receptors i n DMEM/LPDS medium, 
the monolayers were chi I led to 4°C by placing the dishes on 
a steel tray in a 4°C cold room for 10 minutes . Each eel I 
layer was washed once w i th ice-cold PBS, before adding 
medium as described above under the heading "lymphoblastoid 
ce I Is 11 • After 2 hours at 4°C, the incubation media were 
removed, and the monolayers were washed, and subsequent I y 
so I u bi I i zed w i th Na OH, as des c r i bed i n sect ion 2 . 2 . 6 . 
2.2.8 Scrape-loading of ~ 20 1-1 iaand into fibroblasts. 
LDL receptor negative human skin fibroblasts, (strain LVS), 
we r e s e e d e d i n t o 6 0 mm Pe t r i d i s h e s , a n d g r own f o r 7 d a y s i n 
DMEM supplemented with HIFCS (note: no upregulation of the 
LDL receptors was performed) . Immediately pr i or to 
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scraping, each 
2 ml of 37°C 
dish was washed once with 3 ml of DMEM only. 
scrape medium CDMEM + the indicated amount of 
radiolabeled igand) was added to the first dish; the cells 
were then scraped with a rubber policeman, and the 
eel I/medium mixture was transferred to the next dish before 
repeating the above procedure. 3 dishes of cells were 
scraped with each 2 ml of radiolabel-containing medium; the 
combined scrape media were finally added to 5 ml of Eagle's 
minimum essential medium without bicarbonate, supplemented 
with 10 mM Hepes CpH 7.4) at 4°C. After thorough chi I I ing 
on ice, the cells were pelleted (2 000 rpm, 3 mins, 4°C) and 
resuspended in 
suspension was 
2 ml of DMEM + 10% HIFCS C4°C). This 
layered onto 8 ml of DMEM + 50% HIFCS, and 





of DMEM + 10% HIFCS and centrifuged as 
eel Is were finally taken up in 12 ml 
of DMEM + 10% HIFCS C37°C), aliquoted into a 75 cm 2 tissue 
culture f I ask, and incubated at 37°c for 4 hr in a 
hum i d i f i e d i n cub at or . Dissociation of the attached cells 
was then performed using trypsin/EDTA (5 mins, room temp) 
essentially as described (sect ion 2. 2 . 1 ) . A sample of the 
trypsin/EOTA supernatant 
how much 1215 1-LDL was 
was counted 
released. 
in order to determine 
The ce I I p e I I et was 
res us pended i n gr ow th med i um, and a I i quoted i n to 3 5 mm pet r i 
dishes (2 ml/dish); 3x35 mm petri dishes were 
derived from every 2 of the original 60 mm dishes . 
usually 
After 4 
hours, the medium was removed from each dish; the cells 
were washed twice with PBS, once with growth medium, and 
finally incubated in 2 ml/dish of the latter medium. For 
the purposes of subsequent analyses, this was taken as the 
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At various times thereafter, ranging from O to zero t i me. 
90 hours, the f o I I ow i n g assays were performed on each dish 
of cells containing scrape-loaded 128 1-LDL: 
Ci) The medium was removed and tested for the presence of 
radiolabeled degradation products, as des er i bed in section 
2. 2. 6. In some cases (see legend to Fig. 2.11), the TCA 
pellet (obtained from analysis of the medium for degradation 
prod u c ts) , was measured for rad i o act i v i t y . 
( i i ) The ce I Is were washed twice with PBS, and then 
dissociated by mi Id trypsinization at room temperature for 5 
min s. The supernatant was counted for the presence of 
trypsin/EDTA releasable material (surface bound). 
( i i i ) Each eel pellet (obtained in Cii)), was washed twice 
with PBS at 4°C by resuspension and centrifugation 
(2 000 
0.5 ml 
rpm, 2 mins, 4°C). The cell pellet was dissolved in 
of 0. 5 N NaOH; the radioactivity obtained 
represented trypsin/EDTA res i s tan t mater i a I . The solubil-
ized cells were incubated overnight at 37°c, and were 






the c e I Is 
various 
was examined under phase 
ti mes after performing the 
scrape-loading (Fig. 2.4). The eel Is adhered to the dishes, 
and assumed the characteristic spindle-shaped morphology 
within severa I hours after replating. Cel viability, as 
> 95% at each assessed by trypan-blue dye exclusion, was 
ti me point. I n addition, total cellular protein was 
determined at these t i mes C 1 4 7 ) ; the results obtained were 








contrast · micrographs of 
skin fibroblast ce I I I i ne 
visualized at various times after performing 
loading procedure with ' 85 1-LOL . 
A: 24 hours. 
B: 60 hours. 






Determination of the equal ibrium dissociation constant CKol 
and binding capacity CBmaxl. 
Ko and Bma>< values for the binding of LDL to the LDL 
receptors of lymphoblastoid eel Is were determined using data 
from studies in which 1 iu5 1-LDL was bound to cells at the 
fol lowing concentration range: 1-20 µg/ml C4°C). At each 
I ipoprotein concentration used, the receptor-bound (high-
affinity) value was calculated as described (section 2.2.6). 
E q u i I i b r i um b i n d i n g of LDL to the eel I surface LDL receptor 
is only achieved at 4°C, and is analagous t 0 hormone-






where CRJ, [Ll and CR-LJ represent the concentrations of 
receptor, Ii poprote in and receptor-bound lipoprotein, 
respectively. Ko is the ratio of the dissociation to the 
association constants C i e . k - 1 / k , ) . Since internalization 
of LDL at 37°C occurs rapidly, binding equilibrium is not 
achieved at this temperature, thus true Ko at 37°C cannot be 
obtained using intact eel Is. 
Two linearization techniques were 
apparent equilibrium dissociation 







of LDL receptor activity. 
An important assumption is made in these methods of analysis 
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- namely, that the R- L i n t er act i on i s a s imp I e b i mo I e cu I a r 
reaction, as expressed in the equation above. In addition, 
the off-rate of receptor-bound igand at 4°C is extremely 
slow relative to the · time taken to effectively "wash" the 
c e I I s f r om unbound I i g and C 8 3 , 1 8 5) . Thus, al though unbound 
I igand (free) is removed during the washing process, the 
e f f e ct i v e e q u i i b r i um b i n d i n g i s not d i s t u r bed . 
Linearization techniques used were: 
(1) A plot of the Michaelis-Menten equation (193). 
Free I ipoprotein 
the ratio of free 
CS, µg LDL protein/ml) was plotted against 
to receptor-bound I ipoprotein CV , ng LDL 
protein/mg ce 11 protein). 
Bma >< = t he s I ope o f t he r e s u I t an t s t r a i g h t I i n e . 
-Ko= the point of intersection with the y-axis. 
This technique is weighted for Bma>< analysis. 
(2) Scatchard analysis (203) 
The ratio of receptor-bound to free Ii poprote in CV/8) was 
plotted against receptor-bound I ipoprotein CV) . 
-1/Ko = the slope of the resultant straight I ine . 
Bma>< = the x-intercept. 
This technique is weighted for Ko analysis . 
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2.3 Results and Discussion. 
2. 3. 1 Time course c4•cJ of 188 1-LDL binding. 
The kinetics of high-affinity 125 1-LDL binding at 4°C were 
assayed on fully upregulated normal lymphoblastoid cells, as 
described in the legend to Fig. 2 . 5 . The radioactivity 
obtained represents eel I-associated 125 1-LDL, which is 
equivalent to 
was performed 
surface-bound 125 1-LDL in this case (binding 
at 4°C, 
at this temperature). 
and no ligand internalization occurs 





equi I ibruim by 60 mins; this i s 
in cultured fibroblasts at 4°C 
C 8 3) • 
2.3.2 Concentration curve c4•c3 of 188 1·-LDL binding. 
The concentration curve of 125 1-LDL binding at 4°C in normal 
human lymphoblastoid cells was determined C F i g . 2 . 6). 
Cultures were maintained for 48 hr in medium contai~ing 
upregulate the number of L D L receptors max i ma I I y , LPDS, to 
and the cells were subsequently incubated (2 hr, 4°C) with 
12s1-LOL C0.5-20 ug/ml), in the absence or presence of 
300 µg/ml unlabeled LDL. C I n other experiments, 125 1-LDL 
concentrations of up to 300 ug/ml were used, and similar 
results were obtained). Subsequent to binding and washing, 
each monolayer was solubilized in NaOH; the radioactivity 
obtained represents eel I-associated 125 1-LDL (as discussed 
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Fig. 2.5: Time course of ,a 5 1-LOL binding in normal 
lymphoblastoid cells at 4•c. 
LOL receptors · on the cells were upregulated maximally by 
incubating the cultures in medium containin~ LPDS for 48 hr. 
The eel Is were then washed with PBS, and incubated at 4°C in 
binding medium containing 10 µg/ml 125 1-LDL in the absence 
After the indicated binding or presence of 3 0 0 µg/ml LDL . 
ti mes, the high-affin.ity eel I-associated 125 1-LDL was 
calculated as des er i bed in the II Exp er i men ta I Procedures". 
The data are representative of resu I ts obtained in 
2 separate experiments. Each point was performed i n 
duplicate; duplicates differed by I ess than 3% from the 
means. The average content of cellular protein was 
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Fig. 2.6: Concentration curve of 125 1-LDL binding at 4•c in 
normal lymphoblastoid cells. 
After upregulation 
supplemented with 
of the LDL receptors for 48 hr in medium 
LPDS, 1 25 I -LDL Cat the indicated concen-
trations), in the absence or presence of 300 ~g/ml unlabeled 
LDL, was added to the ce 11 s. Binding was performed for 2 hr 
at 4°C, after which the high-affinity earl-associated l.igand 
was calculated as des er i bed in the "Ex per imenta I 
Procedures" . The data represent one of 2 s i mi I a r 
experiments, performed separately. Incubations were done in 
duplicate; duplicates never 
the mean values. The average 
was 0 . 07 mg/10° cells. 
d i f fer e d by more than 6% f r om 
content of cellular protein 
the total 
shown) -
cell-associated 1211 1-LDL was plotted (data not 
such a curve typifies an apparent high-affinity, 
saturable LDL receptor , and a I owe r a f f i n i t y , non - sat u r a t e d 
component. The amounts contributed by the low-affinity 
processes were then subtracted from the total values. Low-
affinity contribution was assessed using the I ines defined 
either by 
12 15 I -LDL 
C i ) t h e values obtained after incubation with 
i n the presence of excess LDL, or C i i ) an 
es t i ma t i on o f the non - specific component from the slopes of 
the linear component of t he exp er i men ta I sat u rat i on curves 
at the high 125 1-LDL concentrations (applicable only in 
those experiments where 125 1-LDL concentrations used were 
> 50 .ug/rnl) . Ci) and Ci i) yielded similar results . A plot 
The Ko of the high-affinity values is depicted in Fig. 2.6. 
value was 2 .u g 12cs1-LOL/ml, and the BmaM was about 20 ng 
1a.s1-LOL/mg cell prate in (see section 2.2 . 9 for methods of 
analysis). The Ko for binding at 4°C in HSF is 1 to 2 .ug/ml 
(29, 83) . 
Using the data obtained in the experiment depicted in 
Fig. 2.6, the number of LDL binding sites per lymphoblastoid 
ce II at 4°C was calculated. On average, the r e were 1 800 
binding sites per lymphoblastoid cell at 4°C . This value is 
in agreement with that reported by Ho tl tl C103) using 
similar cells, 
receptor sites 
and is subs tan t i a I I y I owe r than the 15 000 
detected analagously per fibroblast cell at 
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2.3.3 Time course c31•c) of 1 as1-LOL metabolism. 
The surface-bound, intracellular content and degradation of 
1aa1-LDL were assayed after incubating normal lymphoblastoid 
cells for 
I i gand. 
various times in the 
Prior to initiating the 
presence of radiolabeled 
experiment, maximal LDL 
receptor expression was induced by maintaining the eel Is in 
LPDS-containing medium for 48 hours. Binding incubations 
were performed at 37•c with 1 0 µg/ml ,as1-LDL, in the 
absence or presence of 300 µg/ml unlabeled LDL, for times 
ranging from 10 minutes to 4 hours. The high-affinity 
Ligand binding values obtained, are depicted in Fig. 2.7. 
appears to reach a constant value between 30 and 60 mins Cat 
30 mins, binding is 85% of its maximum value); the 
intracellular content of uu5 1-LDL plateaued by 2 hours, 
wh i I e radiolabeled LDL degradation products were only 
detected in the medium at times longer than 30 mins, and 
hour period increased I inearly - thereafter during the four 
examined. Ho tl tl (103) obtained very similar results also 
using long-term 
in qualitative 
lymphoid cells . This behaviour is similar 
terms to that which has been reported for 
HSF: binding plateaued by hour (84, 89), and detection of 
degradation products in the medium was possible after 30 
mins (15, 84, 89). [Note: the amount of 125 1-LDL degra-
dation products that was detected after the standard 4 hr 
binding incubation performed with lymphoblastoid cells at 
37•c, varied considerably from one experiment to another, 
using the same c e I I I i ne. In a I I experiments, the cells 
were 90% viable Cas determined by trypan-blue dye 
exclusion), were visibly healthy Cas observed under phase-
88 
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Fig. 2.7: Time course of 1as1-LOL metabolism i n normal 
lymphoblastoid cells, at 37•c. 
The cells were incubated in upregulation medium for 48 hr 
before initiating binding incubations containing 10 µg/ml 
1a6I-LDL in the absence or presence of 300 µg/ml unlabeled 
LDL. After incubating for the indicated times at 3 7 ° C, 
high-affinity LDL which was bound (heparin releasable) ce), 
intracellular CA) or 
described in section 
represents the mean of 





degraded was calculated as 
2. 2. 6 . Each experimental point 
duplicate dishes; dup Ii cat es never 
3% fr om the means. The data were 
experiment, and are representative of 
in 3 such expe r irnen ts, performed 
separately. The average content of cellular protein was 



















contrast microscope optics), and dilutions obtained in the 
presence of excess unlabeled LDL were always > 90%1. 
The importance of receptor recycling, as regards cellular 
economy, is obvious: in the case of LDL receptors, despite 
lysosomal destruction of the internalized igand, the 
receptors survive and may be recycled back to the plasma 
membrane for re-use (29). Thus one receptor may faci I itate 
the internalization 
Rec ye Ii ng accounts 
of many Ii gands during its I ife-time. 
f o r the observation that fibroblasts 
continue to ingest LDL at a uniform rate for longer than 6 
hours, even when the 
by cycloheximide (29). 
recycling event may be 
synthesis of new receptors is blocked 
The time taken for a sing I e receptor 
ca I cu I a t e d f r om the i n t e r n a I i z at i on 
i n de X ( I . D . ) a S f O I I ow S : 
Using data obtained at the 4 hr point in Fig. 2.7: 
Bound CB) = 140 ng 128 1-LDL/mg eel I protein 
Intracellular Cl) = 380 ng 128 1-LDL/mg cell protein 
Degraded CD) = 2 800 ng 128 1-LDL/mg eel I protein 
I .D. = Cl + D)/8 = (380 + 2 800)/140 = 22 . 7 
This means that 22.7 recycling events have occurred in 4 hr 
i e. one receptor cycle takes, on average, 10.5 mins. This 
calculation is, of course, only valid if the assumption is 
made that receptor number remained constant during the 4 
hour incubation period, and, for example, no effective 
downregulation had occurred during the 4 hours . This point 
A second w i II be addressed again later (section 4 . 3 . 4). 
assumption made is that no receptors are r ecru i t e d f r om a 
significant (previously inactive) pool during the four hour 
incubation time . This assurnpt ion has been shown to be val id 
90 
in HSF C 1 6 ) , but might not be the case f o r the 
lymphoblastoid cells. Recyc Ii ng times of about 12 mi ns have 
been reported for this receptor in fibroblasts C15, 29, & 
3 0) . 
2. 3. 4 Concentration curves c37•cJ of 1 a•1-LOL metabolism. 
The concentration curves of 12e1-LOL metabolism in 
lymphoblastoid cells derived from an LDL receptor 
human 
normal 
s u b .j e c t w e r e determined as described in the legend to 
Fig . 2 . 8. Incubations were performed for 4 hours at 37°C 
with 128 1-LDL C2-50 µg/ml), in the absence or presence of 
300 µg/ml unlabeled LDL. Cln other experiments, 125 1-LDL 
concentrations of Up t 0 300 µg/ml were used, and similar 
results were obtained) . Surface-bound ute 1-LDL was 
distinguished from that which was internalized by treatment 
of the c e I I s w i th the s u I fated g I y cos am i .no g I y can , hep a r i n -
an agent which removes more than 75% of the total ce I I -
surface associated LDL (83). The high-affinity saturation 
curves of 1ae1-LDL bound, internalized or degraded, were 
obtained as described in section 2 . 3.2, and are depicted in 
Fig. 2 . 8 . 
Half-maximal activity was obtained at 12 µg 128 1-LDL/ml and 
a maximum binding activity of about 90 ng 128 1-LDL/mg eel I 
protein was measured. Ha I f -max i ma I act i v i t y of HSF was 
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Fig 2.8: Concentration curves of 188 1-LOL metabolism in 
normal human lymphoblastoid eel Is. 
Lymphoblastoid cells were incubated 
supplemented with LPDS to upregulate 
for 48 
the 
'1 r in medium 
number 0 f LDL 
receptors maximally. The cells were then resuspended in 
fresh medium containing 125 1-LDL Cat the indicated 
concentrations) in the absence or presence of 300 µg/ml LDL, 
for 4 hr at 37°C. H i g h - a f f i n i t y h e p a r i n r e I e a s a b I e 1 a 'I - L D L 
ceJ, intracellular 125 1-LDL c•J and degraded 125 1-LDL CA) 
were assayed and calculated as described in ·"Experimental 
Procedures". The data, obtained from duplicate dishes in a 
single experiment, is representative of 2 similar experi-
ments, performed separately. Duplicate values never 
d i f f ere d by more than 5% from the means. The average con-
tent of cellular protein was 0.055 mg/10 8 cells. 
2.3.5 LDL receptor binding - some general aspects. 
Acetylation of LDL results in the chemical modification of a 
number of lysine residues in the LDL apoprotein, producing 
an increased net negative charge at neutral pH . Such 
mod i f i e d Ca c e t y I ate d LDL) did not bind the receptor in 
lymphoblastoid cells, using a range of 125 1-AclDL from 10 to 
200 µg/ml (data not shown) . In addition, the presence of 
excess unlabeled AcLDL (300 µg/ml) did not compete with 
,as1-LDL for binding sites. The inability of lymphoblastoid 
c e I I s t o c a t a b o I i z e n e g a t i v e I y - mo d i f i e d L D L i s c o mm o n t o t h e 
ma j or i t y of cu I tu r e d c e I I types , such as f i bro b I as t s C 3 l ) . 
The high-affinity binding and degradation of LDL in norma I 
lymphoblasto i d cells was str i ctly dependent on the presence 
of calcium ions in the i n cub a t i on med i um C Tab I e 2 . 1 ) . The 
a d d i t i o n o f 3 mM E GT A C a c a I c i um i o n c h e I a t i n g a g e n t ) t o t h e 
binding medium, in the absence of any added calcium, 
produced a virtual loss of high-aff i nity 1as1-LDL bind i ng 
and degradation. This effect was reversible, since binding 
and metabol i sm were partially restored after the removal of 
the EGTA . I t is we I established that the LDL receptors in 
cultured fibroblasts also show an absolute requ j rement for 
divalent cations t 0 effect I i ga n d binding C 8 4 , 8 7) . 
Go I d s t e i n tl tl C 8 7 ) ha v e s how n t ha t t h e add i t i o n o f O . 1 mM 
EDTA prevented 1as1-LDL binding C4°C) in HSF (calcium-free 
medium was used in these experiments); this inhibition was 
completely overcome by the presence of low concentrations of 
calc i um or manganese ions; magnesium ions were also able to 
restore b i nd i ng, but only at higher levels . 
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Table 2.1: Binding and metabolism of 
1 a•1-LDL in cultured 
lymphoblastoid cells ia calcium dependent. 
Lymphoblastoid eel Is were incubated for 48 h r in medium 
containing LPDS, to induce maximal upregulation of LDL 
receptors . The eel Is were then washed with PBS, and 
resuspended in media which contained either 10 µg/ml 
1215 1-
LDL + 3 mM EGT A, in the presence or absence of 300 µg/ml 
unlabeled LDL, for 4 hr at 37°C CA), or 3 mM EGTA only, for 
4 h r . In the latter case, this medium was replaced with 
medium containing 10 µg/ml 1215 1-LDL .±. 300 µg/ml LDL (in the 
absence of EGTA) for a subsequent 4 hr at 37°C CB). 
, 2 15 I _ 
LDL which was heparin releasable, intracellular or degraded 
was assayed as des c r i bed i n "Exp e r i men ta I Pro c e du r es" . The 
data were obtained from duplicate dishes; duplicates always 
Tabulated values differed by less than 5% from the means. 
.r e p r es en t r es u I t s expressed as a % of the control dishes 
which were incubated identically, 
a I ways omitted . 
Incubation conditions Bound 
A + EGTA (4 hr, 37°C) 14% 
B + EGTA (4 hr, 37°C),then 94% 











2. 3. 6 The site of ,aa1-LDL degradation. 
The lysosome, an organelle originally characterized in 
biochemical terms by de Duve C56), and known to contain a 
large number of acid hydrolases easily capable of digesting 
the LDL components, was considered to be the most probable 
organelle wher .e LDL could be degraded. In human fibro-
blasts, this 
confirmed Ci) 
proposed lysosomal digestion of LDL has been 
using cells obtained from patients with a 
genetic deficiency of I y sos oma I acid lipase C90) and Ci i) 
using agents suchas chloroquine and in normal 
c e I Is. Chloroquine has been shown 
leupeptin 
to increase the pH of 
acidic intracellular compartments; the increased lysosomal 
pH results in an inhibition of lysosomal enzymes C54). In 
B addition, chloroquine also directly inhibits cathepsin 
C257). The latter lysosomal protease is a 1. s o d i r e c t I y 
inhibited by 
the presence 
leupeptin C7, 246). Fibroblasts, incubated in 
of chloroquine, showed a dramatic decrease in 
the rate of 128 1-LDL degradation, and an almost equivalent 
increase in the amount of intracellular 
Furthermore, 
demonstrated 
resu I ts from this laboratory 
igand 
C 1 2, 
C 8 9 ) . 
249) 
that the intralysosomal degradation of 
apolipoprotein B involves an initial limited endoproteolytic 
attack at susceptible sites by cathepsin D. This and other 
enzymes , i n c I u d i n g cathepsin B, then act synergistically to 
bring degradation to completion . The results i I lustrated in 
Fig. 2.9 were obtained in an experiment using chloroquine in 
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Fig. 2.9: The effect of chloroquine C60 uM) on the 
metabolism of 128 1-LDL in normal lymphoblastoid eel Is. 
Ce I I s were upregulated, then incubated for the indicated 
times at 37°C in binding medium containing 10 µg/rnl 128 1-LDL 
in the absence or presence of 300 µg/rnl unlabeled LDL. with 
C 0) , or without ce) chloroquine. High-affinity values for 
1as1-LDL which was A: int race I lular or B: degraded, were 
calculated as described (section 2 . 2 . 6 ) f r om du p I i ca t e 
dishes at each point. Dup Ii cat es always differed by < 5% 
from the means. These results were obtained in a single 
experiment, and typify those obtained i n 2 separate 
exp er i men t s . 
for ti mes ranging from 1-24 hours in binding medium 
containing 10 µg/ml 125 1-LDL, in the absence or presence of 
300 µg/ml unlabeled LDL, with or without 60 µM chloroquine. 
The results show that the addition of chloroquine caused a 
marked inhibition in the rate 
in the 
0 f I i ga n d degradation, 
accompanied by an increase amount of int race I lular 
,as1-LDL . The reversibi I ity of the chloroquine effect has 
been demonstrated in cultured fibroblasts: 7 hours after 
the removal of this agent, proteolysis was found to resume 
(89). Various investigators have reported the ability of 
chloroquine to block the degradation of other receptor-bound 
and internalized proteins (17, 37). 
2. 3. 7 1as1-LDL metabolism in cultured lymphoblastoid and 
fibroblast · I ines, obtained from 4 different FH patients. 
The high-affinity binding, int race I lular content and 
degradation of ,as1-LDL in cultured human lymphoblastoid 
cells was measured in eel ines derived from 2 unrelated FH 
heterozygous patients and 2 unrelated FH homozygous 
patients . These values were compared with data obtained by 
other workers in th i s laboratory using HSF from the same 4 
FH patients 
Table 2 . 2, 
(248). The 
c I ea r I y s how 
results, 
that similar 
which are isted in 
trends are found in 
fibroblasts and lymphoblastoid c e I Is derived from these 
patients . 
show a 
Cel Is which are heterozygous for the LDL receptor 
reduction ( 0 f about 30-50%) i n the binding, 
i nterna Ii zat ion and degradation of labeled ligand, relative 




1ae1-LOL metabolism in cultured lymphoblastoid 
derived from 4 different FH patients, and a 
comparison with 1ae1-LOL metabolism i n the corresponding 
fibroblasts CF). 
Lymphoblastoid ce I Is, derived 
heterozygous patients and 2 
patients, were first incubated 
from 2 different FH 
different FH homozygous 
in LPDS containing medium 
(section 2.2.5). The cells were then maintained for 4 hr at 
37•c in medium containing LPDS, supplemented with 10 ug/ml 
or presence of 300 ug/ml unlabeled 1as1-LOL in the absence 
LDL. High-affinity values for 128 1-LDL which was bound 
(heparin releasable), internalized or degraded, were 
calculated from duplicate dishes; duplicates never differed 
by more than 5% from the means . I n the case 0 f the 
lymphoblastoid eel I lines, the results shown were obtained 
in a single experiment which is representative of 3 similar 
exp er i men t s . The data for the HSF were obtained by other 
workers in this laboratory (Table 2, ref. 248). All results 
are expressed as a % of the values obtained from normal 
lymphoblastoid or HSF cell lines. 
,a 15 1-LOL (% of normal value) 
LDL receptor status Bound lntracel lular Degraded 
of subject 
L F L F L F 
Heterozygous 40 64 62 73 73 88 
Heterozygous 66 59 63 72 7 1 84 
Homozygous defective 3 7 7 5 5 6 
Homozygous defective 1 2 1 4 1 0 20 1 8 24 
98 
99 
defective patients exhibited values that ranged from 3-25% 
of normal. 
248) prove 
These studies, and those done by others (103, 
that normal lymphoblastoid c e I Is possess LDL 
FH receptors, and that such receptors are deficient in 
homozygote and heterozygote · patients. The decreased 
receptor number results u I t i mate I y 
degradation, 
mediated), i s 
degradat i on. 
since endocytosis, 
normally responsible 
Kayden tl tl (121) 





of the I igand 
that long-term 
lymphoid c e I Is from FH homozygote patients showed no 
suppression of HMG CoA reductase activity, or stimulation of 
cholesteryl ester 
provides additional 
formation, when incubated with LDL . This 
evidence for the lack of LDL receptors 
on these eel Is in such pat i ents . 
2.3 . 8 The degradation of scrape-loaded 18151-LOL a 
comparative perspective. 
We used the technique of scrape-loading, originally 
described by McNeil tl tl (161), as a means to introduce 
1as1-LDL into adherant cultured ce I Is via non-receptor-
mediated processes. Essentially, fibroblasts were scraped 
w i th a rubber po I i c ema n i n the presence of med i um cont a i n i n g 
the desired radiolabeled macromolecule, in order to effect 
incorporation independently of the 
were subsequently rep lated and 
receptors . 
incubated in 
The ce I Is 
a 37°c 
hum i d i f i e d i n cub at or ; at various times, the metabolism of 
the incorporated ligand was assayed as described C section 
2 . 2 . 8 ) . Scrape-loading experiments were always performed 
with the LDL receptor negative human skin fibroblast i n e , 
LVS. 









int race I lular 
f i r s t order 
kinetics; the half-life of this disappearance was about 50 
hours CF i g. 2.10). Fol ch extractions C 7 1 l performed 
concomitantly confirmed that very little radioactivity was 
I ipid-associated C< 1%). 
Control experiments were performed CFig. 2.10) in which the 
labeled macromolecule loaded was 125 1-albumin (iodinated by 
the lodogen method, essentially as described in section 
3.3.2, using a 20 mg/ml BSA solution containing 50 mM NaCl 
and 10 mM sodium phosphate, pH 7. 4; specific activities 
obtained were generally about 100-200 cpm/ng protein). The 
pool 1a 5 1-BSA disappeared 




hours. This was consistent 
with results reported by others (62, 63): these investiga-
tors have shown that BSA, after scrape-loading into 3T3-L1 
c e I Is, is found in the cytosolic compartment, and is 
degraded with a half-life of about 20 hours. 
The value of 50 hr f o r 125 1-LDL disappearance a f t er 
incorporation into HSF by scrape-loading - was compared with 
the half-life of the same Ii gand after uptake by intact 
cells via receptor-mediated endocytosis. To this end, the 
normai fibroblast line GM 3348A,was seeded LDL receptor 
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Fig. 2.10: 1ae1-1 igand metabolism subsequent to incorp-
oration into LDL receptor negative fibroblasts by scrape 
loading ce ,A) CA). or 1ae1-LDL metabolism subsequent to 
uptake via receptor mediated endocytosis in normal 
fibroblasts CO) CB). 




into separate sets of LDL receptor 
CLVS). as 
2. 2. 8), 
described in "Experimental 
and in the text (sect ion 
2 . 3 . 8 ) . After incubating in DMEM/LPDS for various times. 
the amounts 
determined. 
of trypsin/EDTA resistant radioactivity were 
Results are representative, in each case, of 3 
separate experiments; data are the means of duplicates, 
which never differed from the mean values by more than 6%. 
B: Monolayers of LDL receptor normal fibroblasts were 
prepared as described in the text. Pulse-label incubations 
were performed in DMEM/LPDS supplemented with 10 µg/ml 125 1-
LDL ~ 200 µg/ml of unlabeled LDL for 3 hours. After removal 
of the medium, the monolayers were thoroughly chilled, 
washed four times with PBS-ALB and three times with PBS, at 
4°c. Ice-cold sodium heparin solution (0.4% in PBS) was 
added to each dish of cells for 1 hour at 4°C, after which 
the monolayers were washed four times with PBS C4°C). Chase 
incubations were then carried out on the intact eel I layers 
at 37°C in DMEM/LPDS for various ti mes . The data plotted 
are high-affinity values, calculated as described in section 
2.2.6, and were obtained from duplicate dishes; 
did not differ by more than 7% from the means. 
duplicates 
102 
4 8 hr to up reg u I a t e L D L r e c e pt or s max i ma I I y C sect i on 2 . 2 . 5) • 
The cells were then pulse-labeled at 37°C with medium 
containing 10 µg/ml 128 1-LOL in the absence or presence of 
200 µg/ml unlabeled LDL, to measure receptor-mediated I igand 
uptake. After 3 
monolayers were 
hours, this medium was 
treated with heparin at 
removed, and the 
4°C to remove al I 
surface receptor-bound 1as1-LDL. The ce 11 s were the_n chase-
incubated at 37°C for var i o us t i mes , and the met ab o I i sm of 
this intracellular 12s1-LDL pool was analysed as described 
in the scrape-loading procedure (section 2 . 2 . 8 ) . 
results, which are depicted in Fig. 2. 1 0 , indicate 




data are c .onsistent with the well-documented time course of 
12a1-LDL processing in cultured fibroblasts: in normal 
fibroblasts, the receptor-bound LDL 
for less than 10 mins, on average; 
of the surface-bound LDL particles 
remains on the surface 
w i th i n th i s t i me, most 
enter the ce I I , and 
within 30-60 mins, the protein component of 125 1-LDL is 
digested to amino acids and the which had been 
attached to the tyrosine residues on LOL, is released into 
the culture medium as 128 1-monoiodotyrosine (83, 84) . 
The compartmental distribution of scrape-loaded, radio-
active ligand was analysed at various post-incorporation 
t i mes CF i g. 2 . 1 1 ) . Total radioactivity within the system 
remained constant, while the distribution of this label 
within the various cellular compartments varied with time . 
This is consistent with an intact system in which the 
metabolism of the incorporated ligand occurs. The amount of 
material that was trypsin/EDTA resistant decreased with time 
103 






F i g . 2 • 1 1 : Compartmental analysis of 128 1-LDL, subsequent 
to incorporation in fibroblasts by scrape-loading. 
1251-LDL was scrape-loaded into confluent LDL receptor 
negative fibroblasts as described in Section 2.2.8 . After 
post-label incubating for O hours Cl), 21 hours Cl I) or 47 
hours Cl I I), compartmental analyses were performed . 
A. Trypsin/EDTA resistant material. 
B. Trypsin/EDTA releasable material. 
C. PBS wash number 1. 
0. PBS wash number 2. 
E. 1aa1-LDL degradation products in the medium . 
F. Radioactivity in TCA pellet Cie. a count of the TCA 
pellet obtained in E - see section 2.2 . 8 Ci)). 
G. Total counts. 
Similar results were obtained in 3 separate experiments. 
The data were derived from dup Ii cate assays of each 




detected i n 
column A, and also Fig. 
an increase in 1as1-LOL 







radioactivity measured in 
and 
the TCA pellets C F i g . 2 . 1 1 , 
columns E and F, respectively). Thus, a I though some of the 
1as1-LOL was undoubtedly degraded during the chase 
incubation, some relatively intact CTCA precipitable) 
material was released from the cells. 
2.3.9 Concluding remarks. 
I n th i s study, the binding and metabolism of 125 1-LDL were 
examined in 
Ii gand uptake 
res u I ts were 
fibroblasts. 
s umrna r i zed . 
cultured human lymphoblastoid ce I Is, a f t er 
via receptor-mediated endocytosis, and the 
compared with those documented for human skin 
In Table 
Both cell 
2 . 3 , 
types 
th i s comparative 
required calcium 
study is 
ions f o r 
I i gand binding. The simultaneous addition of excess 
unlabeled LDL (200-300 µg/ml) during binding (4°C or 37°C) 
produced a > 90% decrease in the amount of radiolabeled 
I igand bound. Furthermore, mod i f i e d C neg a t i v e I y charged) 
acetylated LDL was unable to bind to the LDL receptor. The 
competition obtained in the presence of excess unlabeled 
ligand, and the lack of binding of modified I i gand, are 
indicative of the specificity of the LDL receptor for LDL. 
The number of LDL receptors on the eel I surface of the two 
culture types under discussion differed greatly: there were 
1 800 
15 000 
such receptors per tymphoblastoid eel I, compared with 
on each fibroblast cell. Ko values for binding were 
105 
106 
Table 2.3: A comparison of 1 * 5 1-LDL binding and metabolism 
in cultured human lymphoblastoid and fibroblast eel I I ines. 
Parameter L, Ref 8 
ca•• dependence of binding yes yes 84, 87 
Binding of AcLDL no no 3 1 
Ko Cug/ml)C4°C binding) 2 1-2 29 
Time for binding to plateau 30-60 30-60 83 
at 4•c Cmi ns). 
Time for degradation products >30 >30 1 5, 84 
to appear at 37°c Cm i n s) 
Effect of chloroquine on LDL deer deer 89 
degradation. 
Receptor recycl ing ti me 1 0. 5 1 2 29,30 
Cmins) 
No. of LDL receptors on ce I I 1 800 1 5 000 87 
surface c4·c). 
,as1-LDL binding i n : 
FH heterozygotes (% of normal) 50-70 50-70 248 
FH homozygotes (% of normal) 3-25 3-25 248 
1 = Lymphoblastoid cells 
2 = Human skin fibroblasts 
3 = Reference(s) for HSF data 
similar in both cell types, viz. about 2 µg ,a-e1-LOL/ml 
C4°Cl. When incubated at 31•c, LDL receptors were 
internalized and were subsequently recycled back to the eel I 
surface within 
products were 
about 10 mi nut es; 128 1-LDL degradation 
detected in the incubation media a f t er 30 
minutes . The addition of the lysosomotropic agent, 
chloroquine, resulted in an inhibition of the degradation 
process. The critical importance of surface LDL receptors -
the initial component of the receptor-mediated endocytotic 
pathway - was emphasised by the finding that lymphoblastoid 
and fibroblast cells derived from patients with the receptor 
negative form of homozygous FH, which lack functional LDL 
receptors, were unable to take up LDL with high affinity. 
Subsequent to endocytosis via receptor-mediated processes, 
i t i s known that the LDL 









receptor and I igand (CURL) (77). It is widely accepted that 
the majority of the LDL receptors are recycled back to the 
cell surface (77), while a few are degraded; the processes 
that determine at what stage a receptor may be routed into 
the latter pathway, and precisely how 
elucidated to 
this degradation is 
affected, have not been date Csee Section 
Four). In contrast, the degradation of LDL, subsequent to 
uptake via receptor-mediated endocytos is, 
characterized as 
ences 34, 89) . 
a I y sos oma I · event CT ab I e 
has been well 
2.3, and refer-
The time taken to degrade LDL, which had been endocytosed in 




about 50% of this I igand was degraded within one 
2. 1 0) . For comparative purposes, 128 1-LDL was 
introduced into the cytosol of cultured fibroblasts by 
scrape-loading (61), and the metabolism of the I igand was 
then analysed: about 50% of the 128 1-LDL was degraded by 50 
hours, which was markedly slower than the degradation rate 
observed for ligand which had been receptor endocytosed. 
This result gives some perspective as to the relative 
rapidity of receptor-mediated delivery of I i gan d t 0 
lysosomes. 
Mayer~~ (159) have proposed a general eukaryotic protein 
turnover cycle, based on protein synthesis and degradation 
studies i_ n several animal models, which involves 
organe 11 es 
degradation 
trans location i e . 
after synthesis, 
proteins enter 
and subsequent I y 
functioning 
leave after 
Ct hose proteins possessing properties precluding such 
transfer - such as mitochondrial inner membrane proteins -
would be excluded from th i s process). 
considerations were later incorporated into the 
Kinetic 
proposed 
cycle (158), to yield a model in which proteins would be 
translocated from functional sites at heterogeneous rates 
for degradation 
Measured protein 
Cby lysosomal or non-lysosomal mechanisms) . 
half-lives would, presumably, reflect the 
rate of the translocative events. 
In order to investigate such protein translocation, Mayer 
and co-workers have made extensive use of the macromolecule 
loading techniques (outlined in section 1. 1 ) . Such 
the methodology is free of the complications inherent in 
108 
classically used pulse-chase labeling procedures f o r 
analysis of protein catabolism Ceg. the radiolabeling of .s....Ll. 
cellular proteins during the pulse period), and has the 
advantage that labeled, soluble macromolecules may be loaded 
into selected target eel Is. 
Evidence has recent I y been provided by Doherty tl E..J.. (63) 
that the microinjection of various glycol·ytic enzymes into 
3T3-L1 cells results in their rapid sequestration to the 
nuclear-intermediate filament fraction Ca cell fraction rich 





system. I t i s I i ke I y that a 
process i s involved in this 
delivery. Results obtained by Earl J!...i E..J._ (68, 69) provide 
additional support 
used reconstituted 
for this mechanism . These researchers 
Sendai-viral envelopes to implant viral 
HN and F proteins into the surface of cultured hepatoma 
cells, as a means to investigate the mechanismCs) of plasma 
membrane protein catabolism. They were able to show that 
the transplanted HN and F proteins were sequestered into a 
perinuclear s i t e, tightly 
i n termed i ate - f i I amen t mater i a I , 
transferred from this fraction 
system for degradation. 
associated with nuclear-
and were then progressively 
into the autophagolysosomal 
In an at tempt to de f i n e t he mo I e cu I a r c r i t e r i a t ha t t a r g e t 
proteins into intracellular degradative pathways, Gaskell tl 
tl (75) microinjected (35S]polypeptides C i e . precursor 
modifica-polypeptides lacking co- and post-translational 
tions) into erythrocytes or 3T3-L1 c e I Is . Very I i t t I e 
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3.1 Introduction. 
It is widely known that certain eel I surface receptors play 
an es sent i a I r o I e in c e I I u I a r home o st as i s by med i at i n g the 
endocytosis of 
nutrients eg. 
biologically important molecules, such as 
LDL (88), hormones eg. ins u I in C 1 5 4 ) and 
growth factors eg . EGF (65). Subsequent to internalization, 
the fates of the igands and their receptors are different 
in various cases: igands may be transported 
degraded, while 
across the 
cell, stored intracellularly or receptors 
i gand) for may be rec y c I e d Cw i t h or w i thou t the end o c y to s e d 
re-use, or degraded. The rates at which receptors are 
turned over Cie. their ha I f - I i v es) may play a significant 
r o I e in determining how quickly, and to what extent, any 
given eel will be able to respond to alterations in its 
external environment. 
Turnover rates of a number of receptors have been determined 
in different cell types, using a variety of methods: i t 
a p p e a r s t h a t mo s t ma mm a I i a n plasma membrane proteins have 
half-lives of between 10 and 80 hours eg . the half-life of 
the EGF receptor in a human epidermoid carcinoma eel ine 
i s 20 hours, in the absence of I i g and C 5 5) ; the 
asialoglycoprotein receptor in Hep G2 ce II s turns over with 
a half-life of 30 hours (216); the transferrin receptor in 
a human I eukemi c T-ce II line has 
(173), and the upregulated ins u I in 
about human lymphocytes, one of 
a half-life of 60 hours 
receptor in cultured 
1 1 hours (120). In 
comparison, the half-life of the LDL receptor in human skin 
fibroblasts was reported in 1975 by Brown and Goldstein (32) 
1 1 4 
to be ab o u t 2 5 hour s , as measured by the de c I i n e of s u r f ace 
receptor activity after the a dm i n i s t rat i on of the protein 
synthesis inhibitor, cycloheximide . (The proposed effect of 
this agent on the receptor ha I f-1 i fe wi 11 be addressed in 
section 4.3 . 5 and 4.4). 
In this section, the development and optimization of the 
[3SSJ-methionine pulse-chase procedure is detailed, as well 
as the obtaining and characterization of lgG-C7 C the 
monoclonal antibody to the I igand binding domain of the LDL 
receptor) . Essentially, the pulse-chase method involved 
biosynthetical ly labeling intact c e I Is with radioactive 
met hi on i n e, f o I I owed b y a s u b s e q u e n t i mm u n o p r e c i p i t a t i o n o f 
LDL receptors using lgG-C7. Quantitation of the fluorograms 
obta i ned from electrophoretical ly separated [31SSJ-labeled 
proteins provided a definitive means for assessing the 
turnover rate of the LDL receptors. The major advantage of 
this technique is that cells can be biosynthetically labeled 
with a radioactive, essential amino acid, and the receptor 
f o I I owed i n a benign manner , w i thou t the use of i n h i b i t or s 
which often introduce artifacts due to . impairment of 
cellular function. In addition, the turnover rate of LDL 
receptors was compared with that of another cell surface 
receptor (namely, the transferrin receptor) . 
monoclonal antibody to the I a t t e r receptor 
i mm u n o p r e c i p i t a t e t h e transferrin receptors 
same c e I I extracts from which the LDL 
precipitated . 
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3.2 Monoclonal antibody to the LDL receptor ClgG-C7). 
3. 2. 1 lgG-C7 producing hybridoma eel la. 







Co I I e Ct i On (Rockville, 
general procedure f o r 
obtaining such a cell line is as detailed by Beisiegel tltl 
C 2 3 ) . I n b r i e f , LDL receptors were isolated from bovine 
adrenal cortex, solubilized with octylglucoside and 
partially purified by DEAE-ce I I u I ose and aga ros·e ge I co I umn 
chromatography (211). Mice were immunized with the 
partially purified receptor protein, and the spleen cells 
polyethylene were fused with mouse myeloma c e I Is using 
glycol, according to standard methods (23). Medium from the 
fused cells was assayed for anti-LDL receptor activity, and 
the hybridoma ce I Is that were positive were cloned by 
limiting dilution (23). 
General aspects. 
T h e c o mm e r c i a I I y obtained hybridoma c e I I I i n e was gr own i n 
suspension in 90% DMEM with 4.5 g/1 glucose, supplemented 
with 10% HIFCS. Ce I I s we r e r o u t i n e I y g r own i n s t e r i I e 9 0 mm 
petri dishes, each containing 10 ml medium with hybridoma 
cells at approximately 0.3x10 8 cells/ml. Typically, healthy 
cells adhered to the bottom of the dishes, but these were 
easily dispersed with gentle aspiration. Medium was changed 
on growing cultures every alternate day. To grow cu I tu res 
f o r asci tes production, the eel .ls · were aspirated, and 
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a I i q u o t e d i n t o 4 s e pa r a t e 9 0 mm p e t r i d i s h e s , an d t h e v o I um e 
in each dish was made up to 10 ml. After 2-3 of medium 
days, the procedure was repeated, unti I the required number 
of dishes was obtained. Periodically, actively growing cell 
cultures were centrifuged C2 000 rpm, 2 mins, room temp) and 
resuspended in 90% HIFCS and 10% dimethylsulphoxide Cat 
2x10° cells/ml). The cells were aliquoted into nunc vials 
Cl ml/vial) and frozen in the gaseous phase of I i quid 
nitrogen, prior to being stored under liquid nitrogen (164). 
Thawing of each vial was done rapidly at 37°C, and the cells 
were washed immediately with medium C 1 0 m I) by 
centrifugation before being seeded into 90 mm petri dishes. 
Growth characteristics . 
The I gG-C7 producing hybr i doma cells typically displayed a 
I o gar i t hm i c gr ow th pattern (Fig . 3.1, Curve A) for about 48 
hours, with a doubling t i me of 15 hours, after which the 
rate of c e I I gr ow t h de c I i n e d . This decline was due at least 
in part to medium depletion since, if the medium was changed 
at regular intervals during eel I growth, the logarithmic 
growth pattern was maintained longer (about 72 hours), while 
the maximum ce I I density that was attained increased 
substantially (Fig . 3.1, Curve 8). 
A control hybridoma eel I i ne. 
A mouse hybridoma ce I I line which produced antibodies 
directed against an irrelevant antigen (testosterone) was 
obtained as a gift from Bioclones (Stellenbosch, S.A.). The 
ce II s were grown in medium containing RPMI, supplemented 
with 10% HIFCS, 300 mg/I L - g I u tam i n e , 5 0 0 µM mercapto-
1 1 7 
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Fig. 3.1: Growth curves of lgG-C7 producing hybridoma 
ce I Is. 
The hybridoma cells were seeded into 35 mm petri dishes at 
0.17x10 8 cells/ml C2 ml/dish) in standard growth medium. At 
the indicated t i mes , the cells in each set of dishes were 
aspirated and counted in a Coulter Counter. A: No fresh 
medium was added throughout the experiment. B: At each t i me 
point from 24 hours onwards, the medium on each 0 f the 
remaining dishes was replaced with an identical volume of 
fresh growth medium. Values represent means~ S.D . obtained 
from triplicate dishes. 
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.ug/ml penicillin G and 100 .ug/ml streptomycin ethanol, 60 
sulphate. General growth characteristics were as described 
for the I gG-C7 producing hybr i doma ce I I Ii ne. 
Testing the hybridoma ce I I culture media for antibody 
production. 
The specificity 
h y b r i d oma c e I I 
of the antibodies produced . by each of the 
I in es was tested by i mm u n o b I o t t i n g C 2 2) . 
Partially purified bovine adrenal receptors (209) were 
subjected to electrophoresis on sos polyacrylamide gels 
under non-reducing conditions . Coomassie blue staining of 
the gels showed many bands (data not given), indicating that 
the preparation contained many different proteins. The 
proteins were then electrophoretical ly transferred from the 
SOS gel to nitrocellulose paper, and incubated with medium 
from each 0 f the hybridoma cell I ines C F i g . 3. 2, lanes 
& 2 ) , fol lowed 
radiolabeled second 
Incubations were . 
monoc Iona I anti body 
by a subsequent 
antibody ( 1215 1-rabbit 
also performed using 
lgG-C7, and lgG-2001 
incubation with 
anti -mouse I gG). 
the purified 
the latter is a 
mouse monoclonal antibody directed against an irrelevant 
antigen CHemophilus influenza type B) - (both antibody types 
were obtained as g i ft s from Ors. Brown and Goldstein 
[Dallas, Texas, U.S.A.]), as 
lanes 4 & 3 respectively). 
standards against which to 
results. A single band of 
either the lgG-C7 hybridoma 
f i r s t antibodies CFig 3 . 2 , 
These latter lanes were used as 
compare 
mwt 13 O 
the hybridoma media 
kd was observed using 
cell medium or the purified 
monoclonal antibody (Fig. 3.2, lanes 2 & 4), and was absent 
f r om t he lanes where incubations had been performed with 
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FIGURE 3.2 
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Fig. 3.2: lmmunoblottlng of LDL receptor from bovine 
adrenal cortex to teat the hybridoma cell media for antibody 
production. 
LDL receptors from bovine adrena I cortex were so I ub i Ii zed 
with octylglucoside and partially purified on DEAE-cellulose 
(209) . 50.ug/well was subjected to electrophoresis in the 
presence of 
conditions). 
SOS on a 5-20% polyacrylamide gel (non-reducing 
The proteins in the gel were transferred 
electrophoretically to nitrocellulose paper C 2 0 O mA , 2 h r , 
room temp) using a modification of the procedure of Burnette 
C 3 5) . The nitrocellulose paper was cut into strips, blocked 
(4°C, overnight) in a buffer containing 5 0 mM Tr i s HC I , 
2 mM CaCl2, 90 mM NaCl, 50 mg/ml BSA, pH 8, and then 
incubated Croom temp, 60 mins) with medium in which the lgG-
C7 or control hybridoma cells were grown (lanes 2 & 1) or 
monoclonal anti-receptor lgG (400 n g Im I ) or lgG-2001 
C mono c I on a I an t i body d i rec t e d a g a i n s t an i r re I e v a !"I t an t i gen ) 
(400 ng/ml) (lanes 4 & 3). Each of the strips was washed 
with a buffer containinQ 0.1% Triton X 1 00, 10 mM Tris, 
9 0 mM Na C I , 1 % BS A , pH 8, then incubated with ,aa1-rabbit 
an t i -mouse I g G (8xl0 8 cpm/ml; iodination performed as 
de ta i I e d i n sect i on 3 • 3 • 2) Croom temp, 3 0 mi n s) . The strips 
were finally washed, dried and exposed for 20 hours to 
Cronex 4 X-ray f i Im. 
1 2 1 
antibodies directed against rrelevant antigens (Fig. 3.2, 
lanes & 3). 
conditions) has 
T h i s p r o t e i n C mw t 1 3 0 k d u n d e r n o n - r e d u c i n g 
been p u r i f i e d by others to homo gene i t y f r om 
the bovine adrenal gland, and has been shown to be the LDL 
receptor (47, 223). 
3.2.2 A&citea fluid formation. 
Since large amounts of 
formation of the immune 
experiments, it was decided 
antibody were needed 
complexes to be used 




to raise ascites fluid, and to 
purify the 
supernatant 
monoclonal antibody fr om th i s. (Tissue culture 
from hybridoma ce I Is contains antibody at 
approximately 5-10 .ug/ml, while the antibody titre in the 
ascites fluid o f i mm u n i z e d mice is usually 100-1000 times 
higher than this). The procedure out I ined below was carried 
out for both the lgG-C7 hybridoma eel line, and that which 
produced antibody to an irrelevant antigen. 
Female Balb/c mice (6-8 weeks old) were used. At least 10 
days before injecting the h y b r i d oma c e I I s , each mouse was 
injected intraperitoneal ly with 0.5 ml of pristane 
(2,6,10,14-tetramethyl pentadecane). This compound i s a 
tumour promoting agent, and priming the mice in th i s way 
increases the frequency of as c i t es tumour formation (123, 
1 5 5 , 1 6 4 ) . The e f f e c t o f p r i s t an e a pp ea r s t o be p.e r mane n t . 
122 
Hy b r i d oma c e I I s were grown and harvested for injection 
wh i I e the c e I Is were growing very actively in the 
logarithmic phase. The cells were aspirated off the dishes, 
centrifuged (2 000 rpm, min, room temp), and gently washed 
once by centrifugation in DMEM only to remove any serum from 
the med i um pr i or to injection Final resuspension of the 
cells was in DMEM only, at 2x1oe to 5x10 8 eel Is per 0.5 ml. 










The mice were 
sacrificed by cervical dislocation, the peritoneal cavities 
opened, the ascites fluid aspirated and then centrifuged 
(2 000 rpm, 15 mins, room temp) to remove al I tumour eel Is. 
The ascites fluid was stored at 4°C in the presence of 0.02% 
sodium azide . 
3. 3 Purification of lgG-C7. 
3. 3. 1 General procedure. 
The asc i tes f I u i d was applied to columns of Protein A-
that were equilibrated with 0 . 1M sodium Sepharose CL-48 
phosphate, pH 7 . 4 C 1 6 4 J • After a 11 the unbound protein had 
in a single large peak (pH 7 ) , the pH was been eluted 
reduced to 3 with a solution containing 1 M acetic acid and 
0.1 M glycine. At this pH, the lgG protein was eluted, 
after which its pH was immediately raised to 7.4 by adding 
the appropriate 
dialysed against 
volume of 2 M Tr is. The I gG fraction was 
buffer containing 10 mM sodium phosphate, 
123 




7 . 4 for 24 
3 mg/ml 
hr at 4 • C, and was then 
using an BMC Amicon Micro-
ultrafiltration system. The antibody containing solutions 
were a Ii quoted and stored under I i quid nitrogen; the 
protein was never frozen and thawed more than -once before 
use. Yields of purified monoclonal antibody averaged 2-3 mg 
protein per mouse. The control monoclonal antibody was 
purified by analagous procedures. Unless otherwise 
specified, the term 11 1gG-C7 11 will be used to refer to the 
monoc Iona I anti body to the LDL receptor that was isolated 
and purified laboratory. Similarly, the term 
11 cont r o I mono c Ion a I ant i body II w i I I be used w i th reference to 
the monoclonal antibody directed against the irrelevant 
antigen (testosterone) which was purified by ourselves. 
3.3.2 Assessme~t of the purification process. 
SOS-PAGE. 





the efficiency of the affinity-
antibody i n the monoclonal 
of asc i tes fluid, the protein peak 
which eluted at pH 7 and the final peak which eluted at 
pH 3, were subjected to 5-20% PAGE in the presence of SOS 
(using both reducing and non-reducing conditions). Fig. 3. 3 
is representative 
unpur if i ed asc i tes 
of a typical purification sequence. The 
fluid contained some i n tact I g G C mw t of 
150 kd under non-reducing conditions) and a large amount of 
imp u r i t i es, main I y albumin Clane 1 ) . The peak which was 
eluted from the column at pH 7 Clane 2), contained most of 
124 
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i n the 
purification of 
receptor . 
tgG-C7. the monoclonal antibody to the LDL 
Samples of the ascites fluid, the peak which eluted from the 
Protein A-Sepharose CL-48 column at pH 7 (containing the 
unbound proteins) and the peak which was eluted at pH 3, 
were subjected to 5-20% SOS-PAGE according to the method of 
L a e mm I i C 1 3 7 ) • Lanes 1, 2 and 3 represent the ascites 
fluid, the pH 7 peak and the pH 3 peak, respective I y, when 
run under non-reducing conditions, wh i I e I anes 5, 6 and 7 
show these proteins after electrophoresis under reducing 
conditions . The positions of the low molecular weight 
marker proteins are shown in lane 4 . 
the impurities 
little intact 
that were present in the ascites, but very 
lgG protein was detected. 




s i mi I a r 
samples were run under reducing conditions, both the ascites 
fluid and the peak which eluted at pH 7 (lanes 5 & 6, 
respect iv e l,y) cont a i n e d re I at iv e I y sma I I amounts of 25 and 
50 kd protein bands. These bands, which represent the 
reduced form of the intact lgG molecule, were the major 
components of the pH 3 peak (reduced) (lane 7). 
ant i bod i es were labeled with ,ae.1 by 
lmmunoblotting. 
The monoclonal 
incubation with lodogen, a solid-phase iodinating reagent, 
using a method based on that described by Beisiegel tltl 
C 2 3) . T y p i ca I I y , 3 0 0 JJ g p r o t e i n i n 3 0 0 JJ. I o f bu f f e r C 5 0 mM 
NaCl, 10 mM sodium phosphate, pH 7.4) and 300 µCi carrier-
free sodium [ 1215 1liodide were added to a glass scintillation 
vial containing 33 µg of absorbed lodogen. After incubation 
at 4°C 
used to 
for 20 mins, Sephadex G-25 column chromatography was 
separate 1215 1-labeled antibody from free 1215 1. The 
fractions containing the 125 1-antibody were pooled, and 
dialysed overnight at 4°C against 5 I i t res of buffer 
c o n t a i n i n g 5 0 mM N a C I , 10 mM sodium phosphate, pH 7. 4 . 
Yields, as measured by protein recovered, averaged 50%, and 
the specific radioactivity of the labeled antibodies ranged 
from 1 000 to 1 500 cpm/ng protein. This procedure was also 
used to iodinate the rabbit anti-mouse lgG which was used as 
t h e s e c o n d a n t i b o d y i n i mm u n o b I o t t i n g . LDL was radiolabeled 
with 125 1 by the iodine monochloride method as described in 




the abi I ity of the proteins fractionated during the 
purification procedure to recognise the LDL 
receptor, the LDL receptor from bovine adrenal cortex was 
immunoblotted, as described in the legend to Fig. 3.2 . As 
was also reported above (Fig. 3.2), a single band Cmwt = 130 
kd under 
from the 
non-reducing conditions) was observed when medium 
lgG-C7 producing hybridoma cell Ii ne was used as 
first antibody C F i g . 3 . 4 , lane 1). When the ascites fluid 
was used in the first incubation, an identical band was 
detected (lane 2) . The monoclonal antibody produced from 
this ascites fluid, as well as the purified lgG-C7 received 
as a gift from Brown and Goldstein, also showed the 130 kd 
protein CI anes 3 & 4) . No bands were detected on the 
autoradiogram when the control monoclonal antibody was used 
as the first antibody (lane 5). This 130 kd band has been 
LDL receptor by others (47, conclusively identified as the 
2 2 3) . 
Binding kinetics of 188 1-labeled monoclonal antibodies to 
human skin fibroblast monolayers. 
Concentration curves for the binding of 125 1-LDL and 125 1-
lgG-C7 to human skin fibroblast monolayers at 4°C are shown 
in Figures 3.5A and 3.58, respectively. For each of the 
labeled ligands used, the curve was found to have two 
a high-affinity component that approached components: 
saturati'on at an LDL concentration of 10 nM (5 µg/ml) (Fig. 
3.5A), or a nt 5 1-lgG-C7 concentration of 3 nM C0.45 µg/ml) 
(Fig. 3.58), and a non-specific component that increased 
linearly at con cent rations of 125 1-LDL up to 50 nM 
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Fig. 3.-4: lmmunoblotting of the LDL receptor from bovine 
ad re n a I co r t e.x , to t es t the p u r i f i cat i on procedure • 
lmmunoblotting of the LDL receptors was performed exactly as 
described in the legend to Fig . 3. 2, except that all 
monoclonal antibodies were used at 250 ng/ml in the first 
incubation (lanes 3, 4 and 5) . The hybridoma medium and the 
ascites fluid were diluted 1:1 and 1:75, respectively, with 
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Fig. 3.5: Concentration curves for the binding of CA) 128 1-
LDL and CB) 1 ••t-lgG-C7 to human akin fibroblast monolayers 
at 4•c. 
Normal fibroblast monolayers were grown for 5 days, after 
which LDL receptors were upregulated in DMEM/LPDS for 48 hr. 
On day 7 of eel I growth, each mono layer was chi I led to 4°C, 
and incubated with 2 ml of ice-cold MEM without bicarbonate, 
supplemented with 10 mM Hepes and 5 mg protein/ml LPDS, 
containing the indicated concentration of either 125 1-LDL 
(570 cpm/ng protein) or 1ae1-lgG-C7 Cl 300 cpm/ng protein) 
for 2 hr at 4•c. The cells were then washed and solubilized 
in NaOH as described in section 2 . 2 . 7 . Total binding was 
of the appropriate obtained by incubating in the presence 
radiolabeled I igand only. In each case, the low-affinity 
component was derived by extrapolation from the slope of the 
terminal linear porti ·on of the relevant concentration curve. 
The dashed Ii nes show the high-affinity binding, and were 
obtained using the slope-peel technique as described by 
Anderson.!!...!.. ~ (3). Experimental points are the means of 
duplicate dishes; these values did not differ from the means 
by more than 5%. The data are taken from one of three 
representative experiments. Molecular weights of 500 000 
and 150 000 were used for LDL protein and lgG-C7 protein, 
respectively, in order to calculate stochiometry . The 
figures in parentheses along the y-axis in each plot are the 
cell-associated values calculated in fmol/mg cell protein. 
130 
(25 µg/ml) (Fig. 3.5A) and 1211 1-lgG-C7 up to 20 nM C3 µg/ml) 
CFig. 3.58). The dashed I ines in the figures represent the 
high-affinity 
technique (3) 
binding, obtained using the slope-peel 
as detailed in the legend to the figure. The 
Ko values for 1211 1-LDL and 1211 1-lgG-C7 binding to the high-
affinity receptors were 3.6 nM Cl.8 µg/ml) (Fig. 3.5A), and 
0.5 nM C0.075 µg/ml) CF i g. 3.58), respectively. These 
values were calculated as described in section 2 . 2 . 9 . 
Approximately equimolar amounts of 125 1-LDL and 125 1-lgG-C? 
were bound to the cells at s a t u r a ·t i o n C a b o u t 400 · fmo I /mg 
ce I I protein), one high-affinity monoclonal 
antibody binding 
indicating 
site for each high-affinity LDL binding 
s i t e . These data correspond exactly with those obtained by 
others, also using the monoclonal antibody t 0 the LDL 
receptor C 2 2, 23, 243). When the control monoclonal 
antibody was iodinated and incubated with human skin 
fibroblast monolayers in an i dent i ca I manner , v i r tu a I I y no 
high-affinity binding was detected (data not shown). 
Inhibition of 1 • 11 1-LOL binding to cells by prior incubation 
of cells in the presence of lgG-C7. 
The monoclonal antibody, lgG-C7, was able to inhibit to some 
extent, the binding of 125 1-LDL to the LDL receptor of human 
skin fibroblasts. When intact ce I I monolayers were 
subjected to prior incubation for various times with the 
anti-LDL receptor antibody CO to 120 mins), subsequent 125 1-
LDL binding ( 1 hr at 4°C) was found to be decreased 
max irna I I y C 50%) after pre-incubation times of 90 mins or 
longer (data not shown). Similar pre-incubations using the 
control monoclonal antibody directed against an irrelevant 
1 3 1 
antigen were shown to have no effect on the amount of 
1as1-LOL bound to the eel Is. Inhibition of 1215 1-LDL binding 
to the cells at 4°C using a range of unlabeled lgG-C7 
concentrations showed a 40% decrease in binding at 2 nM lgG-
C7 (Fig. 3 . 6 ) . Complete inhibition of 1215 1-LDL binding was 
not achieved Ca 50% decrease in binding was observed at 
50 nM lgG-C7, the highest concentration used). When 
1as1-lgG-C7 was bound to the cells in the presence of LDL 
(30 µg/ml), after a prior incubation f o r hr at 4°C with 
LDL, no inhibition was detected (data not shown). These 
effects have also been documented by others (21, 23). The 
of 
exact molecular explanation of the binding behaviour 
these two ligands awaits clarification. 
3.3.3 Other antibodies used in this study. 
The polyclonal antibody to the LDL receptor was a generous 
gift from Drs. Brown and Goldstein (Departments of Molecular 
Genetics and Internal Medicine, University of Dallas Health 
Dallas, Texas, U.S.A.). It was raised in 
a purified LDL receptor preparation f r om 
Science Centre, 
rabbits against 
bovine adrenal cortex, as detailed in reference 21, and has 
been shown t 0 cross react with the partially purified 
receptor preparation that was used to immunize the rabbits. 
This antibody is directed 
protein, in contrast to 
against the 
the monoclonal 
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Fig. 3.6: Inhibition of 1 as1-LOL binding to human skin 
fibroblasts at 4•c by lgG-C7. 
Normal fibroblasts 
in the legend to 
were grown 
F i g . 3 . 5 . 
and upregulated as described 
0 n day 7 of c e I I gr ow th , each 
monolayer was chi led to 4°C, washed and incubated for 2 hr 
at 4•c in MEM without bicarbonate supp I emented with 
1 0 mM Hepes and 5 mg protein/ml LPDS containing the 
indicated concentration of lgG-C7. After th i s ti me, 1251-
LDL C 7 µg/ml) was added to each dish' and binding was 
effected for hr at 4 ° C . The eel Is were washed and 
harvested i n NaOH as described in section 2 . 2 . 7 . 
Experimental points are the means of duplicate dishes which 
did not differ from each other by more 
the 125 1-LDL bound in plotted represent 
lgG-C7, expressed as a percentage of the 
which was bound in the absence of lgG-C7. 
5%. Data than 
the presence 0 f 
labeled I i g and 
133 
83/25, a monoclonal antibody 




Trowbridge (Dept. of 
Cancer Biology, The Salk Institute for Biological Studies, 
San Diego, California, U.S.A.). This antibody was obtained 
from the fusion of Balb/c mice spleen c e I Is, i mm u n i z e d 
against the human hematopoietic ce I I I in e K562, with a 
my e I oma c e I I I i n e C 1 7 4) . 
3.4 Immune complex formation . 
3. 4. 1 Method. 
All monoclonal antibodies ClgG-C7, 83/25 and the control 
monoclonal) were aliquoted and stored under li..quid nitrogen 
in a 50 mM sodium phosphate buffer, pH 7.4, at 3 mg/ml The 
polyclonal antibody was stored at -70°C . P r e f o r me d i mm u n e 
complexes containing lgG-C7, 83/25 or the control monoclonal 
antibody and a second antibody Cgoat anti-mouse lgG, in each 
case - specific for heavy- and I ight-chains) were prepared 
us i n g the method des c r i bed by To I I es ha u g tl tl C 2 4 3) , w i th a 
few further mod i f i cat i on s . The following reagents were 
used: 
I gG-C7 Cor 83/25 or cont r o I mono c I on a I ) : 150 µg in 50 µI 
sodium phosphate buffer. 
Goat anti-mouse lgG: 1 • 5 mg i n 1 5 0 µ I of 2 0 mM PBS , pH 7 . 4 , 
with 0.05% sodium azide. 
Immune complex buffer: 150 µ I , containing 50 mM TrisHCI, 
pH 8 ~ 2 0 0 mM Na CI , 1 mM EDT A and O . 5% C v / v) non i de t P- 4 0. 
1 3 4 
Reaction mixtures were incubated in microfuge tubes at room 
temperature ·for 
incubation, the 
30 mins, then at 4°C for 24 hours. After 
tubes were spun briefly C 2 OOOxg, 
30 sec), and the supernatant fluid above the precipitate was 
removed. Precipitates were resuspended in 
complex buffer, and spun briefly as before. 
m I of immune 
The i mmu no-
p r e c i p i t a t e s we r e t he n d i s p e r s e d i n 5 0 0 JJ I o f i mm u n e c om p I e x 
buffer by repeated passage through a pipette tip, stored at 
4°C, and used within 2 weeks. Preformed immune complexes 
using either 
were prepared 
the polyclonal anti body or t h e n o n i mm u n e I g G 
similarly, except 
was used as the second antibody 
that goat 
for both, 
antibodies had been raised in rabbits. 
anti-rabbit lgG 
because these 
Protein concentrations of the 
ranged from 1 . 5 to 3 mg/ml. 
resuspended immune complexes 
Yields were typically 70-80% 
with respect to total protein used. 
3. 4. 2 Optimization of conditions for immune complex 
formation. 
Time course of precipitation. 
Immune complexes were made as des c r i.b e d above, using 
,.as1-lgG-C7 (specific activity= 300 cpm/ng protein), goat 
ant i -mouse I g G, and immune complex buffer. Control tubes 
contained the identical components, except that the goat 
anti-mouse lgG was omitted. After incubation for 30 mins at 
room temperature, the mixtures were kept at 4°C for various 
times (1 day, 1 1 /.a days or 4 days). At each of these times, 
135 
the tubes were centrifuged briefly, and 10 ul of supernatant 
was counted in a gamma counter. Al I points were done in 
duplicate, and values differed from each other by less than 
5%. Results obtained showed an 8 7% pr e c i p i tat i on of 
1as1-lgG-C7 at day 1, which stayed constant at the i 1 /a and 
4 day ti mes. In al subsequent experiments, immune complex 
formation C4°C) was for 24-48 hours. 
Optimum antibody ratios in the immune complex. 
Immune complexes were made essentially as described in 
sect i on 3 . 4 . 1 , w i t h each t u be con ta i n i n g an i den t i ca I amo u n t 
of 125 1-lgG-C7 (specific activity = 1 300 cpm/ng protein), 
but varying amounts of goat anti-mouse lgG protein, in order 
to obtain 
The ratios 
a range of ratios of first to second antibodies. 
used varied from 1:80 C125 1-lgG-C7 goat anti-
mouse lgG) to 1:1. In order to keep the total volume of the 
immune complex mixture constant, the volume of immune 
complex buffer 
Control tubes 
added in each tube was adjusted accordingly. 
contained the radiolabeled lgG-C7 and the 
immune complex buffer only. At various times (24 hr, 48 hr 
or 66 hr), the percentage of the 1as1-lgG-C7 which had 
p r e c i p i t'a t e d r e I a t i v e to the control was calculated as 
described above. The results, which are shown in Table 3.1, 
indicate that when the goat anti-mouse lgG was present in an 
excess of 10-fold Co r greater), more than 80% of the 
, a 5 I - I g G - C 7 p r e c i p i t a t e d i n t h e i mm u n e comp I e x , i r r e s p e c t i v e 
of the length of the 4°C incubation. A I I s u b s e q u e n t i mm u n e 
complexes were made using a 1 : 1 0 ratio of lgG-C7 goat 
anti-mouse lgG. 
136 
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Table 3.1: Optimization of antibody rat i o s i n the immune 
complex. 
Immune complexes, containing varying amounts of goat anti-
mouse lgG and a constant amount of 125 1-lgG-C?, were made 
and analysed at the indicated times, as described in section 
3. 4. 2. The results were calculated from s i ngle measurements 
at each time point. 
Ratio of " Precipitation of 1 28 1-lgG-C7 125 1-lgG-C7:G anti-M" 
Time (hours) 
24 48 66 
80 80 82 83 
1 40 85 86 87 
1 20 85 89 90 
1 10 81 91 89 
1 5 nd"" nd nd 
1 2.5 nd nd nd 
1 1 nd nd nd 
• = 125 1-lgG-C7:goat anti-mouse complex 
•• = not detectable 
3.5 Cel Is - growth, labeling and aolubi I izat ion. 
3. 5. 1 Cel I growth and LDL receptor upregulation. 
Unless otherwise specified, human skin fibroblasts were set 
up i n 60 mm petri dishes according to the standard format 
described in section 2 . 2 . 1. The 
for 
cells were routinely 
maintained in growth medium 4 days only before 
initiating upregulation of the LDL receptors by incubating 
the monolayers 
Upregulation was 
in DMEM/LPDS, as described in section 2.2.5. 
effected for 16 hr prior to commencing the 
pulse-label, unless otherwise specified. 
3.5.2 Biosvnthet ic labeling of eel I proteins. 
After the LDL receptors on the monolayers had been 
upregulated, the ce 11 s were washed once with 2 ml/di sh of 
PBS, and then incubated with 1.3 ml/dish of methionine-free 
MEM CEMEM) containing 5 mg/ml LPDS and the indicated amounts 
of [ 38 Sl-methionine (the pulse) [Note: The source of [ 38 SJ-
methionine used in the relevant experiments was Tran 38 S-
label, which was the hydrolysate of E. co I i grown in . the 
presence of contained [ 38 SJ-methionine, 7 Oo/o; 
[38S]-cysteine, 20%; (3&8]-methionine sulphoxide, 7%; 
(38S]-cysteic acid, 2% and other 38 S-cornpounds, 1%. In a I I 
cases, the amounts of 38 S-label added to the media have been 
expressed in terms of the actual [ 38 Sl-rnethionine content. 
For convenience, the label wi I I be referred to hereafter as 
138 
[ 38 SJ-methionineJ. 
unless otherwise 
Pulse-labeling was performed for 
specified. The pulse medium was 
8 hr 
then 
removed, after which the eel I monolayers were washed once 
with PBS, then chased with 2 ml/dish of DMEM/LPDS 
(containing 200 
un I ess otherwise 
µM methionine) for various times at 37°C, 
indicated. 
were not chased subsequent 
In those cases where the cells 
to labeling, the dishes - still 
containing the pulse medium were processed f o r 
s o I u b i I i z a t i o n i mm e d i a t e I y . 
In order to assess the effect of the methionine-free medium 
on eel I viabi I ity, the monolayers were grown and upregulated 
as des er i bed in section 3. 5. 1. The cells were then 
incubated either in fresh DMEM/LPDS, or in methionine-free 
medium CEMEM) supplemented with LPDS and 10 µM cold 
methionine Can amount well below the lowest amount of ( 3 tsSJ-
methion i ne used in any of the pulse procedures) . At the 
indicated times, 2.2x10 7 dpm of C3 Hl-phenylalanine was added 
to each dish, and the incubations were continued f o r a 
further 2 hours at 37•c. Protein synthesis rates at each of 
these times was then determined after TCA p r e c i p i t a t i ·on . 
The results, which are depicted in Fig . 3.7, show that there 
was no significant difference in protein synth~sis rates and 
hence, by extrapolation, cell viability, over the 50 hour 
period which was tested. The rates in both cases decreased 
as a function of time, probably due to general "step-down" 
conditions imposed 
medium. 
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Fig. 3.7 The effects of DMEM/LPDS or EMEM/LPDS 
supp I eme n t e d w i th met h ion i n e C • ) , on pro t e i n syn the s i s i n 
fibroblasts. 
Cel Is were grown, upregulated and incubated in DMEM/LPDS Ce) 
or EMEM/LPDS supplemented with 10 µM cold methionine CA) as 
described in section 3.5 . 2. Protein synthesis rates were 
measured at the indicated t i mes a f t e r TCA precipitation. 
The results are means obtained from duplicate dishes at each 
time point. Values never differed by more than 5% from the 
means. 
1 4 0 




indicated chase periods, the cell monolayers were 
4°C for 10 mins, and washed twice with 2 ml of 
con ta i n i n g 1 0 mM Hep es , pH 7 . 4 , 1 5 0 mM Na C I and 
2 mM CaCl2. 
of ice-cold 
The cells were then lysed by addition of 200 µI 
Buffer B containing 10 mM Hepes, pH 7.4, 
200 mM NaCl, 2 mM CaCla, 2 . 5 mM Mg CI a , 1 mM PMS F i n O . 2 5% 
( V / V ) d i me thy I 6 U I p h OX i de , 0 . 1 mM leupeptin and 1% Cv/v) 
Triton X-100. The c e I I s were scraped f r om each d i sh w i th a 
teflon pol iceman, transferred to 1.5 ml microfuge tubes, and 
the dishes were washed with a second 200 µI volume 0 f 
Buffer B; th i s was pooled with the original harvest. 
Centrifugation was performed at 4°C for 10 m i ns at 12 OOOxg 
in a microfuge . The pellets were discarded, and the cell 
extracts (320 µ I out of the total volume obtained from one 
dish of cells) were either processed immed i ately, or were 
i mm u n o p r e c i p i t a t i o n . frozen under I i quid nitrogen before 









s imu I taneous I y 
to 
a f t er i mm u n o p r e c i p i t a t e d 
solubil i zation at the initial staggered chase ti mes. The 
effect of freezing the detergent-solubi I ized eel I extracts 
for various 
ex am i n e d . 
I e n g t h s o f t i me b e f o r e i mm u n o p r e c i p i t a t i o n , w a s 
Irrespective of whether the extracts were frozen 
for 4, 8, 2 4 or 48 hours before thawing and subsequent 
i mm u n o p r e c i p i t a t i o n , o r whether they were frozen and thawed 
i mm e d i a t e I y , s i m i I a r amounts of LDL receptor protein were 
i mm u n o p r e c i p i t a t e d w h e n compared to solubilized cells which 
had never been frozen . Since the freeze-thaw procedure 
1 4 1 
produced no significant loss of LDL receptor activity, it 
was used routine I y to fac i Ii tate subsequent ex per imentat ion. 
3.6 lmmunoprecipitation 
3.6.1 Method 
The i mm u n o p r e c i p i t a t i o n me t h o d used, was based on the 
procedure originally described by Terhorst~ .!1.l. (240), as 
modified by 
alterations. 
Tolleshougtl tlC244), w i th a few add i t ion a I 
320 ul of 35S-labeled eel I extract was mixed 
with a 4 0 u I or an 8 0 u I a Ii quot of one of the preformed 
immune complexes (containing lgG-C7 or control antibody or 
the polyclonal antibody). The mixture was incubated at 4°C 
f o r 1 hour on a rocking platform, and then centrifuged in a 
Microfuge (2 000 rpm, 4°C, 5 mins). The supernatant above 
each pe 11 et was either discarded, or was carefu 11 y aspirated 
off and mixed with a second 4 0 u I aliquot of preformed 
immune complex, then precipitated and processed as per the 
f i r s t i mm u n o p r e c i p i t a t i o n . The latter procedure was mainly 
used for the immunoprecipitation of the transferrin receptor 
Cie. the supernatant from the first precipitation was mixed 
with preformed 
precipitate the 
also used t 0 
immune complex containing 83/25, in order to 
transferrin receptor). This procedure was 
check the effectiveness of the f i r s t 
precipitation Cie. a second precipitation was performed 
using lgG-C7 containing immune complex). 
1 4 2 
Each pellet formed during the precipitation step, was 
dissolved in 
a four-step 
200 µJ of Buffer B, and then layered on top of 
sucrose gradient, prepared as described by 
Toi leshaug tl tl (243). A I I sucrose gradients contained 
1 0 mM Tr i s HC I , pH 8 and 
composed of the following: 
mM PMSF. Each layer (750 µI) was 
Layer ( t O p ) : 
Layer 2: 
Layer 3: 
Layer 4 (bottom) 
10% sucrose, 0.5% CHAPS 
20% sucrose, 0.5 M NaCl, 0.2% Nonidet P-40 
30% sucrose, 0.1% SOS, 0.2% Nonidet P-40 
40% sucrose 
The gradients were centrifuged at 2 000 rpm for 30 mins at 
4°C in a Beckman TJ-6 centrifuge. Each supernatant was then 
carefully poured off, and the remaining pellet resuspended 
in 200 µ I of buffer containing 5 0 mM Tri sC I pH 8 and 
at 2 mM CaCl2, transferred to a microfuge tube and spun 
12 000 rpm for 20 seconds. This f in a I precipitate was 
dissolved in 40 µI of a solution containing 4 M urea, 
100 mM di thiothrei tol, 10% ( V / V) glycerol, 5% ( V / V) 
2-rnercaptoethanol, 2.4% Cw/v) SOS and 75 mM Tris, heated to 
90°C for 3 mins in a water bath and electrophoresed as 
described in section 3.7.1. 
In one experiment, aliquots 0 f the solubilized cells and 
aliquots·of 
with TCA . 
the final immunoprecipitates were precipitated 
I n this way, it was calculated that the labeled 
LDL receptor protein and the labeled transferrin receptor 
protein represented approximately 0.035% and 0.06%, 
respectively, of 
hours . 
total labeled cell proteins pulsed for 8 
1 4 3 
3. 6. 2 Optimization of the precipitation conditions. 
Preclearing 
There existed the distinct possibility that a f i r s t 
incubation of the eel extracts with an immune complex 
con ta i n i n g t he con t r o I mono c I on a I an t i body Cd i rec t e d a g a i n s t 
an irrelevant antigen), would precipitate, and hence remove, 
any non-specific radiolabeled proteins an effective 
11 p r e c I e a r 11 • Thus subsequent pr e c i -p i tat i on s of the L D L and 
t rans f e r r i n rec e p tor s wo u I d C t he ore t i ca I I y) cont~in almost 
entirely the desired protein. This procedure was 
but was not adopted because i t made no investigated, 
difference to the quality of the results obtained when the 
preclear procedure was omitted (data not shown) . 
The order of sequential immunoprecipitations. 
We tested whether the precipitation using the immune complex 
co n t a i n i n g I g G - C 7 w o u I d b e o p t i m i z e d i f t h i s i mm u n e c om p I e x 
was used either before, simultaneously with, or after that 
containing 
receptor. 
the monoclonal antibody to the t r a n s f e r r i n 
To this end, radiolabeled, detergent-solubi I ized 
ce I I extracts were subjected to success i ve i mmunopre-
cipitations with immune complexes containing monoclonal 
antibodies, as follows: ( i ) f i r s t by 
83/25; Cii) first 83/25, followed 
lgG-C7, 
by I gG-C7 
followed 
or C i i i ) a 
combination of lgG-C7 + 83/25 in a single precipitation . 
The latter approach was feasible since the t WO receptors 
differed in their apparent molecular weight on SOS-PAGE CLDL 
receptor = 160 kd; transferrin receptor = 90 kd). The 
1 4 4 
1 4 5 
results showed clearly that in all the above com
binations, 
s i m i I a r am o u n t s o f r e c e p t o r p r o t e i n s w e r e i mm u n o p r e c i p i t a t e d 
(data not given). I n mos t experiments reported in 
t h i s 
thesis, approach Ci) was used, but occassional ly approach 
Ci ii) was adopted (see legends to tigures). 
Time required for invnunoprecipitation. 
When the length of t h e i mm u n o p r e c i p i t a t i o n incubation was 
varied from 1 hour to 16 hours, no detectable difference was 
noted in the amount of receptor precipitated (data not 
shown) . However, at the longer time ·points, the amount of 
labeled, non-specific proteins which co-precipitated was 
great I y increased - very noticable among these were actin 
C 4 3 k d J and myosin (200 kd) . To obviate th i s problem, 
precipitations were always done for I ess than 3 hours 
usually tor hour at 4°C. 
3.7 Visualization of the labeled immunoprecipitates. 
3. 7. 1 SOS-PAGE. 
Electrophoresis was carried out on SDS-polyacrylamide slab 
gels, according to the method of L a e mm I i C 1 3 7 ) , using a 
I inear 5-20% acrylamide gradient . Samples were reduced by 
incubating Cat go•c, for 3 mins) with 2-mercaptoethanol. 
Electrophoresis was performed at 30 mA per slab gel, at room 
temperature, for 3 hours . Gels were calibrated with the 
following standards: myosin (200 k d ) ' phosphorylase b 
C 9 4 k d ) , bovine serum albumin (67 kd), ovalbumin (43 kd), 
carbonic anhydrase (30 kd), trypsin inhibitor (20 kd) an
d 
alpha-lactalbumin C14 k d) . The gels were routinely stained 
prior to drying, in order to visualize the and destained 
positions of the molecular weight marker standards, and to 
check the resolution of protein bands . 
3 . 7 . 2 Fluorography 
Destained gels were enhanced w i t h the wa t er so I u b I e f I u or , 
sodium salicylate, dried and subjected to fluorography using 
the following procedure. The gels were washed in water for 
30 mins to prevent the subsequent precipitation of sodium 
for 30 minutes in 1 M salicylate . They were then soaked 
sodium salicylate at room temperature according to the 
method described by Chamberlain (39). At th i s concentration 
of f I uo r, and after soaking for this length of time in the 
fluor, film darkening was optimal. The ge Is were then dried 
for 3 hours at 60°C on a Dual Temperature Slab Gel Dryer, 
and exposed to a preflashed X-ray f i Im (Kodak XAR-5 f i Im) 
(139) at -70°C for times ranging from 16 hours to 48 hours . 
The rationale behind the use of this method is as follows . 
The fluor converts the energy of the beta-part i c I es to 
vis i ble light, which then forms an image on the X-ray f i Im . 
In this way, absorption of beta-particles within the sample 
is overcome by the increased penetration of I i g ht. 
Pref lash i ng of the fi Im produces a f luorographic image which 
is proportional to the distribution of the radioactivity in 
the sample . At the temperatures used during exposure of the 
1 4 6 
f i Im C-70°CJ, 
increased due 
silver atoms, 
the sensitivity to I ow light intensities is 
to the lengthening of the half-life of single 
which facilitates the initial stage of latent 
image formation. The overall image improvement using this 
method of f luorography over direct autoradiography is about 
1 5- f o Id C 138). 
Quantitation of the fluorograms was performed spectro-
photometrically as described by Suissa (231). The parts of 
the ti Im containing the darkened bands were excised as wel I 







Cthe blanks). These excised 
ml aliquots of N NaOH 
use) and incubated at room 
temperature for 2 hours or longer, untii al the s i Iver 
grains had been e I u t e d f r om the f i Im s I i c es . The solutions 
were vortexed mixed, and the pieces of clear film removed 
f rorn each tube. 30% glycerol was added to each, and the 
tubes were again vortex mixed before reading the absorbances 
on a spectrophotometer at 500 nm. In all cases, care was 
taken to expose the f luorograms such that the darkened bands 
were below 
well within 
the plateau density of film darkening, and hence 
the linear response range of the f i Im. To 
obtain maximum clarity for photographic reproduction only, 
dup Ii cate f.l uorograms were overexposed in some cases. 
1 4 7 
3. 7. 3 Quantitativeness of the immunoprecipitation and 
fluoroaraphic procedures. 
In theory, the proportion of an antigen wh-ich reacts with a 
constant amount of an antibody does not vary with respect to 
antigen concentration provided that the affinity constant 




borne out by a direct test of 
LDL receptor content of a set 
of samples, and the amount of radioactivity detected on 
f luorograms using the standard immunoprecipitation procedure 
with a constant amount of monoclonal antibody complex (fig. 
3. 8). The NaOH extraction method of measuring the density 
of bands on fluorograms was also shown to be quantitative, 
provided that care was taken to expose the f I uorograms in 
such a manner that the darkened bands were below the plate·au 
density of film darkening, and hence well within the linear 
of the film. The absorbance readings within response range 
an individual experiment were generally in the range of 
0.03 - 0.2 units, after subtraction of the fi Im blank value. 
3. 8 Verification of the identity of the immunoprecipitated 
protein. 
3 . 8 . 1 Use of an immune complex containing monoclonal 
antibodies directed against an irrelevant antigen. 
It is well .documented that the mature LDL receptor _has an 
apparent molecular we i g ht of 160 kd when subjected to SOS-
PAGE . under reducing conditions C 2 4 3 ) ; that of the 
148 
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F i g . 3. 8: Quantitation of immunoprecipitation and 
fluorogram extraction procedures. 
Normal fibroblast monolayers were incubated either in 
DMEM/LPDS Cto upregulate the LDL receptors), or in DMEM/LPDS 
+ ug/ml of 25-hydroxycholesterol (to downregulate the LDL 
receptors) for 15 hours. The cells were then pulse-labeled 
f o r 8 hours i n EMEM/LPDS containing 50 uC i Im I 
met h i on i n e i n the absence 
hydroxycholesterol C f o r 
monolayers, respectively). 














was pooled appropriately to yield a stock of 
extracts, in which the LDL receptors had 
been either 
in varying 
up- or downregulated. These stocks were mixed 
accurately known series proportions to give an 
o f d i I u t e d r a d i o I a b e I e d L D L r e c e p t o r s . I mm u n o p r e c i p i t a t i o n 
was performed with 40 µI of lgG-C7 containing immune complex 
per 320 ul of mixture. T h e I a b e I e d i mm u n o p r e c i p i t a t e s we r e 
then sub j ected to SOS-PAGE and f luorography. Quant i tat ion 
of the bands corresponding to the LDL receptors on the 
flourograms was done by NaOH extraction . Data shown 
represent the mean~ S.D. of the absorbances obtained from 
triplicate precipitations . The results are typical of those 
obtained in 3 such experiments, performed at various times 




response was maintained up 










(using flourograms which had been exposed for longer times -
data not shown). 
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transferrin receptor is about 90 kd (173). We demonstrated 
that the i mm u n o p r e c i p i t a t i o n of the 90 kd and 160 kd 
proteins did not merely represent non-specific 
using an immune complex containing the precipitation, by 
control monoclonal antibody (directed against an irrelevant 
antigen). Standard procedures were used for the 
i mm u n o p r e c i p i t a t i o n s a n d fluorography (fig. 
4) . When these results were compared to 







it was evident 
lgG-C7 and B3/25 Cfig. 
that both the 160 kd 
3 . 9 , 
LDL 
receptor bands, and the 90 kd transferrin receptor bands 
were specifically i mmu no pre c i pi tat e d by the appropriate 
monoclonal antibodies. 
To show that the specifically precipitated 160 kd band 
actually represented the LDL receptor, the investigations 
outlined in sections 3.8.2, 3.8.3 and 3 . 8.4 were performed. 
3.8.2 Synthesis and processing of the LDL receptor. 
The precursor 
incubating the 
form of the 160 kd protein was labeled by 





fibroblast monolayers for 30 minutes in 
containing medium. This short pulse-
fol lowed by chase periods ranging from O to 
after which the receptors were immuno-
subjected to SOS-PAGE. The f luorogram was 
the percentage protein in the 120 kd and 
160 kd forms at each time was determined (fig. 3 . 10). When 
the cells were pulse-labeled with [ 35 Sl-rnethionine for 
1 5 1 
152 
FIGURE 3.9 
GM 3348A T.T. Gell line 
LDL 




+ 83/25 control ab (7 + 83/25 comple~ 
1,2 3,4 5,6 7,8 lane no 
LDL-R 
Tf-R 
Fig. 3.9: Verification of the identity of the 160 kd 
immunoprecipitated protein. 
Norma I human skin fibroblast mono I ayers C GM 3 3 4 8 A) C I an es 
1-6) and those f r om pa t i en t T . T . C see sec t i on 3 . 8 . 4 ) C I an es 
7 & 
4 of 
8) were cultured as described in section 3.5.1. On day 
eel I growth, the LDL receptors on the monolayers were 
either upregulated (by incubation in DMEM/LPDS) or 
downregulated Cby incubation in DMEM/LPDS + _µg/ml 25-
hydroxycholesterol) for 16 hours. The monolayers were then 
pulse-labeled for 8 hours with EMEM/LPDS containing 
40 µCi/ml [ 35 SJ-methionine, in the absence or presence of 
25-hydroxycholesterol. After detergent solubilization, the 
c e I I e x t r a c t s we r e i n c u b a t e d w i t h p r e f o rm e d i mm u n e comp I e x e s 
containing lgG-C7 + 83/25 (lanes 1, 2 & 5-8) or the control 
mono c I on a I ant i body C I an es 3 & 4) . The radiolabeled immuno-
precipitates were subjected to SOS-PAGE and 
Duplicate precipitations 
variables tested. 
were performed for 
f I uorography. 
each of the 
1 5 3 
100 
C 
a> ·-a> C -C: 0 ,._ 
0 a. 
~ - ,._ (1) 0 
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Fig 3.10: Synthesis and processing of the LDL receptor from 
120 kd ceJ to 160 kd COl. 
HSF were grown and upregulated as described in section 3.5.1 
then pulse-labeled for 30 mins with 70 .uCi/ml of 
[~ 5 SJ-methionine in EMEM/LPDS. The ce 11 s were chased with 
medium containing complete DMEM + LPDS for the indicated 
times, prior to being detergent solubilized. Cel I extracts 
were incubated with preformed immune complexes co n•t a i n i n g 
lgG-C7, and the labeled immunoprecipitates were subjected to 
SOS-PAGE and fluorography. Darkened f lourographic bands 
were extracted, and absorbances were read at 500 nm . The 
fraction of ~ 5 S-radioactivity in · each band, at each ti me 
point, was calculated by dividing the reading of the 
individual band by the sum of the absorbance readings of 
both bands at that particular chase time. Data plotted are 
the means of duplicates; 
each other. 
these always differed by < 6% from 
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30 minutes and not chased, the 120 kd band was the only 
immunoprecipitated band seen. After 30 minutes of chase, 
about 50% of the protein was converted to the 160 kd form, 
and by 
of 12 0 
hour, about 90% had been converted. As the amount 
kd precursor protein declined, the 160 kd prate in 
increased correspondingly, thus the tot a I amount of [ 3 15 S l -
radioactivity in both bands remained constant. 
The kinetics of this conversion, and the molecular weights 
of the precursor and mature forms, are in agreement with the 
results of Tolleshaug tl tl (243) in their work describing 
the post-translational processing of the LDL receptor. 
3.8.3 Downregulation of the LDL receptor. 
The LDL receptors on normal human skin fibroblast monolayers 
were either upregulated Cby incubation in DMEM/LPDS medium), 
or downregulated 
supplemented with 
C i n 
.u g Im I 
medium containing DMEM/LPDS 
of 25-hydroxycholesterol) for 23 
hours - including the 8 hour pulse pe~iod - according to the 
standard procedure. A f t er the p u Is e, the cells were 
solubilized and p r e c i p i t a t e d w i t h i mm u n e c om p I e x c o n t a i n i n g 
lgG-C7 and B3/25. The f luorogram showed very distinct LDL 
receptor bands (160 kd) obtained from cells which had been 
upregulated (Fig. 3.9, lanes 1 & 2); this band was markedly 
decreased in precipitations which were performed on cells 
where the LDL receptor had been downregulated f i r s t 
C F i g . 3 . 9 , lanes 5 & 6). In contrast, the amount of trans-
ferrin receptor protein which was i mm u n o p r e c i p i t a t e d 
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remained approximately constant, irrespective of whether or 
not the eel Is had been pre incubated in 25-hydroxycholesterol 
containing medium. 
3.8.4 Use of another eel I I ine. 
Fibroblasts obtained from a clinically defined Xhosa 
patient, designated 
to 50-70% of normal 
T . T., have been shown to bind 125 1-LDL 
C 4 3) , wh i I e demonstrating less than 
2% binding activity of lgG-C7 at 4°C and 37°C CCoetzee ..!Lt. 
tl, unpub Ii shed results). These cells, and cells from a 
normal HSF line, were labeled with [ 3 ~SJ-methionine, and 
i mm u n o p r e c i p i t a t e d with the lgG-C7 containing immune 
complex, according to the standard protocol. The f I u or o gr am 
band obtained showed a 




i n e C F i g . 
LDL receptor 
3.9, lanes 1 & 2) , wh i I e 
there was no detectable radioactivity in th i s 160 kd 
position using cells obtained from patient T.T. (fig. 3.9, 
lanes 7 & 8) . Both c e I I types contained transferrin 
receptors, which were imrnunoprecipitated by the 83/25 
antibody present i n the immune complexes. From the 
f I u or o g ram, i t appears that the T.T. cell line has somewhat 
more t rans f e r r i n r e c e p tor s than does the nor ma I c e I I I i n e . 
The results obtained in sections 3.8.1 3 . 8 . 4 indicate 
conclusively that the 160 kd protein, which was specifically 
immunoprecipitated by the lgG-C7 containing immune complex, 
represents the mature form of the LDL receptor. 
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3.9 The half-I ife of the LDL (and transferrin) receptors in 
normal human ski·n fibroblasts. 
The turnover rates of the lDL and transferrin receptors on a 
normal HSF ce I I I i ne CGM 3348A), were measured using the 
[ 3 6 S l -met h i on i n e pulse-chase protocol as described in 
sections 3.4 - 3.7. Monolayers were incubated for 16 hours 
in DMEM/LPDS medium to upregulate the LDL receptors, and 
were subsequently pulse-labeled in methionine-free medium 
CEMEM) containing LPDS and [ 38 Sl-methionine . The cells were 
then chased in complete DMEM/LPDS (containing 200 µM 
unlabeled methionine) for various ti mes before detergent 
solubi I ization. At each t i m e , a f i r s t i mm u n o p r e c i p i t a t i o n 
was performed using preformed immune complex containing lgG-
C7 to precipitate the radiolabeled LDL receptor protein, and 
a s e c o n d p r e c i p i t a t i o n w a s d o n e w i t h B 3 / 2 5 c o n t a i n i n g i mm u n e 
complex to bring down the transferrin receptors. 
Measurement of the radioactivity remaining in the 160 kd LDL 
receptor bands 
t y pi ca I f i rs t 
11.7 .±. 2.2 hr 
mean.±. S.D. of 
Another normal 
half-life for 
fr om the fluorograms CFig. 3.11A) yielded a 
order decay curve with a half-life Ct1/2) of 
C F i g . 3 • 1 1 B ) . These results represent the 
data obtained from 10 separate experiments. 
HSF Ii ne, CFGo), was examined, and a s imi I ar 
the LDL receptors was obtained (data not 
shown). Quantitation of the 90 kd transferrin receptor 
bands from the 
approx i mate t , / :a 
fl ·uorograms 
of 55 .±. 10 
C F i g . 







depicted are one of 6 representative experiments, performed 
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3 . 1 1 : lmmunoprecipitation of 38S-labeled LDL receptors 
and 38S-labeled transferrin receptors c•> from norma I 
human skin fibroblasts. 
Monolayers were 
then incubated 
LDL receptors . 
grown as des er i bed in s e c t i o n 3 . 5 . 1 , and 
in DMEM/LPDS for 16 hours to upregulate the 
The cells were pulse-labeled for 8 hours in 
EMEM/LPDS containing 35 uCi/ml c:sasJ-methionine, and then 
chased for the indicated times in complete medium containing 
200 uM unlabeled methionine. The detergent solubi I ized eel I 
extracts were incubated with preformed immune complexes 
containing lgG-C7, the 
receptor C •). A second 
monoclonal antibody to the 





to the transferrin receptor, was 
performed on extracts C • ). A I I I a b e I e d i mm u n o -
precip i tates were subjected to 5-20% SOS-PAGE and 
and f I uorography. A: Fluorograms showing the LDL-
transferrin receptors at each chase time. 8: Semi log plots 
the first chase of the percentage absorbance (relative to 
point) versus ch as e t i me , we r e ob ta i n e d a f t er ext r act i on of 




LDL receptor values plotted are the means 
Cat the 1 hour chase-incubation time), or 
the 5, 9, 1 6 and 24 hour chase incubation 




Duplicates never differed by more than 1 0% 
from the means . Simi tar results were obtained in 9 separate 
experiments. The transferrin ~eceptor values plotted were 
obtained from single precipitations at each point; 
results were obtained in 5 other experiments . 
s i mi I a r 
separately (in sever a I of the other experiments. longer 
chase-incubation times were used) . This t,,. 2 value is in 
agreement with the pub I ished half-I ife of about 60 hours for 
these receptors on a human T cell line. which was obtained 
using similar procedures (173) . 
3. 10 Concluding remarks. 
A pulse-chase procedure, which would enable the accurate 
quant itation of the total eel lular LDL receptors. was set up 
and optimized. In brief, cultured human skin fibroblasts 
were pulse-labeled with [ 315 SJ-methionine, followed by chase 
incubation for v a r i o us t i mes 
unlabeled methionine . The 
solubilized, and the labeled 
i n the presence 
monolayers were 





the c e I I 
extracts were s p e c i f i c a I I y i mm u n o p r e c i p i t a t e d b y i n c u b a t i o n 
with preformed immune complex containing lgG-C7 C the 
monoclonal antibody to the I igand binding domain of the LDL 
receptor) . Using analagous procedures, the t r a n s f e r r i n 
receptors were immunoprecipitated with 63/25 Cthe monoclonal 
antibody to the transferrin receptor) . From the f luorograms 
which were finally obtained, it was possible to visualize, 
and to quantitate accurately, the turnover rates of these 
receptors . 
Using this protocol, the half-lives of LDL receptors on 
fibroblast monolayers were measured, in the absence of any 
added agents. As is shown in Fig . 3.11, the measurement of 
r ad i o a c t i v i t y r ema i n i n g in the 
f r om the fluorograms yielded 
160 kd 






curve, with a t,.,2 of 11.7 .±. 2.2 hr (mean.±. S.D. of data 
obtained from 10 separate experiments). 
Knight~ .!!..l_ (128) reported a t,.,2 of 
Very 
1 2 hr 
recently, 
for the LDL 
receptor on the same eel type, using asimilar approach. 
is markedly shorter than This half-life 
that obtained 
of about 12 hours 
in 1975 by Brown and Goldstein (32) for these 
receptors. Their value of 25-30 hours was determined by 
performing a 1:as1-LDL binding assay on intact fibroblast 
monolayers, which had been incubated for var i o us t i mes i n 
the presence of the protein synthesis i n h i b i. t o r , 
cycloheximide. 




over much slower than the LDL receptors in 
The turnover rates of other plasma membrane 
been wel documented in the I iterature; i t 
appears that most have half-lives between 10 and 80 hours 
C s e c t i o n 3 . 1 ) . Thus, it would seem that receptor proteins 
turned over as a unit with the plasma membrane; 
rather, i t appears probable that there may be some 
mechanismCs) which determine the unique rate at which each 
of the plasma membrane receptor types is turned over. 
I n the fol lowing section, an in-depth study of LDL receptor 
turnover is presented, including implications as to LDL 
receptor up- and downregulation, as wel I as the effect Cs) of 
various agents - such as cycloheximide - on the half-life. 
Possible siteCs) and mechanismCs) of degradation of the LDL 
receptors were also investigated using this pulse-chase 
protoco I, in an attempt to gain insight into the factors, 
1 6 1 
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Cother than synthesis), governing the expression 0 f th i s 
important transmembrane I ipoprotein receptor. 
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4 . 5 Con c I u d i n g remarks .................................. 2 1 8 · 
4 . 1 Introduction. 
Although the process of receptor-mediated endocytosis has 
been extensively studied, and much is known about the 
synthesis and processing of LDL receptor molecules, the 
int race I lular siteCs) a n d .b i o c h em i c a I mechanismCs) respon-
sible for the final degradation of LDL receptors have not 
been elucidated (reviewed in 3 4, 88, 24 7). It has been 
shown that receptor degradation and I igand breakdown are not 
necessar i I y coup I ed events; there are many wel I documented 
cases where receptors have been observed to recycle in bulk 
to the cell surface s u b seq u e,n t t o internalization, wh i I e 
some, or all, of their ligands are degraded in lysosomes . 
Thus, asialoglycoprotein receptors in isolated rat 
hepatocytes recycle many times in this manner, while their .., 
endocytosed I igand is degraded 
receptors 
(14, 225); LDL receptors 
C 8 8) and ins u I in C 135, 1 5 3) also escape 
degradation and are recycled. Transferrin receptors 
repeatedly traverse the endocytot i c pathway together with 
bound protein I igand (262). In contrast, some receptors, 
such as those specific for EGF in HSF (55, 65), are degraded 






of 11 . 7 ..±. 2 . 2 
cultured HSF, 
hours was obtained for the LDL 
using the radio I abe I pu I se-chase 
described in Section Three. This was 
shorter than that obtained by Brown and 
1975 (32): their assay of the decreased 
surface I igand-binding activity after the administration of 
the protein synthesis inhibitor, cycloheximide, yielded a 
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t 1 .I' :2 0 f 25-30 hours. This agent, however, inhibits general 
as we I I as protein s.y nth es is ( 81). cellular proteolysis 
Knutson tl tl (131), using the heavy-isotope density shift 
technique, showed that cycloheximide inhibited not only the 
syn the s i s of new i n s u I i n receptors but a I so the i n act i vat i on 











the presence of puromycin, 
These authors concluded that 
receptor was mediated by a 
(the mRNA of which was also 
thus exists that determination of the half-
I ife of the LDL receptor in the presence of cycloheximide 
I eads to an overestimation of the actual value. I t 
of 
i s 
noteworthy in this connection that the addition 25-
hydroxycholesterol to fibroblasts produces downregulation of 
the receptor number which occu-rs significantly faster 
10 hr) than when the same effect is produced in the 
presence of cycloheximide (32). Van der Westhuyzen and 
Coetzee (247) have suggested that the hydroxycholesterol 
could cause an increased rate of receptor degradation . This 
is plausible, since Tanaka tl tl (235) have shown that the 
rapid and very marked decrease in HMG CoA reductase activity 
which is caused by the addition of 25-hydroxycholesterol is 
due less to a decreased rate of synthesis than to a dramatic 
increase in the rate of enzyme degradation. Gil tltl (78) 
subsequent I y showed that the truncated soluble part of the 
HMG CoA reductase protein has ful I enzymatic activity, while 
the membrane-bound domain plays a crucial role in the rapid, 
l 6 5 
regulated degradation 
is also worth noting 
differentiated 3T3-L1 
of the enzyme protein as a whole. I t 
that Ronnett tltl (195), using fully 
adipocytes, found no change in the 
rate of i nsu Ii n receptor synthesis associated with up- or 
downregulation of 
receptor half-I ife 
receptor number, but they noted that the 
increased from 8.1 to 1 4 . 8 hr under 
upregulation conditions. A similar effect was reported by 
Kasuga tl tl (120), who est ab I i shed that insulin-induced 
receptor loss i n cu I tu red · I ymp hoc y t es was i n deed caused by 
accelerated degradation of the receptor. 
There are two general classes of mechanisms by which protein 
degradation occurs 
entirely lysosomal, 
in I iv in g 
wh i I e 




is partly or 
independent of 
lysosomes (101). Proteolytic inhibitors such as leupeptin 
(168) and lysosomotropic agents such as chloroquine (54) and 
ammonium chloride (54) are often used, somewhat crudely, to 
distinguish between I y sos oma I and non - I y sos oma I deg rad at i v e 
pathways . 
condition 
Furthermore, incubation of 
in which lysosomal delivery 
ce I Is at 18°C, a 
of intracellular 
vesicular material is completely inhibited (202), permits an 
assessment of the possible contribution of these organelles 
to a particular degradation process . 
In the study reported herein, the pulse-chase protocol, as 
described in Section Three, was used to investigate whether 
cyclohexirnide exerts an inhibitory effect on the degradation 
of the LDL receptor; 
presently accepted 
such a finding would indicate that the 
value of the half-I ife of this receptor 
may be an over es t i mate . The effect Cs) of LDL and 25-
166 
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hydroxycholesterol on the receptor turnover rate were also 
examined. Furthermore, the up- and downregulation kinetics 
of the LDL receptor Cas measured by the binding of 125 1-LDL 
to fibroblast monolayers) were compared, to assess whether 
the receptor degradation rate is altered during these 
changes in physiological status of the cultured cells. In 
the case of cell surface receptors, it is unknown whether 
receptor degradation is governed by the susceptibility of 
the molecules to particular proteases, or by the rate at 
which they are segregated into a defined degradation 
compartment. The turnover rate of LDL receptors i n an 
internalization defective f i bro b I as t I i n e , GM 2 4 0 8 A C J . D . ) , 
was examined in order to · ascertain whether internalization, 
clustering or recycling of LDL receptors are prerequisites 
for their eventual degradation. The possible mechanismCs) 
involved in the degradation of the LDL receptor were also 
investigated using Ci) agents known to be lysosomotropic, or 
Ci i) altered chase-incubation temperatures. Finally, the 
susceptibility to degradation of desialylated receptors 
(obtained from cel1s which had been neuraminidase treated 
subsequent to pulse-labeling), was compared with that of 
normal receptors. 
4 . 2 Experimental procedures. 
Unless otherwise specified, all materials and methods used 
were as described in previous sections, or in the Appendix. 
/ 
4. 2. 1 Stock solutions. 
Stock solutions were made up as follows: 
25-hydroxycholesterol 0.5 mg/ml in 
vortexed into the incubation medium 
concentration of µg/ml. 
ethanol; 
to give a 
always 
final 
C y c I o h e x i m i d e : 1 0 mM i n PBS, used at a final concentration 
of 1 0 0 µM. 
Ammon i um ch I or i de : 1 M i n PBS , used a t a f i n a I con c en t rat i on 
of 10 mM . 
Leupeptin: 15 mg/ml in H.aO, used at 150 µg/ml finally . 
Chloroquine: 2 mM in OMEM, always made up immediately prior 
to the 
7 0 µM . 
ex per imen t, and used at a f in a I concentration of 
Mone n s i n : 1 0 mM i n ethanol, vortexed into the incubation 
med i um to yield an eventual concentration of 25 µM. 
4 . 2. 2 Ce I I s 
The human skin fibroblast strains GM 3348A CLDL receptor 
nor ma I ) and GM 2408A CLOL receptor internalization 
defective), were obtained from the Human Genet i c Cell 
Repository (Camden, N.J. USA), and were maintained in 
culture as described in sect ion 2 . 2. 1 C f o r intact ce I I 
assays) or section 3.5.1 (for pulse-chase experiments). The 
cell line, Hep G2, human hepatoma 
Barbara Knowles CWistar Institute 
Philadelphia, Pennsylvania, USA). 
p u I s e - ch as e exp er i men t s as follows: 





4 . 3 x 10 11 Hep G2 cells 
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were seeded per 60 mm petri dish in MEM supplemented with 
10% fetal ca I f serum, and on day 2 of ce I I growth, 
upregulation of the LDL receptors was performed as described 
for cultured fibroblasts (section 3 . 5.1) . Human 
lymphoblastoid cells were obtained and cultured as described 
in section 2.2.1. 
4. 2. 3 Preformed immune complexes 
Immune complexes were made as described i n s e c t i o n 3 . 4 . 1 . 
They contained goat anti-mouse lgG and one, or a combination 
of (see I e gen d s to f i g u res) , the f o I I ow i n g mouse mono c I on a I 
antibodies: lgG-C7 or 83/25 . Immune complexes were als~ 
prepared using goat anti-rabbit lgG, and one of the 
f o I I ow i n g r ab b i t an t i bod i e s : polyclonal antibody to the LDL 
· r e c e p t o r , o r r a b b i t n o n i mm u n e I g G . 
P u I s e - c h a s e s a n d i mm u n o p r e c i p i t a t i o n s o f 3 5 S - I a b e I e d L D L a n d 
transferrin receptors were performed as described in section 
3 . 6 . The precipitation of transferrin receptors was used as 
a means of assessing whether the effect(s), if any, noted 
under the var i o us exp er i men ta I conditions were specific to 
the LDL receptor only, and, occasionally (see Fig. 4 . 10), to 
compensate for 
isolation. 
differential losses incurred during receptor 
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4. 2. 4 Aaaaya to aaaeas 1 • 5 1-LDL binding and metabolism. 
Surface binding of 1 • 5 1-LOL at 4•c - Fibroblast monolayers 
which had been incubated for 48 hours in DMEM/LPDS to 
upregulate the LDL receptors, were chi I led to 4°C and washed 
once with ice-cold PBS. ,a 15 I-LDL binding was measured, 




200 µg/ml unlabeled LDL C 1 5 ) . High-affinity 
determined by subtracting the values for ,as1-
in the presence of excess unlabeled I igand (non-
specific binding) 
binding) . 
from that bound in i t s absence (total 
Surface binding assay to assess LDL receptor redistribution 
after incubation with various agents . Upregulated 
fibroblast monolayers were incubated with 3 ml/dish fresh 
DMEM/LPDS + 40 µg/ml LDL, supplemented with the appropriate 
agents, as detailed in the I egend to Table 4 . 2 . A f t er 
either hr or 5 hr at 37°C, the surface-bound, unlabeled 
LDL was removed by treatment with 0.4% heparin/PBS for 
40 mins at 
effected for 
Metabolism of 
4 ° C, and ,as1-LDL binding was subsequent I y 
hr at 4°C as described above . 
185 1-LDL after incubation at The 
amounts of surface-bound, int race I lular and degraded ,as1-
LDL, after incubation of fibroblasts at 37°C for 4 hr, were 
measured as des c r i bed i n sect i on 2 . 2 . 6 . 
170 
4. 2. 5 The effect of 25-hydroxycholeaterol on the basal 
intracellular proteolvai& of Iona- and short-lived proteins 
in normal lymphoblastoid cells. 
Normal lymphoblastoid eel I cultures were grown for 43 hours 
at 1x10 8 cells/ml i n growth medium CMEM + 10% HIFCS) 
containing 
additional 
µg/ml [ 3 Hl-phenylalanine. After 30 hours, an 
volume of medium was added to maintain an 
approximately constant ce I I density. This procedure 
Me t hod A - res u I t e d i n the prefer en t i a I I ab e I i n g of pro t e i n s 
having relatively long half-I ives. To label short-lived 
proteins (Method B) ' other normal lymphoblastoid ce I I 
cultures were maintained in f u I growth medium containing 
4 µCi /ml [ 3 Hl-phenylalanine for 1 hour. The analysis of 
basal int race I lular proteolysis was then performed, in 
either case, as f o I I ow s : the c e I Is were spun briefly 
(2 000 rpm, 1 min, 4°C) to remove the radioactive medium, 
and were then washed 
10% HIFCS) 





to remove a I I 




the net release of 





be measured, the cells 
were incubated under conditions allowing car r i er -med i a t e d 
transport of [ 3 Hl-phenylalanine out of the cells. 
Method A, this entailed four consecutive incubations 




1 x 1 O 8 c e II s /m I : the first, second and fourth incubations 
were for 30 mins each, while the third was for 16 hours. In 




carried out by performing three 
at 37°C (each at 1x10 8 eel ls/ml) for 20, 
40 and 60 minutes (first. second and third washes, 
respectively). For both methods, the cells were finally 
resuspended 
containing 
at 1x10 8 
mM excess 
c e I Is /m I in fresh growth medium 
non-labeled phenylalanine, in the 
absence or presence of 0.6 ug/ml 25-hydroxycholesterol; the 
release of labeled amino acid into this medium was used to 
measure intracellular proteolysis. Cells were incubated in 
the various media at 37°c for the indicated ti mes. 
Thereafter, the medium was removed by brief centrifugation 
of the eel I suspensions C2 000 rpm, 1 min, 4°C), and assayed 
for TCA-soluble radioactivity by precipitation with an equal 
volume of 20% TCA for hour at 4°C. The eel I pe I lets were 
washed twice with PBS (4°C) by centrifugation as described 
above; 1 m I 1% SOS was then added to so I ub i Ii ze each ce 11 




sonicated, a 500 ul 
to ta I radioactivity aliquot was 
within the cells, and the remaining 500 ul was supplemented 
with 2 mg BSA as carrier, precipitated with an equal volume 
of 20% TCA at 0°C for hour and then spun at 2 000 rpm for 
15 mins. 
amount of 
The supernatant was counted to obtain the residual 
int race I lular TCA-soluble radioactivity. A I I 
counting procedures were performed in a Beckman scintil-
lat ion counter using Beckman Ready-Solv EP as scintillation 
f I u id. lntracel lular protein degradation in each case was 
expressed as a% of the initial total protein radioactivity 
that was released into the chase medium ie. % proteolysis= 
Cdpm [3H]-phenylalanine i n TCA-soluble medium)/Cdpm i n 
medium+ dpm in TCA precipitable cell fraction). 
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4. 2- 6 Other Assays 
In the cases where eel Is were incubated in the presence of 
µg/ml 25-hydroxycholesterol, the amount of 
methionine incorporated into total eel I protein was measured 
CTCA precipitation of protein). No significant inhibition 
of the rates of total eel I protein synthesis was obtained. 
The inh i bition of protein 
assayed by measuring the 
incorporated into total eel 
synthes i s was 
> 9 5% v i ab I e , 




BSA as a standard . 
synthesis with cycloheximide was 
amount of 
p r o t e i n . 
98%, wh i I e 
by trypan 
[3H]-phenylalanine 
After hr, protein 
the cells remained 
blue dye exclusion . 
by the Lowry method (147) using 
Unless otherwise specified, all [ 315 Sl-methionine pulse-chase 
experiments were performed on the LDL receptor normal human 
skin fibroblast cell line, GM 3348A. 
Where relevant, statistical analysis of data was performed . 
Best fit curves were obtained using a weighted non-linear 
regression programme adapted from Duggelby (64), and the 
parameters thus derived were compared using Peritz' F test 
(95) . 
1 7 3 
4.3 Results 
4 . 3 . 1 The LDL receptor half-I ife remains constant over a 
range of cellular receptor protein content. 
Using the [3 5 Sl-methionine pulse-chase protocol, the LDL 
receptors on HSF were found to turn over with a t,,a of 11.7 
.±. 2 . 2 hr (section 
upregulation period 
3 . 9 ) . 
of 1 6 
This result was obtained after an 
hr , f o I I owed by an 8 hr pulse-
I abe I in EMEM/LPOS i e. a 24 hr upregulat ion pr i or to 
initiating the chase incubation Cat this 24 hr time, eel I-
surface LOL receptor expression was about 85% of the maximum 
value - see Fig. 4.2). To ascertain whether this half-life 
remained constant in the f u I I y upregulated or i n the 
downregulating states of the receptors, other monolayers 
were incubated in OMEM/LPOS for 40 ~r before initiating an 8 
hr pulse C i e. > 9 7% of maxi ma I 
expression at the end of the 
chased for varying ti mes in 
eel I-surface LDL receptor 
pulse-incubation), and then 
these DMEM/LPDS. Under 
conditions of maximal LDL receptor upregulation at the start 




CP > 0. 0 5) 
half-I ife of the receptors remained 
a t t , / 2. = 1 1 . 5 hr 4 . 1 ) . 
Alternately, monolayers were maintained i n 
CF i g . 
f u I I growth 
medium CDMEM supplemented with 10% HIFCS), resulting in a 
low level of LDL receptor expression. After pulse-labeling 
for 8 hr in EMEM/LPDS C ie. about 45% of maximal LDL receptor 
expression induced by the end of the pulse-period), the 
cells were chased in the upregulation medium supplemented 
with 10 µg/ml LDL, to suppress any further increase in LDL 
1 7 4 
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F i g . 4 . 1 : Turnover of 3BS-labeled. LDL receptors from 
normal fibroblasts. 
In Procedure A C ., solid I in e) the monolayers were 
upregulated for 40 hr, then pulse-labeled for 8 hr with 
EMEM/LPDS containing 35 JJCi/ml [35SJ-methionine. Chase-
incubations were performed for the indicated ti mes in 
DMEM/LPDS (containing 200 µM methione). I n Procedure B 
C Q,dashed Ii ne) 
supplemented with 
the monolayers were maintained i n DMEM 
10% HIFCS. 30 mins prior to initiating 
the pulse, the cells were incubated with DMEM/LPDS at 37°C. 
The ce 11 s were then pulse-labeled in EMEM/LPDS containing 
100 JJCi/ml [ 35 SJ-methionine for 8 hr , and chase-incubated 
for the 
with 10 
indicated times in complete DMEM/LPDS supplemented 
µg/ml LDL. I n b o t h p r o c e d u r e s • i mm u n o p r e c i p i t a t i o n 
and quantitation of labeled LDL receptors were performed as 
described in "Exper imenta I Procedures". Semi log plots are 
shown, depicting the percentage absorbance (relative to the 
first chase point) versus chase time . Values plotted as eel 
are the means of duplicates obtained from a s in g I e 
experiment; dup Ii cat es never 
from the means. The values 
mean .±. S. D. of results 
d i f fer e d by more than 1 0% 
plotted as 
obtained 
CO) represent the 
from triplicate 
pre c i p i ta t i on s a t each t i me i n a s i n g I e exp er i men t . 
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receptor number. As shown in Fig. 4.1, the half-life of the 
LDL receptors under these downregulating conditions was not 




cells Ct,.,a = 13.7 hr). In the downregu-
shorter 
label 
chase times were 
was incorporated 
used, s i n c e 
into the LDL 
receptors under these conditions, resulting in f I uorogram 
bands which were too faint if longer chase times were used. 
Thus, the half-I ives of the LDL receptors remained unchanged 
over the range of eel lular LDL receptor content tested. 
4. 3. 2 A comparison of the up- and downregulation kinetics 
of LDL receptors. 
The normal downregulat ion kinetics of LDL receptors in 
fibroblasts were measured by adding medium containing 
40 µg/ml LDL to previously fully upregulated 
surface LDL receptors were 
monolayers 
measured at (Fig. 4.2A). The 
var i o us t i mes 
activity after 
by 1 215 I -LDL 
addition of 
binding at 4 °C. The receptor 
LDL remained constant for about 
4-5 hr before it began to decrease with apparent first order 
kinetics. The half-life determined from th i s 
procedure (using 
apparent 
the end of the lag phase as the starting 
point ) was 1 3 h r , similar to that found above (sect ion 
4. 3. 1). The upregulat ion curve was a mirror image of the 
curve (excluding the lag Thi s downregulation 









synthetic rat e·s. order 
t,.,a = 11 .7 ~ 2.2 hr were generated 
1 7 7 
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-C 300 











































Fig. 4.2: A compar i -son of 






the upregulation ce, • ,Al and 
of LOL receptors in fibroblast 
A: In the upregulat ion protocol, monolayers were incubated 
in DMEM/LPDS for the indicated times (Note: No prior upreg-
ulation of LDL receptors) . For the downregulation kinetics, 
cells were first incubated for 48 hr in medium containing 
1 7 8 
LPDS, after which each monolayer received fresh LPDS medium, 
supp I emented with 40 µg/ml LDL. The cells were then 
maintained at 37°C for the indicated times, after which they 
were further incubated with fresh DMEM/LPDS medium 
Ccontaining · no added I ipoproteinsl for 30 mins at 37°c. 
CThe latter incubation ensured that no LDL occupied surface 
receptors in the case of the 11 down reg u J at i on protocol"). 
The monolayers were then chilled to 4°C, and high-affinity 
binding Cin 
was measured 
the case of both types of receptor regulation), 
as described in section 4 . 2 . 4 . Results were 
calculated from data obtained from triplicate dishes at each 
point. Non-specific binding was always <10% of 
binding in 
experiments 
the fully upregulated state. All 




different batches of 128 1-LDL in each case. Theoretical LDL 
receptor up- and down- regulation kinetics were obtained 
using the first order exponential equation; in each case, 
the solid line represents the kinetics obtained using an LDL 
receptor half-life = 1 1 . 7 hr , with the broken I in es 
representing~ one standard deviation from this . 
B: Fibroblast monolayers, which had been maintained i n 
growth medium CDMEM + 10% HIFCSJ, were washed with PBS, and 
then incubated in DMEM/LPDS to upregulate LDL receptors. 30 
mins before each of the indicated times, this medium was 
replaced with EMEM/LPDS, and each dish was subsequent I y 
pulse-labeled with 60 µCi /ml of C 3 e SJ -met hi on i n e for 
90 mins. I mm u n o p r e c i p i t a t i o n of labeled LDL receptors was 
then performed as described in "Experimental Procedures" . 
Results represent the mean ~ S.D. of data obtained from 
triplicate dishes at each point. 
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and also plotted for comparative purposes. These curves 
were remarkably similar to those obtained for the up- and 
downregulation kinetics. 
The synthesis rates of mature LDL receptors in fibroblasts 
which were 
measured by 
incubated for various times in LPDS medium, were 
pulse-labeling the receptors for 1.5 hr at each 
of the time points. As is depicted in Fig. 4 . 28, the LDL 
receptor synthesis rate increased inearly up to 30 h r , 
after which it became constant at this high level . 
4. 3. 3 A putative degradation intermediate of the LDL 
receptor . 
Lehrman .!l.t ~ (140) have observed is 
apparently a high molecular weight 





receptor degradation in HSF, and s i mi I a r 
observations were made by Kozarsky ~ ~ (133) in the case 
of Chinese Hamster Ovary ce I Is. In this study, such 
intermediates were sought in pulse-labeled eel extracts 
polyclonal 
Two labeled 
subjected to i mm u n o p r e c i p i t a t i o n w i t h a rabbit 
antibody directed at the entire LDL receptor. 
apparent molecular weights of 1 6 0 kd and peptides with 
approximately 120 kd were i mm u n o p r e c i p i t a t e d w i t h the 
polyclonal antibody 
lmmunoprecipitations 





ti me point 
performed 
C F i g . 4 . 3A). 
us in g control 
no case was either of these proteins 
detected. The 160 kd band clearly represented the mature 
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Fig. 4.3: Degradation of 35S-labeled LOL receptors and the 
formation of a putative degradation intermediate from normal 
fibroblasts . 
Monolayers were pulse-labeled f o r 8 hr in EMEM/LPDS 
containing 70 µCi/ml ( 38 81-methionine, then chase-incubated 
for the indicated times in complete DMEM/LPDS medium. Ce I I 
extracts were incubated w j th preformed immune complexes 
containing either rabbit polyclonal antibody (PC), or rabbit 
non-immune lgG 
were subjected 




38 8-labeled immunoprecipitates 
SOS-PAGE and f luorography . 
Precipitations with the polyclonal antibody were performed 
in duplicate, a f t e r ch as e - i n cub a t i on t i mes of O , 5 , 9 . 5 and 
15 hours (values never d i f f e red by mo r e than 7% from the 
means), or in trip I icate, a f t er chase-incubat i ng f o r 24 
hours; those with the non-immune lgG were done using single 
dishes . The data represent results obtained from a single 





showing the mature 160 kd LDL 
120 k d LDL receptor degradation 
with the polyclonal antibody. at 
various chase ti mes. The non-immune lgG precipitated 
neither of these proteins . C B J Plot of the relative 
percentage absorbance of the 160 kd LDL receptor (expressed 
relative to the 160 kd LDL receptor at zero hr) at each 
chase time . 
degn = degradation 
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significantly different ( p > 0 . 05) from that of the LDL 
receptor when t h e I a t t e r w a s i mm u n o p r e c i p i t a t e d w i t h I g G - C 7 
CFig . 4.38) . The 120 kd band remained virtually unchanged 
in absolute amount throughout the chase period CFig. 4.3A). 
I t thus seems I i ke I y that the 120 kd protein was a 
degradation product of the mature 160 kd form of the LDL 
receptor, analagous to the degraded forms of the LDL 
receptor mentioned above. The label detected in the 120 kd 
band at zero chase time could have been present either in 
the known precursor of mature LDL receptors (about 120 kd) 
or the deg rad at i on f r a gme n t w i t h i t s v er y s i mi I a r mo I e cu I a r 
weight on SOS-PAGE analysis under reducing conditions. At 
later chase time points, however, the label clearly was not 
due to the receptor precursor, since a II of it had been 
con v e r t e d t o t he 1 6 0 k d ma t u r e f o rm w i t h i n hour after a 30 
minute pulse-label period in other experiments (data not 
shown) . 
i n the 
If the 120 kd protein was in fact an intermediate 
LDL receptor degradation pathway, a constant flux 
through this intermediate form must have occurred, followed 
by a slow proteo I yt i c s t e p C s ) catabolizing the large 
fragment . A similar situation has previously been observed 
in the case of apol ipoprotein B degradation as catalysed by 
ca the p s i n s i n the I y sos ome s of cu I tu red c e I I s C 1 1 , 2 4 9) . 
4 . 3 . 4 The turnover of LDL receptors in two other eel I 
types. 
A second human c e I I type, Hep G2 cells, representing well-
d i f fer en t i a t e d hep at oma cells, was a· I s o i n v e s t i g a t e d with 
183 
respect to the turnover rates of both LDL and transferrin 
receptors (Fig. 4 . 4). A half-I ife of 8.5 hr was obtained in 
the case 
Fig . 3.11; 
f r om t hat 
of LDL receptors, using the procedure out I ined in 
this was not significantly different CP > 0.05) 
obtained for fibroblasts. Transferrin receptors 
i n Hep G2 c e I I s turned over with a half-I ife of 12.5 hr; 
this was markedly less than the value of 55 hours observed 
for this receptor in fibroblasts (Fig 3.11), and the value 
of 60 hours obtained by Omary and Trowbridge (173) in a 
human leukemic T-cell line . 
In addition, the expression of LDL receptors on cultured 
human lymphoblastoid c e I I s was measured by assaying the 
cell-associated 1215 1-LDL on intact cells (Fig . 4 . 5) Cit was 
not possible to perform the pulse-chase experiments using 
lgG-C7 to immunoprecipitate LDL receptors, since 
lymphoblastoid eel Is contain Fe receptors which bind to the 
monoclonal antibodies). The LDL receptors were upregulated 
prior to c ornrne n c i n g the exp er i men t , and the c e I I s were then 
incubated for the indicated times in medium supplemented 
with the agents as described in the figure legend . Assays 
were also performed to 
inhib i ted general protein 





wh i I e ce I Is 
remained more 
dye exclusion, 
than 90% viable, as determined by trypan blue 
and Ci i) that the presence of the compounds 








values obtained were due 
internalization 
the decreased 
to a decrease in 
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F i g . 4 . 4 : T-u r nove r of 35S-labeled LDL receptors and 35S-
labeled transferrin receptors from cultured Hep G2 eel Is. 
Monolayers were incubated for 16 hr with DMEM/LPDS, then 
The pulse-labled for 8 hr with 50 µCi/ml [ 35Sl-methionine. 
monolayers were chase-incubated for the indicated t i°me s, 
after which the detergent solubilized eel extracts were 
incubated C f i r s t precipitation) with preformed immune 
complexes containing lgG-C7, ce,solid i n e) , f o I I owed by a 
second i mm u n o p r e c i p i t a t i o n , using immune complexes 
containing B3/25 
precipitates were 
C 0, dashed 
subjected 
f luorography. Semi log plots 
i n e ) . 
to 
of the 
(relative to the first chase point) 
The 35 S-labeled immune-
5-20% SOS-PAGE and 
percentage absorbance 
versus t i me of chase 







( . ) or s i ngle C O) 
a single experiment. 
Duplicates never differed by more than 10% from the means . 
















Fig. 4.5: Surface LDL receptors in lymphoblastoid cells, as 
assayed after the administration of various agents. 
Lymphoblastoid cells were incubated in LPDS medium for 24 hr 
as described i n section 2 . 2 . 5 . Incubations were then 
performed at 37°c for the indicated t i mes in MEM, 
supplemented with 10% HIFCS and 40 µ/ml LDL, in the presence 
0 f : no further additions ce), 30 µM cycloheximide CD) , 
0.6 µg/ml 25-hydroxycholesterol CA), or cycloheximide + 25-
hydroxycholesterol (.6. ). The cells were then maintained for 
a further 30 mins at 37°C in L PD.S containing medium to 
remove bound LDL. Cells were further incubated in medium 
containing Hl 6 1-LDL (10 µg/ml) .±. LDL (300 µg/ml) for 30 mins 
at 37°c. High-affinity eel I-associated values were 
calculated as described in section 2 . 2.7. Results represent 
cell-associated ,a 15 t-LDL values expressed as a % of a 
control Cno add i t i on s , as say e d a t z e r o t i me ) . Al I the data 
plotted were obtained in single experiments, and they typify 
the results obtained in 3 separate experiments. 
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internalization of bound LDL (Note: no degradation of the 
I igand occurred 
s e c t i o n 2 . 2 . 7 ) . 
after incubating for 30 minutes at 37°C -
Incubation in the presence of LDL only, or 
LDL + 25-hydroxycholesterol, resulted in a loss of surface 
receptors, with first order kinetics Ca lag phase of about 5 
hours was noted in the presence of L DL only, before any 
decrease was observed); the half-I ife of the LDL receptors 
was estimated to be about 4 hours in each of these cases. 
Cycloheximide greatly reduced the rate of measured receptor 
Io s s, a trend which was also noted when cycloheximide and 
25-hydroxycholesterol were added simultaneously . 
In section 2.3.3, an average LDL receptor recycling time of 
about 10.5 minutes was calculated using data obtained from 
4 hour , 37°c incubations, and assuming that 







results indicate that this 
effective downregulation of LDL 
receptors only became apparent after a lag phase of 5 hr. 
4.3.5 The turnover of LDL receptors i n human skin 
fibroblast~ in the pres~nce of various agents. 
Since LDL, 25-hydroxycholesterol and cycloheximide 





lymphoblastoid cells, the effects HSF 
were analysed as we I I It is known that these agents alter 
the eel I surface expression of the LDL receptor in HSF (32). 
Thus, the turnover of LDL receptors was measured in this 
1 8 7 
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eel I type as before Cie. [ 35 Sl-methionine pulse-chase) in 
the presence of: 50 µg/ml LDL (to check for possible I igand-
induced changes in receptor turnover); µg/m I 0 f 25-
hydroxycholesterol (which causes a marked decrease in LDL 
receptor expression after uptake of the sterol by non-
receptor-mediated processes); 100 
total 
µM cycloheximide Cat a 








In the case of the f i r s t two 
eel Is after chase-incubations was 
rates of total protein synthesis, 
the same as in the untreated controls (data not 
shown), indicating that any effectCs) produced by these 
ce I I agents were not due to toxicity and decreased 
v i a b i I i t y . 
obtained 
As shown in Fig. 4 . 6, the LDL receptor half-life 
after chase-incubating i n the presence of LDL or 
25-hydroxycholesterol did not differ significantly . 
( p > O. O 5) fr om that obtained in the absence of the added 
agents. The presence of cycloheximide in the chase-medium 
produced an initial transient decrease in the number of LDL 
receptors, roughly similar to that obtained in the absence 
or presence of the other agents . After about 5 hr, however, 
the rate of receptor I o s s de c r ea s e d mar k e d I y , r es u I t i n g i n 
an appa r ently constant content of labeled receptors over the 
next 20 hr . The addition of either 25-hydroxycholesterol or 
cycloheximide to the chase media produced no marked effect 
on the turnover rate of transferrin receptors; in both 
instances, approximately 25% of these receptors were 
















Chase time (hr) 
The degradation rate of 38 S-labeled LDL receptors 
from normal fibroblasts in the presence of various agents. 
The eel I monolayers were upregulated for 16 hours and pulse-
labeled with 50 µCi/ml of [ 36 S]-methionine, and then chased 
for the indicated ti mes in complete DMEM/LPDS medium 
supplemented with no further addition ce), 50 µg/ml LDL 
(0)' 1 µg/ml 25-hydroxycho I este ro I Cb.. J or 100 µM cyclo-
heximide c•J. The solubilized c e I I extracts were then 
analysed as des c r i bed i n II Exp er i men ta I Procedures 11 • Values 
plotted represent the percentage absorbance, relative to the 
first C1 
S. D. of 
the case 
hr) chase point, at each time, and are the mean.±. 
results obtained from triplicate precipitations in 
of cycloheximide, or are the means obtained from 
du p I i cat e i n cub at i on s Ce, 0 ,b..) . Duplicates never differed by 
more than 15% from the means. Each curve represents a 
single experiment, which typifies r es u I t s ob ta i n e d f r om at 
least 2 other such experiments. 
4.3.6 Surface LOL receptors, as assayed after the addition 
of various agents. 
The expression 
surface binding 
of L D L receptors on HSF, as assessed by 
of 128 1-LDL, was next studied (Fig. 4.7J. 
The LDL receptors in the monolayers were fully upregulated 
p r i o r t o co mm e n c i n g t h e e x p e r i men t C 4 8 ho u r s ) , a n d t h e c e I I s 
were then incubated for various times at 37°C in medium 
supplemented with 
high-affinity cell 
the indicated agent Cs) . At each ti me, 
surface receptor a c t i v i t y was assayed . 
Incubation in the presence of 25-hydroxycholesterol resulted 
in a loss of surface receptors after an initial lag period 
of about 5 h r . The kinetics of LDL receptor loss were 
apparently first order thereafter, with a t 1 , 2 _ 0 f 1 3 h r , 
similar to the t,,2 value obtained using the [~ 8 SJ-pulse-
chase protoco I. In line with the results reported in Fig. 
4.6 and Fig. 4.5, cycloheximide markedly reduced surface LDL 
receptor Io s s, irrespective of whether 25-hydroxy-
cholesterol was present or not. 
From the above, i t is clear that 25-hydroxycholesterol 
affected the synthesis of LDL receptors only, and had no 
apparent effect on LDL receptor degradation . Since 25-




i t i s conceivable that t h i s agent might 
degradation systems on a wider scale; LDL 
perhaps, merely an exception to this gener~I 
r u I e . To investigate t h i s , t h e effect of 0 . 6 µg/ml 25-
hydroxycholesterol on the endogenous long- and short-lived 
protein turnover rates in normal lymphoblastoid cells was 
190 
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F i g . 4 . 7 : Surface LDL receptors in fibroblast monolayers. 
On day 7 of eel I growth, after incubation for 4 8 hr in 
medium containing I ipoprotein-def icient serum, each 
monolayer received a fresh 2 ml of this medium containing 
the f o I I ow i n g agent Cs): µg/ml 25-hydroxycholesterol ceJ, 
100 µM cycloheximide CO) or 1 µg/ml 25-hydroxycholesterol + 
100 µM cycloheximide C.6.). M~nolayers were maintained at 
37°C for the indicated times, after which 126 1-LDL binding 
was performed . A I I incubations containing ,2a1-LDL only 
were performed in triplicate, wh i I e 
excess of LDL were done in dup Ii cate. 
a single experiment, and are typical 
those containing an 
The results represent 
of several identical 
ex per irnents. Non-specific binding was always < 10% of the 
total binding in the fully upregulated state. 
examined. 
release of 
Int race I I u I ar proteo I ys is was measured by the 
labeled amino acids into the cellular incubation 
media, as described in section 4. 2. 5. The long-lived 
proteins were degraded at a rate of 1.3% per hour CF i g. 
4 . 8A) , wh i I e 8% of the short-lived proteins were degraded 
per hour (Fig. 4.88). The addition of 25-hydroxycholesterol 
altered neither 
t ions performed 
of these rates. Parallel binding incuba-
on cells which had been maintained in 
upreguiation medium containing 25-hydroxycholesterol (using 
the same stock solution as for the previous rates), showed a 
significant reduction of surface LDL receptors as obtained 
previously (Fig. 4 . 5 ) . This indicates that the lack of 
effect of the 25-hydroxycholesterol on the proteolysis rates 
was not due to an inactive stock solution. Similar basal 
degradation rates have been reported by other investigators 
i n th i s laboratory using cultured smooth muscle cells: 
Bates tl tl (17) obtained a degradation rate for long-lived 
proteins of 1.5% per hour in smooth muscle cells, and one of 
6 . 5% per hour for sh or t - I i v e d p r o t e i n s . 
4. 3. 7 The half-life of LDL receptors in internalization-
defective mutant cells. 
The next question addressed was whether the turnover rate of 
the LDL 
that the 
receptor protein was in any way related to the fact 
receptor nor ma I I y recycles in and out of cells. 
The GM 2408A fibroblast line (corresponding to patient J.0.) 
bound 128 1-LDL normally, but, as expected, showed greatly 
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F i g . 4 . 8 : Time course of general protein degradation in 
normal lymphoblastoid ce I Is . CA) , long-I ived proteins 
(circles); CB), short-I ived proteins (squares) . 
Cultured lymphoblastoid cells were 
with medium containing µCi /m I 
preferentially label the long-lived 
incubated for 43 hours 
( 3 Hl-phenylalanine 
proteins CA), or for 
to 
hour with medium containing 4 µCi/ml ( 3 H1-phenylalanine to 
label the short-I ived proteins C B ) . The cells were then 
washed, and proteolysis was measured in the absence Copen 
symbo Is, dashed I ines) or presence (closed symbols, solid 
I ines) of 0.6 µg/ml 25-hydroxycholesterol at the indicated 
times, as described under "Experimental Procedures" (section 
4.2.5). Al I incubations were performed in duplicate, and 







Table 4. 1 : ,a _11 I-LDL metabolism with LDL receptor 
internalization defective fibroblasts CGM 2408A) and normal 
fibroblasts CGM 3348A). 
On day 7 of eel growth, after incubation for 48 hr in 
DMEM/LPDS medium, each monolayer received 2 ml fresh medium 
containing 10 µg/ml 128 1-LDL in the absence or presence of 
200 µg/ml unlabeled LDL . After incubation for 4 hr at 37°C, 
the high-affinity values for surface-bound, int race I lular 
and degraded 12a1-LDL were measured and calculated . 
Incubations were per formed in duplicate. Duplicate values 
never differed by more than 5% from the means . 
Handl"ing Parameter 
Surface bound 









1 4 1 
128 
1 1 1 
1 9 4 
4. 1 ). This internalization-defective phenotype is known to 
be caused by the substitution of cysteine for tyrosine at 
residue 807 in the 
conformation of the 
LDL receptor 
cytoplasmic 
(51), which may alter the 
ta i I resulting in the 
inability of 
cell surface 
the receptors to cluster in coated pits on the 
C 5 ) . The mutant receptors remain randomly 
scattered over the entire plasma membrane (200), do not 
recycle, and thus provide a mode I sys tern for non-recyc Ii ng 
LDL receptors. The turnover rate of ::uss-labeled LDL 
receptors was measured in c e I I s f r om 
protocol 
preformed 
thi ·s line, using the 
standard pulse-chase f o I I owed by 
with immune complexes i mm u n o p r e c i p i t a t i o n 
containing lgG-C7: this gave a first order decay curve with 
a t 1 , 2 = 1 0. 5 hr (Fig 4 . g) . This value was not 
significantly different CP > 0.05) from that determined for 
actively recycling LDL receptors in normal fibroblasts, in 
the presence of LDL. These res u I t s i n d i cat e t ha t the nor ma I 
degradation pathway for the LDL receptor is not dependent on 
receptor clustering, internalization or recycling. 
4. 3. 8 The nature of the proteolytic systemCs) involved in 
the degradation of LDL receptors. 
In an attempt to identify the nature of the rate-I imiting 
protea I yt i c entities which might 





var i o us agents kn own to affect ma i n I y I y sos oma I pro t e o I y s i s , 
were examined. Fi rs t , the behaviour of eel I-surface 
receptor activities was measured. The data obtained, 
195 
100 
'"' cfi 75 ......, 
(1) 
(.) 
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Fig. 4. 9: Turnover of acss-Jabeled LDL receptor from 
GM 2408A. 
Monolayers of GM 2408A were incubated for 1 6 hr with 
DMEM/LPOS, then pulse-labeled for 8 hr in EMEM/LPDS 
containing 40 µCi Im I [3GS]-methionine. The chase-
incubations, solubi I izations a n d i mm u n o p r e c i p i t a t i o n s w i t h 
lgG-C7 were 
semi log plot, 
receptor at 
chase time, 
as described in the legend to F i g . 3 . 1 1 . A 
of% relative absorbance Cabsorbance of LDL 
each time, relative to that at one hour) versus 
was constructed. Values plotted represent mean 
±_ S.D . of triplicate i mm u n o p r e c i p i t a t i o n s a t each point. 
The results shown were fr om a single experiment, 
representative of 2 such experiments, performed on separate 
days . 
196 
s u mm a r i z e d i n T a b I e 4 . 2 , s h ow t h a t t h e a d d i t i o n o f 1 5 0 µ g / m I 
leupeptin to normal fibroblasts for e i ther 1 or 5 hr at 37°C 
did not change the number of surface LDL receptors relative 
to untreated controls. The addition of 70 µM chloroquine 
produced a decrease of about 30% relative to controls at 
b o t h t i me s , w h i I e 1 0 mM ammo n i um c h I o r i d e d e c r e a s e d 1 a 5 I - L D L 
bind i ng by 60% after hr and by 80% after 5 hr . Treatment 
with25 µM monensin produced the most marked effects, 
decreasing the 
96% after 5 hr 
surface LDL 
at 37°c. 
receptors by 82% at hr and by 
In all cases, 40 µg/ml LDL was 
present in the 37°C incubation media, to faci Ii tate the 





case of monensin (15). The a1°c 
and 5 hr were chosen since I i t t I e 
downregulation of the LDL receptors has been observed to 
occur during periods as short as these (Note: the I ag phase 
for downregulat i on in the presence of LDL is 5 hr) . Because 
I eupept i n caused no apparent decrease in the number 
surface LDL receptors, i t was considered necessary 
of 
to 
demonstrate that this agent in fact inhibited lysosomal 
degradation under the conditions used . 1ae1-LOL was 
accordingly incubated with normal fibroblast monolayers in 
the absence or presence of leupeptin for 4 hr at 37°C (Table 
4 . 3 ) . Wh i I e s u r f ace 12e1-LDL binding remained unaltered, 
the int race I lular 1a 15 1-LOL content increased by 76% and the 
degradation rate of radioactive Ii gand was inhibited by 54% . 
The effects of these inhibitors were also analysed in [ 315 Sl-
methionine pulse-chase exp er i men t s i n order to compare the 
absolute turnover rates of the receptors with the binding 
1 9 7 
Table 4.2: The effect(s) of various agents on the surface 
LDL receptors in normal fibroblasts. 
On day 7 of eel growth, after 48 hr i n DMEM/LPDS, each 
monolayer received 2 ml/dish fresh DMEM/LPDS + 40 µg/ml LDL, 
supplemented with the additions listed in the Table . A f t er 
37°c, incubating the monolayers for either or 5 hr at 
i:l6I-LDL C10 µg/ml) was bound to the cells at 4°C for 1.5 hr 
in the absence or presence of unlabeled LDL (200 µg/ml), and 




obtained from a single experiment, with duplicate 
Duplicates never differed by more than 5% from the 
Non-specific values were less than 10% of the total 
in the absence of additions, and these values 
approximately 
additions. 





leupeptin (150 µg/ml) 
chloroquine C70µm) 
ammo n i um c h I o r i d e ( 1 0 mM ) 
monensin (25 µM) 
1as1-LDL bound Cng/mg protein) 
after adding agentCs) for: 
1 hr 












Table -4.3: The effect Cs) of leupeptin on "' 25 1-LDL 
met ab o I i sm i n nor ma I f i bro b I as ts . 
On day 7 of ce I I growth, after 48 hr i n DMEM/LPDS, each 
monolayer received 2 ml/dish fresh DMEM/LPDS ·containing 
10 µg/ml 125 1-LDL with or without 200 µg/ml LDL, in the 
absence or presence of 150 µg/ml leupeptin. The monolayers 
were incubated for 4 
bound, intracellular 
hr at 37°C, and high-affinity surface 
and degraded 125 1-LDL were determined. 
All incubations containing 125 1-LDL only C~ leupeptin) were 
performed in triplicate, while those done in the presence of 
excess unlabeled 
means~ S.D .. 
LDL were done in duplicate. Values are 
Th i s exp e r i men t was performed poncurrent ly 




leupeptin (150 t.rg/ml) 
Fig. 4.10, using the same leupeptin 
1aa1-LDL Cng/mg eel I protein) 
Bound lntracel lular 
382 + 8 2449 ~ 119 
413 + 35 4324 + 479 
Degraded 
1881 ~ 118 
867 + 58 
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data reported above. The agents were added, at the same 
concentrations as tested previously, to the chase media of 
fibroblasts. Chlor-0quine, ammonium chloride and monensin 
al I produced the same effect - an extremely rapid and marked 
decrease in receptor protein Cas detected by immunoprecipi-
tat i on w i th I g G- C 7) , such that i n each case I es s t ha n 2 0% of 
the labeled receptors remained after 8 hr (Fig. 4.10A). In 
contrast, the presence of leupeptin in the chase media was 
a decay curve which did not differ associated with 
significantly CP > 0.05) from that obtained in the absence 
of the inhibitor (Fig. 4.10A) . The simultaneous addition of 




< 0.0001) decrease in the rate 0 f LDL 
relative to that obtained i~ the presence of 
CF i g. 4 . 1 OB). presence of a I I these 
agents in the chase media 
The 
did not result in a marked 
alteration in the degradation rate of transferrin receptors. 
After a 15 hr chase in the absence or presence of monensin, 
NH .. CI, chloroquine or leupeptin, the relative amounts of 
transferrin receptors compared to those present at the start 
of the chase-incubations were 90%, 100%, 100%, 85% and 83%, 
respectively. Because of the latter finding, the amount of 
35 S-labeled LDL receptors was also expressed relative to the 
radioactivity in the 






C F i g . 
the 
Ly sos oma I pro t e o I y s i s of ext er n a I I y added I i g ands i s tot a I I y 
inhibited at 
the inability 
18°C (10, 6 7, 1 52) . This is probably due to 
of lysosomal membranes to fuse with those of 
200 

















(%) 88UBq.1osqB 8A!+Bl8cJ 

























2 0 1 
F i g . 4 . 1 0 : The degradation of LOL receptors from normal 
fibroblasts in the absence or presence of various agents. 
Monolayers were pulse-labeled f o r 7 hr in EMEM/LPDS 
containing 50 µCi/ml [ 35 Sl-methionine, then chase-incubated 
for the 
40 µg/ml 
i n d i ca t e d t i mes 
LDL containing 
in complete 
the f o I I ow i n g 
DMEM/LPDS medium + 
agents: no further 
addition ce J; 150 µg/ml leupeptin CO); 70 µM chloroquine 
( b ) ; 1 0 mM ammo n i um ch I or i de C • ) ; 25 µMmonensin (A) or 
25 µM monensin + 150 µg/ml leupeptin C D ) . lmmuno-
precipitations were performed w i th preformed immune complex 
containing lgG-C7 and 63/25, and the results were analysed 
as described 
represent the 
in "Experimental Procedures". Values plotted 
amounts of LDL receptor present at each time, 
expressed as a% of that present at the first point. In ExpA 
the values are either t he means .:. S . D . of r es u I t s ob ta i n e d 
f r om t r i p I i ca t e 
f r om du p I i ca t e 
i n cub at i on s C O ) or a r e the means ob ta i n e d 
incubations ce, •, A,b). Duplicates never 
differed by more than 20% from the means. Each curve 
represents the results obtained from a single experiment, 
wh i ch in some cases CO), was typical of results obtained in 
3 similar experiments, performed on separate days. In Exp B 
the values plotted were calculated by expressing the amount 
of LDL receptor present at each time relative to the amount 
receptor present at the same time . Thi s o f t r a n s f e r r i n 
compensated for differential losses during the isolation 
procedure of the receptors . Oupl icate 
plotted) from a single 
point . 
experiment were 
dishes (each value 
analysed at each 
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endocytic vesicles at this temperature. The effect of an 
18°C chase-incubation on the turnover rate of 35 S-labeled 
LDL receptors was examined CFig. 4.11). Degradation rates 
slower compared to were still 
the rates 
clearly detectable but were 
at 37°C: i t took 50-70 hours for 50% of the 
receptors to be degraded, compared with the 12 hours taken 
to achieve a similar reduction at 37°C. That the decrease 
in labeled LDL receptors detected a f t er the chase-
incubations at 18°C in fact represented the turnover of this 
protein (and 
confirmed by 
not loss of cell viability or cell death), was 
Ci) visual inspect ion of the monolayers under 
the phase-contrast microscope and ( i i ) comparing the 
turnover rate 
receptors, at 
of LDL receptors with that of the transferrin 
1 8 ° C. As is i 11 ustrated in Fig. 4 . 1 1 , the 
rate of 
markedly 
degradation of the transferrin receptors was also 
decreased, which is consistent with a simple 
temperature efferit 
viable cells. 
on the protein turnover processes i n 
4. 3. 9 The effect of neuraminidase treatment on the LOL 
receptor half-life. 
LDL receptors are enriched in sialic acid residues on their 
ext race I lular aspect C 4 6) . To determine whether these 
residues are important in determining the rates of receptor 
degradation, fibroblast monolayers were pulse-labeled with 





at 37°C in the absence or presence of 






















0 20 40 
Chase time (hr) 
60 
F i g . 4 . 1 1 : Degradation of ass-labeled LDL receptors ce,O) 
and ass-labeled transferrin receptors (A, 1),.. ) from normal 
fibroblasts at various temperatures. 
The eel I monolayers were pulse-labeled for 8 hr in EMEM/LPDS 
medium containing 50 µCi/ml caesJ-methionine, then chase-
incubated for the indicated t i mes in complete DMEM/LPDS 
medium at either 18°C (closed syrnbo Is) or 37°C Copen 
symbols). After detergent solubilization, the cell extracts 
were incubated with preformed immune complexes containing 
lgG-C7 and 83/25, to precipitate the LDL (. '0 ) and 
transferrin receptors C A,1),.. ), respectively. Precipitations 
I 
after chase-incubating at l8°C were done in triplicate, 
while single precipitations were performed at each ti me 
after the 37°C chase. Al I 4 curves were obtained from the 
same single experiment. 
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incubated CF i g. 4. 1 2) . Neuraminidase treatment, which 
removes the terminal sialic acid residues from both the 
N- and 0-1 inked ol igosaccharide chains of mature receptors, 
produced a 
receptors of 
decrease in the apparent molecular weight of the 
about 10-12 kd . The half-life of the desia-
lylated mature LDL receptors (13 hr) did not differ signifi-
cantly CP > 0.05) from that of sialylated receptors (Fig. 
4 . 12 B) , sh ow i n g that the presence or absence of the sial ic 
acid residues played no r o I e in determining the rate of 
degradation of the receptor proteins. It is noteworthy that 
receptors did not become resialytated for the duration of 
the 24 hr subsequent to the neurami n i dase treatment. In 
addition, it i s I i k e I y that s i a I i c acid residues were 
removed from different types of eel surface glycoproteins, 
sin.ce the neuraminidase treatment was performed on whole 
c e I Is . From this, it can be inferred that the other eel I 
surface glycoproteins 







need terminal s i a I i c acid 
involved in LDL receptor 
Cas described i n Section Using the 
Three) on cultured human skin fibroblasts, a half-I ife of 
11.7 .±. 2.2 hr for the LDL receptor was obtained (section 
3 . 9 ) . In this study, the turnover of LDL receptors (and the 
imp Ii cations for LDL receptor up- and downregulation), were 












































































































































































Fig 4.12: Degradation of 35S-labeled LDL receptors from 
fibroblasts either with Ce) or without C6) neuraminidase 
treatment . 
Monolayers were pulse-labeled for 7.5 hr in EMEM/LPDS medium 
[35SJ-methionine. The cells were containing 50 
washed, then 
uC i /m I 
1. 3 m I of but fer containing 50 mM sodium 
c i t r a t e , pH 6 , 1 0 O mM Na C I and 2 mM Ca C I 2 was added t o each 
dish. In some cases, 50 µI neuraminidase (containing 0.05 
enzyme u n i ts) was added to the a ppr op r i ate dishes C • ) wh i I e 
in other cases it was omitted ( 6 ) . Al I monolayers were 
incubated at 37°C for 30 minutes, then washed twice with PBS 
before adding the chase medium (complete . DMEM/LPDS 
containing 200 µM methione). At the indicated times, the 
chases were terminated and the solubilized eel 
were incubated with preformed immune complexes 







receptor C- neuraminidase treatment) and the 150 
protein obtained (+ neuraminidase 
p I o t , sh ow i n g the absorbance of the 
treatment) 
extracted 
radioactive LDL receptor band 
the absorbance 
at each time, expressed as a 
percentage of obtained at 
point (2 h r ) . I mm u n o p r e c i p i t a t i o n s at 
the 
each 




performed on duplicate dishes C+ neuraminidase) or on single 
dishes C- neuraminidase). Duplicates never differed by more 
than 10% from the means. 
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It was important to consider whether the half:-1 ife of the 
LDL receptor was affected by the considerable difference in 
LDL receptor concentrations in the up- and downregulating 
states, and whether the mechanismCs~ of the LDL receptor 
regulation involved changes in the relative turnover rates. 
This was tested directly by performing the exp er i men t 
depicted in Fig. 4.1. 
the half-lives of LDL 
range of 
t e s t e d • 
cellular LDL 
The res u I t s showed u n e q u i v o ca I I y t ha t 
receptors remained the same over the 
receptor protein content that was 




that LDL receptor regulation is a function of 
in the receptor synthetic rate, was obtained 
theoretical curves using first order kinetics 
with a half-I ife for the LDL receptor of 11.7 ~ 2.2 hr, and 
then comparing these curves with the experimental data CFig. 
4. 2A). 
use of 
The f o I I ow i n g 
th i s mode I : 
important considerations underly the 
C i ) the LDL receptor half-I ife is 
independent of 
clearly shown 
the concentration of the receptor. This was 
to be true over the range of LDL receptor 
concentration which was examined CFig . 4.1). This means 
that the degradation rate of the receptor protein depends 
linearly on the LDL receptor concentration, assuming the 




undersaturated or non-saturable; C i i ) a f t e r 
upregulation process, the ti me course of 
new steady state depends solely on the hfilf-
I ife of the receptor, while the actual level depends both on 
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t he r e c e p t o r ha I f - I i f e and on t he mag n i t u de o f t he i n c r ea s e d 
synthetic rate of the receptor protein. The fact that the 
experimental curves for up- and downregulation kinetics were 
mi r r or images indicates conclusively that up- and down-
regulation of the LDL receptor is due only to changes in the 
rates of receptor synthesis. In contrast, Knight ~ ~ 
(128) have recently reported that incubation of fibroblasts 
in LPDS produced an initial increase in the rate of LDL 
receptor synthesis, f o I I owed by a decrease of over 6 0% to a 
new constant value; 
inhibited by compact in. 
t h i s decrease was 





synthesis during the period of upregulation of the receptors 
was not obtained in the studies described here (Fig. 4.28): 
no explanation for this difference can yet be offered . 
I t i s 
of the 
very interesting 
i nsu Ii n receptor 
that insulin-induced downregulation 
is caused solely by an accelerated 
receptor degradation rate, with synthetic rates remaining 
unaltered (120, 195) , whereas the decrease in HMG CoA 
reductase in the presence of 25-hydroxycholesterol is due 
both to a decreased synthetic and an increased degradation 
rate in respect of the protein (78, 235). 
A putative degradation intermediate. 
A putat i ve 
degradation 
intermediate was identified i n the LDL receptor 
pathway of apparent molecular weight 
approximately 120 kd (Fig. 4.3), using a polyclonal antibody 
directed against the LDL receptor. This fragment was not 
recognized by 
specific for 
the monoclonal antibody, lgG-C7, which i s 
the NH2- terminal I igand-binding domain of LDL 
209 
receptors. This suggests that the large degradation 
intermediate represents a proteo I yt i ca 11 y processed form of 
the LDL receptor which has lost part of the amino-terminal 
domain . It is also possible, but less likely, that some as 
yet un i dentified factor in the i n i t i a I stages 0 f the 
degradative 
change in 




160 kd receptor, prior to proteolytic 
in a loss of lgG-C7 recognition and a 
decrease in molecular weight of the 
protejn as observed on SOS-PAGE. An analogous intermediate 
has been previously observed i n experiments where a 
polyclonal antibody, directed against a synthetic peptide 
co r respond i n g to the COO H- term i n a I 1 4 am i no a c i d s of t .h e L D L 
receptor, was used for immunoprecipitation (146) . 
LDL receptor turnover in two other eel I types. 
The turnover rate . of LDL receptors on the wel 1-establ ished 
human hepatoma ce I I i n e , Hep G2, was measured (Fig. 4.4). 
This cell type was chosen since it is widely regarded, and 
genera I I y used, as a good model system to study the 
catabol ism of LDL by human hepatocytes .l..n. vitro (96), and 
because the I iver is known to play an important role in LDL 
uptake from the circulation. The half-I ife of the LDL 
' 
receptor in the Hep G2 cells was not significantly different 
f r om that obtained in HSF, indicating that the half-life of 
11.7 hr in the latter cell line is probably not a tissue-
specific feature. 
The half-life of the LDL receptor in cultured human 
lymphoblastoid cells was about 4 hours, as assayed by 
2 1 0 
eel I-associated 1215 1-LDL after preincubating the cells for 
various t' i mes in either LDL on I y, or in LDL + 25-
hydroxycholesterol (Fig. 4.5). This value was significantly 
shorter than that obtained for these receptors in HSF or Hep 








of the receptor 





decreased, as was the case, although to a 
significantly 
lesser extent, 
when LDL, 25-hydroxycholesterol and cycloheximide were added 
simultaneously . This general trend was s i mi I a r to that 
noted with the fibroblast monolayers (section 4.3.6) . 
rout 1ng of receptor and Ii gand towards Independent 
degradation. 
The pulse-chase experiments which were performed in the 
for presence of 
independent 
LDL CF i g. 
routing 
4 . 6 ) have 
of receptor 
provided evidence 
and I i g and t ·owa rd s 
degradation, since the addition of LDL to the chase medium 
yielded a receptor half-life which did not differ 
s i g n i f i can t I y f r om t hat ob ta i n e d in .the absence of the 
I i gan d. 
of the 
This is in agreement with the widely accepted role 
LDL receptor in receptor-mediated endocytosis (77, 
8 8) . Similar pathways are traversed by many other receptors 
and their Ii gands, such 
the half-life 
as the asialoglycoprotein receptor 
(28, 256), 
remain unaffected .l.n.. vivo 
(233). In contrast, the 
receptors has been shown 
presence of their ligands 
of which has also been shown to 
in the presence of i ts I i gan d 
other degradation of several 
to be drastically altered in the 
e.g. when EGF is added to cells, 
the receptors are internalized and degraded with the ligand, 
2 1 1 
resulting in a marked decrease in the half-life of the 
receptors (55, 65). 
The effect of cycloheximide. 




number of LDL 
was i n presence of receptors which 
cyclohexirnide (Fig. 4.6) suggests that a rapidly turning 
over protein 
degradation 
is necessary for a rate-limiting step in the 
of the LDL receptor. A f t er blocking 
synthesis and depleting the intracellular pool of 
the 
this 
the putative short-I ived 
drama t i ca I I y de c r eased 
protein by adding cycloheximide, 
rate of receptor loss would account 
for the apparently constant content of labeled receptors at 
chase times 5 h r . An analogous effect on the insulin 
receptor (i.e . initial rapid degradation, followed by a very 
reduced rate of receptor turnover) has been documented by 





puromycin also decreased 
cyclohexirnide effect is due 
to an inhibition of protein synthesis itself, and is not due 
to a specific effect of a particular inhibitor on receptor 
synthesis. Additional support for t h i s mode of 
cyclohexirnide action 
have shown that the 
growing 
results 
is provided by Stimac tl tl (227), who 
increased stability of histone mRNA in 
S49 c e I Is in the presence of 
from loss of an activity which 
exponentially 
cyclohexirnide 
regulates rnRNA turnover in the cell, and is not due to an 
alteration in the rnRNA structure. Kusari and Sen (136) have 
shown that 
in Hela 
the rapid turnover of interferon-inducible mRNA 
ce I Is is blocked by either cyclohexirnide or 
212 
actinomycin D, an effect which they concluded was due to the 
need for protein synthesis to bring about catabol ism of the 
mRNA. 
The effect of 25-hydroxycholesterol. 
In the presence of 25-hydroxycholesterol, an exponential 
loss of high-affinity eel I surface receptors was detected by 
1aal-LDL binding, after an i n i t i a I 5 hr lag period 
C F i g . 4 . 7 ) . . The decay curve was identical to that obtained 





Both curves displayed f i r s t 
half-lives of about 1 3 h r , 
s i mi I a r to that o.b ta i n e d using the 3158-pu I se-chase 
procedure. It is I ikely that the sterols strongly repressed 
the synthesis of the 
for the LDL receptor 
LDL receptor 
C 7 7 , 1 9 9 ) l , 
[by repressing the gene 
during which time normal 
receptor turnover brought about a reduction in the number of 
surface receptors. A marked reduction i n surface LDL 
receptor loss was also obtained in the presence of 
cycloheximide, in both the absence or presence 0 f 25-
hydroxycholesterol, which is consistent with the results 
depicted in Fig. 4.6 and discussed above. 
Receptor Rec ye Ii ng. 
The pathways and processes involved in the degradation of 
the LDL receptor are unknown. It is genera 11 y accepted that 
some or most endocytosed LDL receptors recycle to the eel I 
213 
surface via a pre-lysosomal route ("short loop"). 
tl (30) 
receptor 
have spe 7ulated that a small proportion 
Brown tl 
of the 
population could be partitioned into the lysosome-
targeted route, leading either to degradation of receptors, 
or to passage through a separate salvage pathway involving 
the trans-golgi reticulum ("long loop"), before returning to 
the cell surface. Strong evidence is now provided, from 
pulse-chase experiments on the LDL receptor internalization-
defect i v e f i bro b I as t c e I I I i n e C GM 2 4 0 BA, f r om pat i en t J . D . ) 
C F i g . 4 . 9 ) , that participation of the receptor i n the 
receptor-mediated endocyiotic pathway i s not an essent i a I 
prerequisite for degradation of the receptor at the rates 
observed in normal cells. 
Possible degradation mechanism(s). 
A useful way of distinguishing between lysosomal and 




the use of proteinase inhibitors, lysosomotropic 
ionophores. To this 
or presence of the 
performed (Tables 4.2 & 4.3 and 
inhibitor of lysosomal cathepsins 
calpains (245); chloroquine or 
end, chase-incubations, in 




8, H and L (168) and of 
ammonium chloride, weak 
bases which increase the pH of acidic int race I lular 
compartments (54); and mo n ens i n , a carboxylic ionophore, 
which among other effects, is known to increase 
intravesicular pH (237). A I I the agents except leupeptin 
caused a significant and rapid redistribution of the surface 
LDL receptors to intracellular locations; corresponding 
pulse-chase experiments showed an extremely rapid, marked 
decrease in labeled LDL 
these effects. neither of 
group of agents affected 
receptors. Leupept in produced 
I t is I i k e I y that the former 
ce I Is in such a way that the 
214 
concentration of lysosomal enzymes in certain cellular 
vesicles was increased, or indeed the number of lysosomes -
effects which have been noted by others (226). On exami n-
at ion under the phase-contrast microscope, fibroblasts 
incubated in the presence of monensin, ammonium chloride or 
chloroquine . were observed to assume a distinctly 11 bubbly 11 
mo r p ho I o g y , poss i b I y due to II pro I i fer a t i on " and exp ans i on of 
various kinds of vesicles. I t 







lysosomes. The f o I I ow i n g possible explanation is proposed 
for the 
apparent 
observed events: since these agents caused an 
receptor redistribution to the int race I lular 
vacuolar compartment (Table 4.2), and because there may have 
been an increased concentration of lysosomal enzymes in this 
system, the relocated receptors may have been rapidly 
degraded by enzymes able to operate at the pH levels in the 
particular locations. 
An a I t e r n a t.e plausible explanation (which may, or may not, 
occur i n addition to the above proposed degradation 




rapid loss of LDL 
the presence of chloroquine, 
ammonium chloride or monensin, could be that the receptors 
merely undergo a partial denaturat ion (or even j us t a subtle 
conformational change) that results in the loss of 
recognition f o r lgG-C7. This could account f o r the rapid 
loss of the 160 kd LDL receptor bands, as i S i I lustrated in 
Fig. 4. 1 OA. When I eupept in and monensin were added 
s imu I taneous I y to the chase media, the rate of LDL receptor 
loss decreased significantly but only partially (relative to 
2 1 5 
that ob ta i n e d w i th mo n ens i n only) CF i g. 4.108). The 
leupeptin:-inhibitible receptor losses caused by monensin may 
represent actual receptor degradation, whereas the monensin-
induced loss of receptors which was not inhibitible by 
leupeptin could be due t 0 a partial denaturat ion of 
receptors, accompanied by a concomitant loss of lgG-C7 
recognition. The experimental ·data obtained to date cannot 
distinguish between 
partial denaturation 
the possibilities of degradation and/or 
resulting in the observed LDL receptor 
loss in the presence of the above-mentioned agents . 
In a recent study by Davis ~ ~ (50), deletion 0 f the 
domain of the receptor that contains "growth factor repeats" 
was associated with i nab i Ii ty of the receptor · to dissociate 
from LDL at acid pH; as a result, the receptor was no 
longer recycled 
ligand binding. 
efficiently, and was rapidly degraded after 
Leupeptin, which neither altered the surface distribution of 
the LDL receptor, nor produced any visible proliferation of 
large vesicles, had no effect on receptor turnover. I t 
appears that the proteases which are inhibited by leupeptin 
(amongst which are the non-lysosomal calpains) do not play a 
rate-limiting role in the degradation of the LDL receptor, 
excepting when eel Is are severely disturbed by drugs which 
prevent normal vesicular function. 
Aul inskas ~ ~ (10) have demonstrated that at temperatures 
between 10 and 20°C, LDL receptors on HSF retain the abi I ity 
to bind and internalize LDL, and to recycle to the ce I I 
2 1 6 
surface, but degradation of the i gand, Ca I ysosoma I event), 
is completely 
probably due 
inhibited. This lack of degradation was 
to inhibition of fusion between lysosomes and 
endocytosed vesicles at the reduced temperatures (67, 152). 
LDL receptors were degraded at this temperature at a rate 
commensurate with the approximated four-fold slowing slowing 
down of chemical processes when stepped down from 37°C to 
18°C. This observation suggests that inhibition at least of 
LDL receptor degradation is non - I y sos oma I ; this contrasts 
with the notion that receptor degradation is a lysosomal 
event, associated somehow with ligand targeting to lysosomes 
C for rev i ew, see (247)). The possibility that "downstream" 
steps in the pathway for degradation of LDL receptors occur 




leupeptin to alter the turnover 
not conclusive evidence against 
the "downstream" steps may not 
rate 





limiting until they are inhibited to a very severe degree. 
The possible non-lysosomal mechanisms of receptor 
deg rad a t i on are d i s cussed mo r e f u I I y i n Sec t i on F i v e . 
Desialylation of the mature LDL receptor. 
Many membrane 
are covalently 
proteins contain oligosaccharide chains which 
attached to either asparagine CN-linked) or 
to serine and threonine CO-I inked). The precise function of 
the o I i gos a cc ha r i de mo i et i es has not yet been clearly 
established. For example, Prives and Olden (189) found that 
the impairment of protein glycosylation of the acetylcholine 
receptor in cultured embryonic muscle cells increased the 
susceptibility of this receptor to degradation by cellular 
2 1 7 
proteases. In contrast, it was shown C 1 90, 196) that 
glycosylation of the insulin receptor was necessary for its 
activation after translation, while having no effect on the 
susceptibility of the receptor t 0 degradation. In the 
studies reported herein, i t has been found, using 
neuraminidase treatment C F i g . 4 • 1 2 ) , that the absence or 
presence of sial ic acid residues on the carbohydrate chains 
of mature LDL receptors plays no r o I e in determining the 
degrada .tion rate of these proteins. Furthermore, the LDL 
receptors were not re-sialylated during the 24 hr chase 
period. This could suggest that recycling mostly occurs via 
the pre-lysosomal "short I oo p" route, thus bypassing the 
















Resialylation of asialo-transferrin receptors in human 
erythroleukemia eel Is occurs with a half-time of 2-3 hr 





There is some speculation that this 
iron uptake, since the 
that followed by the receptor during 
receptor is known to recycle within 
mi nut es under such conditions (221). 
4.5 Concluding remarks. 
In conclusion, r es u I t s f r om these studies have shown that 
the half-life of LDL receptors is 11.7 .:!:. 2.2 hr in human 




Evidence is provided for Ci) the independent routing 
and its receptor within the cellular degradation 
machinery and C i i ) a constant LDL receptor half-life over 
of cellular receptor protein content that was the range 
tested. 
rapidly 




the data indicate that 
"factor" which is necessary for 
and thus this agent stabilizes the 
doubling the half-life. In addition, 
receptor is regulation of the LDL 
brought about 
on I y. 
by changes in the rate of receptor synthesis 
The present data are consistent with a pathway for LDL 
receptor degradation which does not necessitate procession 
of this protein along the coated pit-based endocytotic 
route, and for which the rate-limiting step is apparently 
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5. 1 Introductory remarks. 




eukaryot i c ce II s to their environment. The 
of receptor molecules at the surface is a key 
receptor function in th i s context. This 
number wi I I be affected inter~ by dynamic processes such 
as the specific polypeptide synthesis, processing through 
the intracellular "production I ine", distribution to the 
cell surface and , u I t i ma t e I y , degradation. Each of these 
processes is complex, and is probably I inked to the others 
to ensure optima I ce I functioning. The studies described 
i n th i s thesis focus on the LDL receptor system, and more 
particularly, on the degradation of this receptor and of its 
ligand CLDL), in an attempt to clarify certain mechanistic 
aspects of these important processes. 
I t i s generally accepted that lysosomes are the intra-
cellular sites for the degradation of the different 
structural components of LDL. Workers in this laboratory 
(249) have demonstrated that lysosomal cathepsins 
synergistically to bring the degradation of Apo B-100 
act 
to 
completion. This degradation sequence occurs via a number 
of well-defined large intermediate fragments . In contrast, 
virtually nothing 
re c ·e pt or for this 
is known 
igand. 
very . basic 
whether the 
questions, such 
I igand CLOL) 
about the degradation 0 f the 
Th i s I a ck of kn ow I edge ext ends to 
as the site(s) of degradation, 
affects the rate of degradation, 
the role of the covalently I inked carbohydrates i n 
determining the susceptibi I ity of receptors to degradation, 
221 
and whether receptor up- and downregulation are linked to 
alterations in the rates of receptor degradation. 
At the start of this work, it was reasonable to assume that 
receptor degradation occurred in the lysosomes after 
frequent cycles of internalization and returning to 
data 
the 
to surface. In other cases, there are substantial 
indicate that receptor degradation is a lysosomal event. 
For example, the EGF receptor i s degraded i n t r a I y sos oma I I y 
(together with its ligand) subsequent to internalization via 




noted that non-lysosomal mechanisms may be 
the degradation of other receptor · types; this 
chick example, to insulin receptor loss in 
iver eel Is (135). 
It should be mentioned, albeit briefly in this context, that 
mys t e r y st i I 
segregation of 
surrounds the sorting steps resulting in the 
recycling receptors from other endosomal 
structures containing receptors (and ligands) putatively 
scheduled for lysosomal degradation. One possibi ity would 
be that receptors that may be destined for lysosomal 
I i mi ting 
vesicles 
degradation are extruded from the 
the 
endosomal 
intrusion membrane into the membrane of 





subsequently be combined with other lumenal 
targeted to lysosomes. Ligands present no 
they have been dissociated from the receptors, 
acidification of the ·environment i n the 




a step(s) which ceases to operate at 20°c or 
The major focus of this thesis has been an investigation of 
the turnover 
The results 




human skin fibroblasts. 
Four suggest that the 
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I y s o s om a ·I r o u t e i s not the ma j or i n i t i at or i n th i s process , 
at least as assessed under the experimental conditions used. 
Leupeptin did not inhibit the degradation of the receptors 
(Fig. 4. 10), [but did inhibit I i gan d degradation (Table 
4.3)), i·ndicating that one or more of the 
LDL 
f o I I owing 




occurs independent I y the 
leupeptin; Cii) intralysosomal 
proteinases 
"downstream" 
do not become rate-limiting u n t i I severely 
i n h i bi t e d , may 
( i i i ) d i S t i n C t 
the degradation 
be involved in LDL receptor degradation; or 
lysosomal populations may exist - some for 
of I igand, others for that of the receptor. 
Alternately, entirely non-lysosomal mechanisms for receptor 
turnover may be operative. The observation that receptor 
I o s s s t i I I occurred at 18°C CFig. 4.11) provides additional 
arguments against a classic lysosomal route, since there is 
a complete block in I y sos oma ~ de I i very and degradation at 
this temperature (10). 
Gevers ~ ~ (77) 
cyclic synthesis, 
have proposed a general scheme for the 
functioning and turnover of LDL receptors 
C F i g . 5 . 1 ) . Based on the results reported in Section Four, 
v a r i o us mod i f i ca t i on s to this scheme of the figure must now 
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Diffuse Receptors in-•h Clustered Receptors 1n 
Plasma Membrane ' Coated Pits 
t ' Vesicles Recycling t Receptors 
. 'Endosomes (CURL) 
Golgi Apparatus 
t ......_ ? l few receptors ·~. some most 1· t · recept~ 1popro ems 
Endoplasmic Reticulum Lysosomes 
l 
Receptor Synthesis I I Receptor Degradation! 
Fi g . 5 . 1 : Scheme for the c y c I i c syn the s i s , fun ct ion i n g and 
turnover of LDL receptors. 
Adapted from Reference 77. 
be proposed. These are explored below, and the more I ikely 
p o s s i b i I i t i e s a r e s u mm a r i z e d i n F i g . 5 . 2 . 
5.2 Receptor ·shedding as a mechanism for eel lular receptor 
IO S8. 
Several investigators have documented an alternate, and 
somewhat nova I, mechanism of transferrin receptor loss. I t 
is we I I 
recycled 
established that transferr in receptors are usually 
subsequent to internalization 
reticulocytes, however, are 




fr om the cells during 
some receptors 
differentiation into erythrocytes. 
Such loss apparently occurs via incorporation of the 
transferrin receptors into the membranes of inclusion 
vesicles (92. 1 7 9 , 180) . Since these c e I Is have few 
lysosomes, the mu I t i v es i cu I a r endosomes seem to escape 
lysosomal fusion, and lose their contents from the eel by 
exocyt9sis of multivesicular endosomes. Thus, receptor loss 
occurs by a p r o c e s s t e r m e d II r e ·c e p t o r s h e d d i n g 11 , r a t h e r t h a n 
via intracellular degradation mechanism(s). 
I t is 
may be 
tempting to specu I ate that ce 11 u I ar LDL receptor I oss 
due, at least in part, to receptor shedding . This 
would provide a plausible explanation for the finding that 
participation of LDL receptors i n the receptor-mediated 
endocytotic pathway is not an essential prerequisite for LDL 
rec e p tor deg rad at i on , a t r a t es observed i n nor ma I c e I I s C see 
sections 4.3.7 a n d 4 . 4 ) . However, experiments performed by 





• independent of 
route A. 
i 
• not inhibited by 
leupeptin. 
• still occurs at 18 ·c 
D.f':'\ 
\!..)Lysosomes 
Fig. 5.2: Proposed cycling and degradation routes of LDL, 
and LDL receptors. to incorporate new findings obtained in 
this thesis . 
A:Receptor cycling route C"retro-endocytosis") 
B:Receptor recycling route ("receptor-mediated endocytosis") 
C:Receptor degradation 
0:Site of ligand degradation 
Y, receptor e, ligand Q. vesicle. 
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shedding mechanism. These investigators biosynthet ical ly 
labeled normal fibroblasts with [35S]-methionine for up to 
1 8 h r , then subjected both the c e I Is and the media t 0 
s e p a r a t e i mm u n o p r e c i p i t a t i o n s with lgG-C7 . In t h i s way, 
they showed that >98% of the LDL receptors were associated 
with the ce I I membrane in contrast to the situation with 
receptors lacking the membrane-spanning and cytoplasmic 
domains (145)1 . These results prove that the observed 
cellular loss of radiolabeled LDL receptors in normal 
fibroblasts must be attributable to mechanism(s) other than 
receptor shedding. Ce I I u I a r receptor degradation presents 
itself as the most obvious, and I ikely, candidate. 
5 . 3 Mechanisms of cellular LDL receptor degradation. 
The possibility that the rate-I imi ting steps of intra-
cellular degradation of LDL receptors are lysosomal events, 
appears uni ikely (section 5 . 1 ) . Alternate potential 
mechanisms, which are non-lysosomal, are discussed below . 
5. 3. 1 Calcium-dependent neutral proteinases. 
The ca lci um-dependent neutral proteinases (calpa i ns) are a 
novel class of thiol endopeptidases which characteristically 
I 
b r in g about selective but i mited proteolytic protein 
mod i f i ca t i on s ( for review, see reference 187) . Variations 
i n the concentrations of proteinaceous inhibitors and 
activators, and in the intracellular ca 2 • concentrations, 





low Ca 2 • 
proteinases . 
requirement 
Cmicromolar range), and are resistant to calpastatins (187); 
they remain sensitive to leupeptin, never-the-less, and so 
the inhibition data reported in section four exclude what 
other w i s e wo u I d be a very i n t ere st i n g poss i b i I i t y. 
5.3.2 The ubiguitin pathway. 
Ubiquitin is a 76-residue protein, present in all eukaryotic 
cells, which participates in a complex, multi-component 
proteolytic pathway C for review, see reference 7 0) , and 
results in the complete degradation of proteins to the amino 
acid level, without the involvement of lysosomes. 
Indiscriminate proteolysis along this pathway is prevented 
by a requirement for a processive ATP-dependent conjugation 
of target proteins with u b i q u i t i n C 4 2 , 1 0 1 ) . Tanaka tl tl 
(236) have employed a no v e I met hod to i n v es t i g a t e t he r o I e 
of ubiquitin-mediated proteolysis i n the accelerated 
degradation of HMG CoA reductase caused by the presence of 
25-hydroxycholesterol. A c e I I I in e that expressed a 
temperature-sensitive mu tat ion in the ubiquitin pathway was 
used; incubations were carried out at the non-permissive 
temperature, and were compared to those performed at the 
permissive temperature. No inhibition of the effect of 25-
hydroxycholesterol on enzyme act i v i t y a t the non - perm i s s i v e 
temperature was detected . These results indicate that the 
increased rate of degradation of the reductase upon addition 
of the sterol is not dependent on the ubiquitin pathway. An 
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analogous approach could be used to · investigate the 
contribut'ion of this proteolytic system to LDL receptor 
degradation. I t i s , however, unlikely that ubiquitination 
is involved to any significant extent in this process, since 
the covalent linking of ubiquitin units to the substrate 
proteins is processive from an (unblocked) N-terminus (102), 
and in the case of mature membrane-bound receptors, this is 
outside the eel I. 
5.3.3 High molecular weight proteinases 
Un ti I a few years ago, little was known about cytosolic 
prote i nases . Several, apparently different, high molecular 
weight proteinases C mw t range: 450 000 to 700 000 daltons) 
have been p u r i f i e d f r om v a r i o u s ma mm a I i a n tissues but the 
relationships between these enzymes are, as yet, unclear . 
Some of the more recently documented high molecular weight 
proteinases include the "macropa ins" C 160), the "i ngens ins" 
(112, 113, 261), and a multifunctional seryl proteinase 
which is present in the cytosol of al I rat tissues (234) . 
The possible contribution of such proteinases to LDL 
receptor degradation 
stage . 
is an entirely speculative one at this 
5. 3. 4 
I n the 
Section 







the data obtained in 
clearly show that the 
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degradat i ve system i nvo I ved exists in ."excess": irrespective 
of the physiological LDL receptor up- or downregulation 
status, the half-life remained constant, indicating that the 
degradation pathways are not saturated over the range of 
receptor amounts that were tested. 
Denaturation. 
I t i s not unreasonable to hypothesise that the rate-
determining step in selective protein degradation may be a 
"physic a I" one - namely, the denaturation of polypeptides . 
LDL receptor 
proteolysis at 
denaturation could be followed by non-specific 
sites previously "protected" by the higher-
order structure of the receptor. 
Defective and abnormal proteins. 
Defective proteins 
mutation, synthetic 
(such as those produced as a result of 
error or denaturat ion) and abnormal 
proteins (for example, th~se containing amino acid analogs), 
are degraded rapidly in the cytoplasm (130). On the basis 
of data obtained from pulse-chase studies, it would appear 
that some mutant forms of the LDL receptor which are 
synthesised in different FH pat i en t s , are turned o v e r more 
than the i r normal counterparts (four i a-Jacobs, rapidly 
Coetzee, Gevers, Van der Westhuyzen, unpub Ii shed 
degradat ive observations). The extent to which "normal" 
mechanisms partake in the degradation of the mutant 
receptors are unclear at present. 
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Extracellular or eel I-surface proteases. 
Plasma membrane proteins offer targets for degradation by 





exposed domains. The possibility therefore 
receptor degradation is initiated by cleavages 
catalyzed by 
Doyle (18) 
surface-bound or serum proteases. 
have reported the existence of a 
plasma membrane protein from a hepatoma eel I ine which is 
degraded by this . mechanism. It is conceivable, in the case 
of the LDL receptor, that ext race I lular proteases mai attack 
the amino terminal (outer) domain, and thereby initiate 
receptor degradation. In this regard, it must be noted that 
plasma Cand ext race I lular fluid) contains a vast array of 
protease inhibitors. 
receptors on 
However, the exquisite susceptibility 
eel Is to proteases such as pronase and of LDL 
trypsin C 8 4 ) , might predispose the receptors to 
"ext race I lular" degradation. 
lntramolecular disulphide bridges. 
Several cell surface receptor proteins (including the LDL 
receptor) are relatively abundant in cysteine residues: the 
role these play i n the format ion of intramolecular 
disulphide bridges and protein conformation, i s a we I I -
established one. Malbon~.!!..!. (150) have recently reviewed 
a putative 
activation. 
contribution of disulphide bridges to receptor 
It appears that many cell surface receptors 
that are coupled to their effector systems via G proteins, 
possess intramolecular disulphide bridges. The cleavage of 
these by thiol compounds Cat least in the case of the beta-
adrenergic receptors) produces receptor activation sirni lar 
2 3 1 
to that achieved by agonist binding. The relevance of 
intramolecular disulphide bridges to receptor protein 
turnover in general and, more specifically, its possible 
r o I e in LDL receptor degradation - has not been addressed 
y e t . 
5.4 The proposed 11 N-end 11 rule for protein degradation. 
The successful application of the postulated "N-end· rule" 
(13), which states that the l.n. vivo half-I ife of a eel lular 
protein is a function largely of its amino-terminal residue, 
has so far been _possible only with non-compar tmenta Ii zed 
proteins; Bachmair .!Lt..!!..!. (13) have suggested that proteins 
with unblocked N-termini featuring 11 destabi I izing" amino 
acids lodged in the external environment may well be stable 
i n this situation, but could be rapidly degraded i f 
introduced into the intracellular space. 
The amino-terminal sequence of the mature LDL receptor 
starts with three so-cal led 11 stabi I izing 11 residues Ca I a, 
va I , g I y; t 1 / 2 > 20 hours), fol lowed by twelve that are 
"destabi izing 11 Ct,,.a < 30 mins) - but three of these have 
not yet 
( V i Z • 
been characterized 
cys, a s n , cys). 
ami nopept i dase could remove 
in terms of the "N-end r u I e 11 
Conceivably, a rate-I imi ting 
the "stabi izing 11 





rapid degradation of the protein. These 
require events in which the binding domains of 
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the LDL receptors are exposed to the cytoplasm - no evidence 
for such events exists. 
As a side-issue, it might be informative to consider the 
degradation of the LDL apolipoprotein (Apo B-100) in the 
context of the "N-end" rule. The amino-terminal sequence of 
Apo B-100 
g I u, g I u; 
starts with 
t,,. a about 
three "destabilizing" residues Cglu, 
30 mins), fol lowed by a methionine 
residue Ct,,.2 > 20 hours), then two "destabi I izing" residues 
C I e u , t , ,. 2 about 3 mins; glu, t,,.a about 30 mins). When 
this ligand was introduced into cultured fibroblasts by 
scrape-loading, it was degraded with a half-life of about 50 
hours, compared with that of about 1 hour subsequent to 
Ii gand uptake via receptor-mediated processes and lysosomal 
delivery (section 2 . 3 . 8 ) . The former half-life is not 
consistent with that which is predicted according to the "N-
e n d r u I e 11 - perhaps, after incorporation of the ligand via 
scrape-loading, a cytoplasmic am i nope pt i d as e removes the 
three terminal glu residues, leaving exposed a " stabilizing" 
residue. The slow degradation of scrape-loaded LDL could 
reflect either Ci) slow degradation by neutral Ccytosolic) 
proteases, or C i i ) slow lysosomal sequestering of the 
I i ga n d . On the basis of the experiments reported in section 
2.3.8, possibilities Ci) and C i i) cannot be distinguished 




culture media, or the 
at 18°C, should yield 
incubation .of scrape-
results which clarify 
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5.5 Sorting domains. 
General importance. 
Domains that determine the cellular location as opposed to 
the fun ct i on of a pro t e i n are termed "so r t i n g d oma i n s" . The 

















the unidirectional f I ow of 
pr o t e i n s f r om one o r g an e I I e t o an o t he r . It is thought that 
newly synthesised proteins are directed to the Golgi 
. complex; here, the proteins are sorted and routed to their 
correct intracellular destinations. A well-studied example 
of this is the mannose-6-phosphate receptor, which targets 
newly synthesised lysosomal enzymes from the Golgi cisternae 
to the lysosomes (132). 
A proposed "C-terminal" protein salvage mechanism. 
I t i s interestfng to speculate on the existence of putative 
sorting mechanisms for mislocated LDL receptors Ca "salvage" 
operation). The concept of protein "salvage sequences" was 
formulated as a result of experimentation to investigate how 
proteins i n the ER lumen resist export (reviewed 
compared 
in 
reference · 255). Munro and Pelham C 167) the 
sequences of three major ER proteins, and found that all 
contained the same tetrapeptide sequence Clys-asp-glu-leu) 
at the carboxy terminus. Remo v a I of th i s sequence res u I t e d 
in the secretion of the truncated proteins; the same effect 
was obtained by adding two extra amino acids to the 
tetrapeptide, but when the sequence was transferred to the 
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carboxy terminus of a secretory protein, the protein 









proteins (soluble in the 
effective "salvage sequence", which 
f o I I owing hypothetical "salvage 
receptor (due to its location) may 
the tetrapeptide only after the 
ER I ume n) have been erroneously 
exported from the ER. This process would require only small 
numbers of receptors because they would recycle ~etween the 
ER and the compartment to which the proteins had been 
mistakenly directed. There appears, in any case, to be an 
intermediate compartment between the transi.tional elements 
of the ER and the Golgi stack (201) which might be rich in 
the salvage receptors, and which presents a possible site of 
protein recovery. The fundamental assumption that the 
tetrapeptide is available for binding is reasonable, given 
that the carboxy terminus should be the last part of the 
protein to fold, and hence should remain exposed on the 
protein surface. 
One might consider that such a "C-terminal salvage 
mechanism" may play a role in the LDL receptor system. The 
carboxy terminal sequence of the LDL receptor is: 
CC-terminus) ala-val-asp-asp-glu-leu-ser- . . . .. CN-terminus) 
The underlined tripeptide bears remarkable similarity to the 
tetrapeptide lys-asp-glu-leu (167). Receptors which 
inadvertantly end up in the ER (perhaps during the complex 
re-routing processes i nvo I ved in recyc Ii ng during receptor-
mediated endocytosis), could conceivably bind t 0 the 
putative "salvage receptor", and hence be relocated for use. 
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However, if the LDL receptors remain inserted in membranes 
vi a the membrane-spanning domain, their C-termi na I sequences 
w i I I most I ikely not be exposed to vesicle lumens, and wi I I 
thus not be avai I able to bind to the "salvage receptors" . 
5. 6 A potential role for fatty acylation. • 
The occurrence of post-translational mod i f i ca t i on by the 
addition of covalently bound fat t y acids t 0 certain 
polypeptides has been we I I documented; examples are 
enveloped virus glycoproteins C 1 4 8 , 207), r e t r o v i r a I 
proteins C 3 6 , 1 5 1 , 2 1 3 , 2 1 7) and several eukaryotic 
proteins, such as the receptors for t r a n s f e r r i n ( 1 7 3 ) a n d 
acetylchol ine (171). No uniform function has yet been 
established for such "direct" protein acylation. One view 
is that such mod i f i ca t i on s may provide hydrophobic domains 
to the protein, and thus serve as static anchorage points to 




in recognition mechanisms has been proposed 
for the myristyl moieties of transforming 
In this regard, a significant observation 
is that mutation of the N-terminal glycine of the tyrosine-
specific protein of Rous sarcoma virus prevents both 
my r i sty I at ion and morphological transformation, without 
affecting its tyrosine-kinase activity (116, 117). Thus, it 
appears that myristylation of the Rous sarcoma virus is 
important for the subcellular I o ca I i z a t i on o f t he mo I e c u I e 
(36). Hedo _g_-1 ~ (97),working on cultured human lymphocytes, 
have recently reported that the alpha and beta subunits of 
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as the pro-receptor) we I I 
and [:SHJ-pa lmi tic acids 
indicate the existence of two 





respectively compatible with 
the alpha subunit contains 
being 
only 
amide-linked fatty .acid, while the beta subunit has both. 
Omary and Trowbridge (173), in studies performed using a 
human I eukemi c T-cel I I ine, have shown that the mature form 
of the transferrin receptor can be labeled with 
palmi tate, and have provided evidence that the fatty acid is 
probably covalently attached to the membrane-associated 
portion of the molecule (172). In addition, they found that 
the receptor protein was degraded with a half-l if e of about 
60 hours, whereas the pa Im i tat e mo i et y turned over . more 
rapidly (60% was lost within 12 hours) . The significance of 
these different turnover rates has not been elucidated yet. 
I t should be noted that a second class of acylated 




complex glycosyl-inositol phospholipids . 
this acylation is unequivocal and uniform: 
One 
the 
attached phosphatidyl inositol acts as a 
hydrophobic anchor, and i s the sole means of membrane 
attachment (reviewed in reference 45) 
To date, no investigations have been reported concerning the 
absence or presence of 
t rans I at i on a I mod i f i cat i on 
fat t y 
of the 
acylation as a post-
LDL receptor . If such a 




have important implications in terms of the more 
aspects of receptor stability , I if e cycle or 
functioning. Could this putative modifi :at ion provide the 
recognition signalCs) for the complex int r acellular sorting 
processes involved in receptor-media t ed endocytosis? 
Perhaps fatty a c y I at i on fa c i I i tat es the I i1 t er a I movement of 
receptors in the membran~s? 
5.7 The relative lack of complexity of the regulation of 
the LDL receptor system in comparison with several other 
receptor systems. 
The mechanisms regulating the level of c e I I surface LDL 
receptor expression are relatively "un ophisticated" in 
comparison with the exquisite sensitivi t ies and complex 
controls inherent in other receptor systems - notably those 
which mediate 
factors. 
the eel lular uptake of hormones and growth 
LDL receptors are synthesised as single polypeptides, and, 
apart from cleavage of the signal sequence, do not appear to 
undergo any further pre-functional 
Downregulation of 
expression appears 
the level of eel 
to be due solely 
prote o lytic processing . 
surface LDL receptor 
to a decrease in the 
biosynthetic rate of the receptors (sections 4.3.2 and 4.4) . 
By contrast, insulin receptors are synthesised as single 
glycoprotein precursors, which are f i (st proteolytical ly 
cleaved to yield mature receptors, each of which comprises a 
disulphide-I inked heterodimer C2 alpha subunits the 
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I igand-binding domain, and 2 beta subunits - the tyrosine 
kinase domain). In addition to participating i n the 
classically described recycling pathway of receptor-mediated 
endocytosis, very r e cent exp er i men ts performed by Podlecki 
tl tl (186) on isolated hepatocytes, using biologically 
covalently active, photosensitive ins u I in derivatives 
attached to insulin receptors, have generated speculation as 
to additional receptor routing. These investigators showed 
that about 5% of the internalized receptor-I igand complexes 






to nu c I e i , and have proposed that 
insulin-dependent genes may be stimulated 
insulin receptors to specific genomic 
th i s nuclear binding i s functionally 
important. and whether it involves proteolytic degradation 
of the receptors, is presently not clear. 
A further contrasting aspect of the insulin system is that 
insulin-induced receptor downregulation has been attributed 
to an accelerated insulin receptor degradation rate, while 
unaltered (see section 4.4, and the synthetic 
references 120 
rate remains 
& 195). Fat t y acylation of the ins u I in 
receptor has also been reported; the functional significance 
of this is, as yet, unclear Csee section 5.6 and reference 
9 7) . In addition, co v a I en t mod i f i ca t i on of ins u I in 
receptors by phosphorylation appears to play a key role in 
regulating the function of these receptors: 
phosphorylation of the beta-subunit produces an 
auto-
enhanced 
tyrosine kinase activity towards exogenous substrates, and 
increased receptor f u n c t i on , whereas phosphor y I a t i on of the 
beta subunit on serine (and maybe threonine) residues leads 
t 0 decreased autophosphorylation and receptor tyrosine 
kinase activity (reviewed in reference 220). 
Phosphorylation also plays an essential role in regulating 
the EGF receptor functioning (220). EGF stimulation induces 
both a rapid autophosphorylation of tyrosine residues, and 
The latter effect results the phosphorylation of thr-654. 
in receptor internalization and tyrosine kinase inhibition. 
Downregulation of 
to internalization 
this receptor is brought about subsequent 
of the 
receptor and ligand are 
rece-ptor-1 igand complex 
degraded i n t r a I y sos oma I I y . 
both 
This 
ensures a very rapid alteration in the level of cell surface 
EGF receptor expression in response to changes in the 
external environment. 
Very recently, Kishimoto .!L!. l!.J.. (127) have described a 
soluble kinase fr om bovine adrenal cytosol that 
phosphorylates a specific serine residue (serine 833) which 
is located in the cytoplasmic domain of the LDL rec~ptor, 
six amino acids from the carboxy terminus. This enzyme was 
shown to resemb·I e casein 
properties, but to differ 
kinase 
in the 
I I in i t s 
following ways: 
catalytic 
( i ) i t s 
apparent mwt is about 500 000 dalton, compared with that of 
130 000 for casein kinase II, Cii) its affinity for the LDL 
receptor (apparent KM about 5 nMJ is much greater than its 
affinity for casein CKM about 10 µM), and Ci ii) polylysine 
inhibited its activity, whereas this agent stimulates casein 
kinase II . The physiologic roleCs) if any - of the LDL 
receptor kinase is unknown. 
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The steps of transduction and amp I i f i oat ion that activate 
cAMP-dependent kinases i I lust rate the extreme complexity and 
regulation inherent in second messenger pathways (reviewed 
in reference 2 5). I n 
at 
essence. external signals C f i r s t 
messengers) arrive receptor molecules in the plasma 
membrane where they activate a closely re I a t e d f am i I y of 
tran~ducer molecules (which carry signals through the 
membrane) and amp I i f i er enzymes (which activate internal 
signals carried by second messsengers). The pathways in 
which cAMP acts as the second messenger 
Signals 
have both 
stimulatory and inhibitory receptors. from these 
Cadenylate receptors converge on the amp I i f i er enzyme 
cyclase), which converts adenosine triphosphate into cAMP. 




convergence: these G proteins are activated 
triphosphate CGTP). and are curtailed by GTP 
cAMP binds to the regulatory component of its 




response. The second 
catalytic component, 
proteins regulating a 
messengers 
triphosphate and diacylglycerol function in the 
inositol 
inositol-
I ipid pathway to produce phosphorylation of distinct sets of 
proteins, via equally sophisticated regulatory mechanisms 
(reviewed in reference 25). 
These somewhat 
for formulating 
brief comparisons have been used as a basis 
t he f o I I ow i n g generalization: it would 
appear that receptors that bind, and in some cases mediate, 
the uptake of hormones and growth factors. function within a 
system which is "f in e I y tuned" to changes i n the 
2 4 1 
ext race I lular environment, and which are capable of 
responding rapidly, with great precision. In comparison, 
the LDL receptor system appears to lack this complexity, and 
to operate 
could be 
at a more "pr i mi t i v e" I eve I • Conceivably, this 
due to the nature of the wh i I e i t i s 
physiologically essential that the 
ligands : 
cellular response to 
altered hormonal levels should be extremely rapid (hence the 
need for a "sophisticated" sys t em) , i t is not immediately 
lethal i f the cellular response to altered plasma 
cholesterol levels is somewhat slower (hence the adequacy of 
a more "primitive" system). · 
Abundant epidemiologic evidence indicates that plasma LDL 
levels in Western civilized nations are generally much 
higher than those found in primitive societies . On the 
basis of the affinity of LDL receptors for LDL (assayed in 
cultured human cell lines), it has been proposed that the 
p I a sma I eve I of L D L - ch o I ester o I i n Western cu I tu res i s about 
f i v e t i mes higher than that which should, in theory, be 
adequate to nourish dividing and steroid hormone 
synthesizing 
reference 34). 
body cells with cholesterol (reviewed i n 
Also, as evidenced by the situation in non-
human mammals, a relatively lower supply of cholesterol to 
the I i v er suffices for ts structural r o I e in VLDL 
production. 
f a t d i e t s , 
That human neonates, and humans raised on low-
have substantially lower plasma LDL-cholesterol 
levels (relative to the i r ad u I t, Western-diet fed 
counterparts), substantiates the notion that these reduced 
levels are in fact physiologic for humans. 
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In a situation where LDL receptors are saturated with LOL, 
no mechanism exists whereby the regulation of LDL receptor 
activity ensures "low" plasma LDL concentrations. In fact, 
in the case of human beings ingesting excess dietry fats and 
cholesterol Ca typical Western d i e t ) , LDL receptor 
saturation and downregulation are thought to play central 
cholesterol roles in producing the elevated plasma LDL 
levels that are commonly found. The rate of LDL removal is 
proportional to the number of receptors which are ~resent on 
the ce I I surfaces. Since hepatic uptake of dietry 
cholesterol is mediated by chylomicron remnant receptors , 
cholesterol which are expressed independent I y of 
accumulation (219), exc~ss cholesterol accumulates in the 
the I iv er . This, in t u r n , results in a reduction in 
synthesis and expression of hepatic LDL receptors . Bearing 
in mind the key role of the I iv er in whole body LDL 
metabolism (section one), it is obvious that the combined 
saturation and suppression of hepatic LDL receptors may 
contribute significantly to elevated plasma LDL levels when 
there is excess cholesterol in the diet . 
speculation that the LDL receptor system 
" d e s i g n e d " to retain, 
cholesterol Viewed i n 




essential requirement for cholesterol to 
This invokes the 
is one which is 
remove, dietry 
perspective, the 
neonates have an 
faci I itate ce I I 
d i v i s i on and gr ow th , and pr i mi t i v e man C pres uma b I y i n g est i n g 
a "prudent" diet), would have needed to retain and mobilize 
all dietry cholesterol Ceg. ,for hormone synthesis). In the 
latter situation, a controlled level of LDL receptor 
expression to prevent 11 over a cc umu I at ion 11 of plasma LDL, 
would therefore appear to be unnecessary. 
5.8 Con~luding remarks. 
In ending, let us return to the beginning. 
The study of the disease, Fami I ial hypercholesterolemia, led 
to the discovery of LDL receptors. Subsequent investigation 
of the pathways by which these receptors operate faci Ii tated 
the understanding of the 
far 
b ·iochemical nature of th i s 
inherited disease. Of greater general importance, 
however, was the concomitant elucid~tion of the process of 
receptor-mediated endocytosis (which was "stumbled upon", so 
to speak, in delineating the LDL receptor pathway). This, 
i n t u r n , has emphasised the role played 
receptors in maintaining normal 
critical 
eel lular and whole 
by 
body 
functioning. The study of receptors, and a I I aspects of 
t he i r I i f e - c y c I es , has rap i d I y become a f i e I d of i n tense and 
exciting research. 
And in concluding, let us project to the future. 
There are many fundamental questions -
routing of 
particularly con-
earning the segregation and various receptors 
along different pathways, such as those involving degra-
dation - that remain unanswered. 
supplemented with data available 
and constructed genetic mutations, 
The LDL receptor system, 
f r om n at u r a I I y 
is a model 
occurring 
system on 
which to challenge these biologically important unknowns . 
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Tran 38S-label 
2 r.: • 
8 MC Am i co n M i C r o - u I t r a f i I -
tration system 
261 
TJ 6 centrifuge, L8-70 ultra-
centrifuge, microfuge, Paragon 
Lipoprotein Reagent Kit, 
Beta scintillation Counter, 
Ready-Solv EP Scintillation 
fluid, DU-50 Spectrophotometer 
Coulter Counter, Model Zf 
Dual Temperature Slab Gel 
Dryer Model 1150 
Millipore filters 
PG D - A u t o g a mm a s c i n t i I I a t i o n 
counter 
FBE 3000 Electrophoretic 
System 
~isposable plastic pasteur 
pipettes (Style No. 202) 
